{ "protocol": "direct-confirmation-grok-v2", "model": "grok-4.5", "condition": "grok-generated", "cohortSha256": "dc965b953bb2e17b9da8e357f90d1056da41e94febfb36d8ace049ae1dbf4c3b", "samples": [ { "task": "R42581103", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIntestinal stem-cell function and regenerative capacity decline with age, compromising maintenance and repair of the intestinal epithelium. Both cell-intrinsic changes and signals from the aged systemic environment may contribute to this decline. Chronic inflammation and altered cellular metabolism are common features of ageing, but how circulating conditions are translated into functional defects in intestinal regeneration was unresolved. It was also unclear whether manipulating systemic or metabolic processes could preserve or restore aged stem-cell activity.\n\nRESEARCH QUESTION\nHow does the aged systemic environment causally impair intestinal stem-cell metabolism and regenerative function?\n\nHYPOTHESES\n[H1] Elevated circulating ceramides and related sphingolipids in aged blood directly rewire ISC lipid metabolism and inhibit regenerative proliferation. Lowering systemic ceramide burden should preserve ISC metabolic fitness with age. Mechanism: Aged plasma ceramides enter ISCs, activate stress kinases and disrupt mitochondrial membrane composition, impairing fatty-acid oxidation and the metabolic flexibility needed for injury-driven regeneration. Prediction: Ceramide-enriched young serum will phenocopy aged-serum impairment of ISC OCR and organoid regeneration; pharmacologic inhibition of ceramide synthesis or depletion of ceramides from aged plasma will specifically rescue ISC metabolism and regeneration.\n\n[H2] Pro-inflammatory cytokines enriched in aged plasma, particularly IL-6 and TNF-α, act on intestinal stem cells (ISCs) to suppress mitochondrial oxidative phosphorylation and thereby reduce regenerative capacity. Neutralizing these cytokines in aged systemic circulation should restore ISC metabolic and regenerative function. Mechanism: Aged circulating IL-6/TNF-α engage JAK/STAT and NF-κB in ISCs, downregulating mitochondrial biogenesis and electron-transport chain activity and shifting cells toward a less regenerative metabolic state. Prediction: Heterochronic exposure of young ISCs to aged serum will impair OCR and organoid-forming efficiency in an IL-6/TNF-dependent manner; cytokine blockade or genetic ablation of cognate receptors in ISCs will rescue metabolism and regeneration without requiring changes in other aged plasma components.\n\n[H3] Age-related depletion of circulating NAD+ precursors causally impairs ISC NAD+-dependent sirtuin activity and mitochondrial metabolism, limiting epithelial regeneration. Restoring systemic NAD+ bioavailability should rejuvenate aged ISC function. Mechanism: Lower circulating nicotinamide riboside/NMN reduces ISC intracellular NAD+, weakening SIRT1/SIRT3-driven mitochondrial quality control and oxidative metabolism required for proliferative regeneration. Prediction: Aged plasma will lower ISC NAD+ and OCR relative to young plasma; systemic NAD+ precursor supplementation or CD38 inhibition will restore ISC NAD+, mitochondrial function, and regenerative output even when inflammatory cytokine levels remain elevated.\n\n[H4] Decline of circulating IGF-1 and related anabolic growth factors with age fails to sustain PI3K–AKT–mTOR metabolic programming in ISCs, causing reduced biosynthetic capacity and regeneration. Restoring youthful IGF-1 signaling systemically should reverse aged ISC defects. Mechanism: Insufficient systemic IGF-1 weakens ISC PI3K–AKT–mTOR tone, lowering glycolysis-coupled biosynthesis and mitochondrial priming that support crypt regeneration after injury. Prediction: Supplementing aged hosts or aged serum with IGF-1 will restore ISC mTOR activity, metabolic flux, and regenerative organoid/crypt formation; ISC-specific Igf1r deletion will abolish rescue by young plasma while leaving cytokine- or NAD+-based rescues intact.\n\n[H5] Senescent-cell-derived SASP factors in aged circulation impose a p38 MAPK–driven metabolic brake on ISCs that limits regenerative proliferation. Clearing senescent cells or blocking key SASP mediators systemically should restore ISC metabolism and repair. Mechanism: Circulating SASP components (e.g., selected chemokines and TGF-β family members) activate p38 MAPK in ISCs, repressing mitochondrial gene programs and enforcing a quiescence-like metabolic state incompatible with robust regeneration. Prediction: Senescent-cell-conditioned medium or recombinant SASP cocktails will impair young ISC OCR and regeneration via p38; senolytic treatment of aged donors or p38 inhibition in ISCs will restore function under aged systemic exposure even if bulk IL-6/TNF or NAD+ levels are only partially corrected.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5197, "promptSha256": "2270982f8103654ab527d5d92e70fa1a819a4bcc4b6d3b95aa39ed6a01e3c14e" } ] }, { "task": "R42601407", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian ageing progressively reduces fertility, disrupts endocrine function and contributes to later-life disease risk. This decline involves losses in follicle quantity and quality as well as deterioration of the ovarian tissue environment. Although lifestyle and systemic metabolic factors have been associated with reproductive ageing, the causal mechanisms connecting them to ovarian function remain poorly understood. No approved treatment currently delays ovarian ageing or reliably extends reproductive lifespan.\n\nRESEARCH QUESTION\nThrough what molecular mechanism does physical activity delay ovarian ageing and extend reproductive lifespan?\n\nHYPOTHESES\n[H1] Physical activity raises ovarian NAD+ via increased NAMPT expression and reduced CD38 activity, activating SIRT1/SIRT3 which deacetylate histones and mitochondrial proteins to maintain oocyte genomic and metabolic integrity. This NAD+/sirtuin axis specifically extends the window of high-quality ovulation. Mechanism: Exercise → ↑ovarian NAD+ (NAMPT↑, CD38↓) → SIRT1/SIRT3 → epigenetic and mitochondrial protein deacetylation → delayed oocyte ageing. Prediction: Oocyte- or granulosa-specific Sirt1 deletion, or pharmacologic CD38 overexpression that depletes ovarian NAD+, will eliminate exercise-mediated improvements in spindle integrity and live births; NAD+ precursors will restore fertility gains in exercised CD38-high animals but not in Sirt1-null ovaries.\n\n[H2] Physical activity delays ovarian ageing by chronically activating AMPK in granulosa cells and oocytes, which increases PINK1–Parkin-dependent mitophagy and thereby preserves mitochondrial quality in the follicular pool. Sustained clearance of damaged mitochondria reduces ROS-driven oocyte aneuploidy and follicle atresia, extending reproductive lifespan. Mechanism: Exercise → ↑AMPK → PINK1/Parkin mitophagy → improved oocyte/granulosa mitochondrial fidelity → less oxidative DNA damage and delayed follicle depletion. Prediction: Ovary-specific Ampkα1/α2 knockout or granulosa-targeted Parkin deletion will abolish exercise-induced gains in oocyte mitochondrial membrane potential, mtDNA integrity, and litter size, while systemic AMPK activators in sedentary animals will partially phenocopy exercise; alternative pathways (e.g., irisin or NAD+) will remain intact yet fail to rescue fertility in these knockouts.\n\n[H3] Exercise-induced circulating irisin (cleaved FNDC5) binds ovarian αV/β5 integrin receptors, inducing PGC-1α–driven metabolic reprogramming of theca and stromal cells that lowers local inflammation and fibrosis. This remodeling preserves the follicular niche and slows age-related decline in oocyte competence. Mechanism: Muscle FNDC5/irisin → ovarian integrin signaling → PGC-1α/mitochondrial biogenesis and anti-fibrotic gene programs in stroma/theca → healthier follicular microenvironment. Prediction: Neutralizing anti-irisin antibodies or ovary-restricted Itgb5 knockout will block exercise benefits on ovarian collagen deposition, follicle survival, and blastocyst rates, whereas recombinant irisin in sedentary females will improve those endpoints without requiring AMPK activation in oocytes.\n\n[H4] Regular physical activity suppresses ovarian mTORC1 signaling through reduced insulin/IGF-1 tone and elevated AMPK, thereby enhancing macroautophagy in granulosa cells and clearing protein aggregates and damaged organelles that accumulate with age. Enhanced autophagy sustains follicle quality and slows the rate of primordial follicle activation and loss. Mechanism: Exercise → ↓mTORC1 / ↑autophagy (ULK1, LC3-II flux) in granulosa cells → proteostatic and organelle quality control → slower follicle exhaustion. Prediction: Granulosa-specific Rptor (mTORC1) constitutive activation or Atg7 knockout will prevent exercise from improving oocyte competence and follicle counts, while rapamycin in sedentary mice will mimic exercise on autophagy markers and fertility; irisin or NAD+ interventions will not restore LC3 flux or fertility in Atg7-null ovaries.\n\n[H5] Physical activity dampens NF-κB–driven sterile inflammation and SASP in ovarian immune and stromal cells via myokine- and cortisol-linked suppression of NLRP3 inflammasome activity, reducing IL-1β/IL-6–mediated follicle damage. Lower chronic ovarian inflammation preserves the primordial pool and endocrine output into later reproductive age. Mechanism: Exercise → ↓NLRP3/NF-κB and SASP in ovarian stroma/immune cells → less cytokine-induced follicle atresia and stromal fibrosis → extended reproductive lifespan. Prediction: Ovary-targeted Nlrp3 gain-of-function or chronic intraovarian IL-1β will abolish exercise benefits on follicle reserve and hormone profiles despite intact AMPK/NAD+/autophagy responses; NLRP3 inhibitors in sedentary animals will partially recapitulate exercise fertility gains without raising ovarian NAD+ or irisin signaling.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5518, "promptSha256": "ca71cd6c68a036ee7c61576eda8624786cdd8de9f856329d253760ec4f23235d" } ] }, { "task": "R42605193", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence increases with age and can disrupt tissue function through persistent changes in cell state and signaling. Metabolic dysfunction and chronic inflammation are closely associated with this process and with broader age-related deterioration. Circulating factors can coordinate physiological changes across organs, but it remains unclear which factors actively cause senescence rather than merely correlate with ageing. Identifying the responsible signals and their intracellular mechanisms could reveal targets for extending healthspan.\n\nRESEARCH QUESTION\nWhich circulating regulator causally promotes cellular senescence and organismal ageing, and through what intracellular signaling mechanism does it act?\n\nHYPOTHESES\n[H1] Chronically elevated circulating insulin and IGF-1 in mid-to-late life causally accelerate cellular senescence and organismal ageing through nutrient-sensing pathways. Reducing late-life insulin/IGF-1 tone will delay senescence accrual more effectively than anti-inflammatory interventions alone. Mechanism: Circulating insulin/IGF-1 activates IR/IGF1R → PI3K–AKT–mTORC1, suppressing FOXO and autophagy, increasing mitochondrial ROS and DNA damage, and thereby inducing p53/p21- and p16-dependent senescence across insulin-responsive tissues. Prediction: Late-life insulin receptor or mTORC1 attenuation will reduce senescence markers and extend healthspan even when circulating TGF-β1 and IL-6 remain high; raising insulin/IGF-1 in calorically restricted or young animals will restore a senescence signature that depends on mTORC1 and is insensitive to Smad or STAT3 blockade.\n\n[H2] Circulating extracellular vesicles from aged hematopoietic and stromal cells deliver senescence-inducing miRNAs (notably miR-34a family members) that causally propagate systemic cellular senescence and organismal ageing. Depleting these EV cargoes will interrupt inter-organ spread of senescence. Mechanism: Aged EVs are taken up by distant cells, releasing miR-34a that represses SIRT1 and other longevity effectors, raising acetylated p53 activity, lowering autophagy and mitochondrial quality control, and locking cells into a senescent state that itself sheds more pro-senescent EVs. Prediction: Clearance or cargo-editing of aged circulating EVs (or antagonism of EV miR-34a) will reduce multi-tissue senescence and improve healthspan even when bulk plasma TGF-β1, IL-6, insulin, and ceramides are held constant; transferring aged EVs into young recipients will induce SIRT1-dependent senescence that free TGF-β1/IL-6 protein transfer does not fully recapitulate.\n\n[H3] Persistently elevated circulating IL-6 causally promotes systemic cellular senescence and organismal ageing independently of local SASP niches. Age-associated IL-6 is necessary and sufficient to expand the senescent cell burden across metabolically active tissues. Mechanism: Circulating IL-6 engages IL-6R/gp130, drives chronic JAK1/2–STAT3 signaling that induces CDKN1A and SASP genes, and stabilizes senescence via autocrine/paracrine reinforcement and mitochondrial ROS amplification. Prediction: Pharmacologic JAK inhibition or IL-6/IL-6R blockade will lower multi-organ senescence and improve frailty indices in aged mice even when TGF-β1 and IGF-1 levels are clamped; young mice given chronic IL-6 infusion will acquire a STAT3-dependent senescence signature that is blocked by STAT3 deletion but not by Smad3 deletion.\n\n[H4] Age-elevated circulating TGF-β1 is a causal driver of multi-tissue cellular senescence and organismal ageing. Chronic exposure of young tissues to aged plasma levels of TGF-β1 is sufficient to induce p16INK4a/p21-positive senescence and accelerate functional decline. Mechanism: Circulating TGF-β1 binds TGFBR1/2, activates Smad2/3–Smad4 complexes that transcriptionally induce CDKN2A/CDKN1A and remodel chromatin toward a stable senescence program, while also reinforcing SASP output that further elevates systemic TGF-β1. Prediction: Neutralizing circulating TGF-β1 (or tissue-specific TGFBR1 deletion) in aged animals will reduce senescence markers across distant organs and improve healthspan metrics more than neutralizing IL-6 or insulin signaling alone; conversely, sustained infusion of TGF-β1 into young animals will recapitulate the aged senescence signature even when inflammatory cytokines remain low.\n\n[H5] Age-increased circulating ceramides are causal pro-senescence factors linking metabolic dysfunction to organismal ageing. Lowering plasma ceramides will reduce tissue senescence and improve metabolic and inflammatory ageing phenotypes. Mechanism: Circulating long-chain ceramides enter cells and activate PP2A and atypical PKC while impairing mitochondrial electron transport, elevating ROS and inflammasome activity that converge on p53/p21 and NF-κB-driven senescence programs. Prediction: Genetic or pharmacologic reduction of circulating ceramides (e.g., serine palmitoyltransferase inhibition or ceramidase elevation) will decrease senescence burden and improve glucose tolerance in aged animals without requiring reductions in TGF-β1 or IL-6; ceramide infusion into young animals will induce senescence that is rescued by mitochondrial antioxidants or PP2A inhibition but not by JAK or TGFBR blockade alone.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5903, "promptSha256": "d328672c177365c9f1082c357526c1234ab093f62a360bea142b49a4889786f7" } ] }, { "task": "R42608398", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIdiopathic pulmonary fibrosis is a progressive, age-associated disorder characterized by recurring tissue injury and excessive fibrotic remodeling. Abnormal cell-fate programs, including apoptosis, senescence, and phenotypic transitions, are thought to contribute to disease progression. Changes in the lung microbiota have also been associated with disease severity, but association alone has not established a direct pathogenic mechanism. It remained unclear whether a microbiota-derived product could independently initiate the cellular dysfunction and progressive fibrosis observed in this disease.\n\nRESEARCH QUESTION\nCan a microbiota-derived factor directly cause the cellular dysfunction and progressive tissue remodeling characteristic of idiopathic pulmonary fibrosis, and if so, through what mechanism?\n\nHYPOTHESES\n[H1] A microbiota-derived metabolite accumulates in the aging lung and directly induces irreversible senescence in alveolar type II epithelial cells, whose senescence-associated secretory phenotype then drives progressive fibrotic remodeling without requiring ongoing microbial colonization. Mechanism: The metabolite activates a DNA-damage or mitochondrial-stress sensor that stabilizes p53 and induces p21-dependent permanent cell-cycle arrest; senescent AT2 cells secrete TGF-β, IL-6, and matrix-remodeling factors that activate resident fibroblasts into collagen-depositing myofibroblasts. Prediction: Sterile administration of the purified metabolite alone will increase lung p21+/SA-β-gal+ AT2 cells and progressive collagen deposition in germ-free or antibiotic-cleared mice, whereas genetic ablation of p21 in AT2 cells will block fibrosis despite continued metabolite exposure.\n\n[H2] A microbiota-derived pathogen-associated molecular pattern (e.g., LPS or analogous ligand) engages TLR4 on alveolar epithelial cells and drives epithelial–mesenchymal transition, generating a stable population of matrix-producing cells that sustain progressive tissue remodeling. Mechanism: TLR4–MyD88/NF-κB and concurrent TGF-β crosstalk repress epithelial junctions (E-cadherin) and induce Snail/Slug and mesenchymal genes (vimentin, α-SMA, collagens), converting AT2 cells into fibroblast-like effectors of fibrosis. Prediction: The purified ligand will induce EMT marker switches and fibrosis in wild-type lungs but will fail to do so in epithelial-specific Tlr4 knockout or MyD88-deficient mice, and EMT inhibitors will block remodeling even when senescence and apoptosis pathways remain intact.\n\n[H3] A microbiota-derived toxin or pore-forming factor directly triggers apoptosis of alveolar epithelial cells, releasing DAMPs that chronically activate TGF-β signaling and thereby initiate progressive fibrosis characteristic of IPF. Mechanism: The toxin permeabilizes epithelial membranes, causing caspase-dependent apoptosis; released HMGB1, ATP, and oxidized phospholipids engage receptors on macrophages and fibroblasts that amplify latent TGF-β activation and Smad-dependent myofibroblast differentiation. Prediction: In vivo delivery of the purified toxin will produce epithelial apoptosis followed by fibrosis that is prevented by pan-caspase inhibition or by neutralizing antibodies to key DAMPs, while senescence markers remain largely unchanged relative to alternative hypotheses.\n\n[H4] A microbiota-derived metabolite impairs mitochondrial electron transport in alveolar epithelial cells, elevating ROS that both damage DNA and activate redox-sensitive fibrotic transcription programs, thereby linking microbiota products to the cellular dysfunction and progressive fibrosis of IPF. Mechanism: The metabolite inhibits a respiratory-chain complex, raising mitochondrial ROS; ROS oxidize mtDNA and nuclear DNA, activate NRF2 and HIF pathways, and stabilize hypoxia- and stress-responsive drivers of fibroblast activation and collagen transcription. Prediction: Purified metabolite will increase epithelial mitochondrial ROS, mtDNA damage, and fibrosis; mitochondrially targeted antioxidants or epithelial overexpression of catalase/SOD2 will prevent fibrosis despite metabolite presence, distinguishing this from senescence- or TLR-primary models.\n\n[H5] A microbiota-derived protease independently initiates progressive fibrotic remodeling by cleaving basement-membrane and interstitial matrix proteins into bioactive fragments that activate fibroblasts and disrupt epithelial–matrix adhesion, without requiring live microbes after the initial enzymatic insult. Mechanism: The protease generates cryptic ECM peptides (e.g., from laminin, collagen IV, or elastin) that ligate integrin and EGFR pathways on fibroblasts, inducing myofibroblast differentiation and further protease/MMP expression in a self-amplifying remodeling loop. Prediction: A catalytically inactive point-mutant protease will not cause fibrosis, whereas the active enzyme will; fibrosis will persist after clearance of the enzyme if ECM fragments remain, and integrin/EGFR blockade will suppress remodeling more effectively than anti-senescence or anti-TLR interventions.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5705, "promptSha256": "cb6bc18c86d2052f9cd6a18ae3851c1fe26320bae04becf546dd8d972a3186b0" } ] }, { "task": "R42627902", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 1 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing alters blood-cell production, commonly shifting lineage output and reducing regenerative balance. These changes can contribute to anemia, impaired immunity, and abnormal clotting in older organisms. Age-related transcriptional and epigenetic remodeling has been implicated, but the regulators that causally connect altered gene programs to lineage imbalance remain incompletely understood. Identifying such regulators could reveal ways to restore healthier blood production during ageing.\n\nRESEARCH QUESTION\nWhich regulatory mechanism drives the age-associated shift away from erythroid differentiation and toward platelet-producing lineage programs?\n\nHYPOTHESES\n[H1] Age-related decline in GATA1 dosage or activity within MEPs tips the GATA1–FLI1 cross-antagonism toward FLI1, causally diverting differentiation from erythroid to megakaryocytic programs. Mechanism: Reduced GATA1 transcription, translation, or post-translational activation with age weakens repression of FLI1 and megakaryocyte genes, allowing FLI1 to dominate the mutual antagonism that normally partitions MEP fate. Prediction: Restoring GATA1 levels or activity in aged MEPs will reinstate erythroid differentiation and suppress megakaryocyte markers, whereas heterozygous Gata1 reduction in young MEPs will phenocopy the aged erythroid-to-platelet shift.\n\n[H2] Age-associated epigenetic remodeling at key lineage loci locks MEPs into a megakaryocyte-primed chromatin state and closes erythroid enhancers. Loss of erythroid-permissive chromatin accessibility is the primary causal driver of reduced erythropoiesis with age. Mechanism: Progressive DNA methylation and H3K27me3 accumulation at GATA1/KLF1-bound erythroid enhancers, together with H3K4me1/H3K27ac gain at FLI1/RUNX1 megakaryocytic enhancers, stably biases differentiation toward platelets. Prediction: Single-cell ATAC-seq and histone profiling will show age-specific closing of erythroid enhancers in MEPs; CRISPR-mediated reopening or demethylation of those enhancers in aged progenitors will rescue erythroid differentiation without changing cytokine levels.\n\n[H3] Aging selectively expands a pre-existing platelet-biased HSC subset at the expense of balanced and erythroid-biased HSCs, so the lineage shift is driven by clonal composition change rather than cell-intrinsic reprogramming of every progenitor. Mechanism: Platelet-biased HSCs (often Vwf-high) have a selective survival or self-renewal advantage under aged bone-marrow niche and inflammatory conditions, progressively dominating the stem-cell pool and feeding megakaryopoiesis. Prediction: Lineage tracing and limiting-dilution transplants will show enrichment of platelet-biased HSC clones with age; transplanting purified aged platelet-biased HSCs into young hosts will transfer the skew, while depleting that subset in aged mice will restore erythroid balance.\n\n[H4] Mitochondrial dysfunction and elevated ROS in aged hematopoietic progenitors activate stress-responsive pathways that preferentially favor megakaryocyte differentiation and impair erythroid maturation. Mechanism: ROS and impaired oxidative phosphorylation stabilize HIF-1α and stress kinases that upregulate megakaryocytic programs and destabilize erythroid mitochondrial and heme-biosynthetic gene expression required for effective erythropoiesis. Prediction: Mitochondria-targeted antioxidants or genetic rescue of mitochondrial function in aged progenitors will increase erythroid output and reduce platelet bias; inducing comparable mitochondrial stress in young progenitors will reproduce the aged lineage skew.\n\n[H5] Age-driven chronic inflammatory signaling, especially IL-1 and TNF, reprograms megakaryocyte-erythroid progenitors so that megakaryocytic gene programs dominate and erythroid commitment is suppressed. This inflammatory milieu is both necessary and sufficient for the age-associated erythroid-to-platelet lineage shift. Mechanism: Elevated IL-1/TNF activate NF-κB and MAPK cascades that induce megakaryocyte-biased transcription factors (e.g., FLI1, RUNX1) while repressing GATA1-dependent erythroid programs in MEPs and platelet-biased HSCs. Prediction: Neutralizing IL-1 and/or TNF in aged mice (or blocking their receptors on hematopoietic progenitors) will restore erythroid output and reduce megakaryocyte/platelet bias, whereas exposing young progenitors to the same cytokines will recapitulate the aged lineage skew.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5058, "promptSha256": "8eec3af5c6d4ff91212d9f8e2e162a885aad135c63f95c0fd07358de4b71c400" } ] }, { "task": "R42630044", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nMechanical loading normally stimulates bone formation and helps maintain skeletal strength. This anabolic response becomes weaker with age, contributing to cortical bone loss and osteoporosis risk. Bone cells detect physical forces and translate them into signals that regulate the balance between bone formation and resorption. The molecular defect responsible for diminished mechanosensitivity in aged bone, and whether it can be overcome, remained unclear.\n\nRESEARCH QUESTION\nWhat mechanism limits the anabolic response of aged bone to mechanical loading, and can targeted stimulation restore this response?\n\nHYPOTHESES\n[H1] Aging impairs load-induced suppression of osteocyte sclerostin, so Wnt/β-catenin remains inhibited and periosteal bone formation fails to increase after mechanical loading. Pharmacologic or genetic sclerostin blockade will restore the anabolic loading response in aged bone. Mechanism: Persistent SOST/sclerostin expression after strain keeps LRP5/6-Wnt signaling repressed in osteoblasts and lining cells, blocking load-coupled matrix formation. Prediction: Aged loaded bone will show high sclerostin and low β-catenin target-gene induction versus young loaded bone; anti-sclerostin treatment plus loading will recover periosteal mineral apposition to near-young levels, whereas loading alone will not.\n\n[H2] Aging disrupts osteocyte gap-junction and hemichannel communication (notably Cx43), preventing propagation of load signals through the osteocyte network and thereby limiting coordinated anabolic output. Restoring Cx43 function will recover the loading response. Mechanism: Impaired Cx43-mediated intercellular coupling and PGE2/ATP release truncates network-level mechanotransmission from strained to effector cells. Prediction: Aged bone will show reduced load-triggered PGE2 release and dye coupling; Cx43 rescue or hemichannel opening will restore formation after loading, while Cx43 disruption in young bone will abolish the anabolic response.\n\n[H3] Age-related decline in osteocyte Piezo1 (or associated ion-channel/Ca2+ entry) blunts early mechanotransduction, so downstream anabolic gene programs are not activated by physiological strain. Agonism or overexpression of Piezo1 will restore loading responsiveness in aged bone. Mechanism: Reduced Piezo1-dependent calcium influx and YAP/TAZ or NFAT activation in osteocytes cuts the initiation of load-adaptive transcriptional responses. Prediction: Aged osteocytes will show weaker load-evoked Ca2+ transients and Piezo1-dependent gene induction; Piezo1 activation will rescue formation indices after loading, while Piezo1 loss in young bone will phenocopy the aged loading defect.\n\n[H4] Excess or mis-timed TGF-β signaling in aged bone restrains osteoblast recruitment and matrix deposition after mechanical loading. Transient TGF-β pathway inhibition concurrent with loading will restore anabolic responsiveness. Mechanism: Elevated TGF-β/Smad activity keeps progenitors in a non-mineralizing state and antagonizes Wnt and other load-activated anabolic pathways at the periosteum. Prediction: Aged loaded periosteum will show higher p-Smad2/3 and lower osteoblast differentiation markers than young; TGF-β blockade plus loading will increase mineralizing surface more than loading or blockade alone, without fully mimicking young bone if sclerostin remains high.\n\n[H5] Accumulated senescent osteocytes and their SASP actively suppress the anabolic response to loading in aged cortex. Clearing senescent cells or neutralizing key SASP mediators will reinstate load-induced bone formation. Mechanism: SASP factors (e.g., inflammatory cytokines, matrix-remodeling proteases) desensitize neighboring osteocytes/osteoblasts to strain and favor resorption over formation. Prediction: Senescent-cell burden will correlate inversely with loading gain; senolytic treatment will restore periosteal bone formation after loading in aged animals without equivalently boosting unloaded controls.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4612, "promptSha256": "311abfc320fefd7252f7b7a160b14b17ff360710405d6c815d292e4296d87b55" } ] }, { "task": "R42639736", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nPersistent DNA damage responses contribute to cellular senescence and age-related loss of tissue function. Disturbances in intracellular homeostasis can promote genomic stress through several mechanisms, including metabolic dysfunction and impaired cell-cycle control. Communication between organelles is increasingly recognized as an important regulator of stress responses during ageing. However, the causal mechanisms connecting disrupted cellular homeostasis to DNA damage in senescent cells remain incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism links disrupted intracellular homeostasis to DNA damage and senescence?\n\nHYPOTHESES\n[H1] Impaired lysosomal acidification secondary to metabolic imbalance causes undegraded cytosolic DNA and damaged organelles to accumulate, chronically stimulating cGAS–STING and thereby coupling homeostasis failure to senescence. Mechanism: Defective V-ATPase activity and reduced TFEB-driven lysosomal biogenesis allow mtDNA and nuclear fragments to leak into the cytosol, activating type-I IFN and SASP programs that reinforce growth arrest. Prediction: Pharmacologic re-acidification of lysosomes or STING inhibition will lower cytosolic DNA sensors and senescence markers even when mitochondrial membrane potential remains depressed.\n\n[H2] NAD+ depletion from disrupted metabolic homeostasis inhibits SIRT1/PARP1-coordinated DNA repair and chromatin maintenance, converting transient damage into persistent lesions that drive senescence. Mechanism: Falling NAD+ lowers SIRT1-mediated deacetylation of repair factors and PARP1 substrate availability, delaying DSB resolution and allowing unrepaired foci to accumulate at lamin-associated domains. Prediction: NAD+ repletion will accelerate clearance of 53BP1 foci and reduce senescence entry specifically in NAD+-starved cells, whereas boosting antioxidant capacity alone will not restore repair kinetics.\n\n[H3] Disruption of ER–mitochondria contact sites impairs Ca2+ transfer and elevates mitochondrial ROS, which oxidizes dNTPs and nuclear DNA, activating a persistent DDR that locks cells into senescence. Mechanism: Loss of VDAC1–IP3R–GRP75 tethering reduces mitochondrial Ca2+ uptake, collapses OXPHOS efficiency, and generates superoxide that damages DNA and sustains ATM/p53 signaling. Prediction: Restoring MERCS density or buffering mitochondrial ROS will reduce γH2AX foci and SA-β-gal positivity without correcting unrelated ER stress markers, distinguishing this from pure proteostasis failure.\n\n[H4] Loss of nuclear–cytoplasmic transport homeostasis mislocalizes DNA repair proteins and cell-cycle regulators, causing replication stress and unrepaired damage that precipitates senescence. Mechanism: Altered Ran gradient and nuclear pore complex composition trap key factors (e.g., 53BP1, RPA, CDK inhibitors) in the wrong compartment, producing fork collapse and chronic ATR/ATM activation. Prediction: Forced nuclear retention of repair factors or restoration of RanGTP levels will reduce replication-stress markers and senescence without normalizing mitochondrial ROS, separating transport failure from redox damage.\n\n[H5] Disrupted intracellular ion and pH homeostasis activates Ca2+/calpain and acidic-stress pathways that cleave or inactivate DNA-damage checkpoint adapters, allowing lesions to persist and push cells into senescence. Mechanism: Cytosolic Ca2+ overload and cytoplasmic acidification trigger calpain-mediated cleavage of key DDR adapters and histone modifiers, weakening checkpoint fidelity and promoting irreversible arrest via p16/p21. Prediction: Calpain inhibition or clamped intracellular pH will preserve adapter integrity, reduce persistent DNA lesions, and lower senescence incidence under the same homeostatic insults that otherwise elevate ROS or mtDNA release.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4453, "promptSha256": "05db52c05df95f9c1d2f884cb737b53237c88f45e361dec4e092c137084aa12d" } ] }, { "task": "R42642518", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nBiological ageing progresses at different rates among individuals and is associated with broad changes in physiology and chronic-disease risk. Women and men can follow different ageing trajectories, particularly during midlife, but the biological basis and functional significance of these differences remain incompletely understood. Large clinical datasets can identify circulating features that change with age, although association alone cannot establish whether such features actively promote ageing. Experimental validation is therefore needed to distinguish causal contributors from passive biomarkers.\n\nRESEARCH QUESTION\nWhich circulating factors that accumulate with age actively induce ageing-related cellular phenotypes, and is their resulting biological burden reversible?\n\nHYPOTHESES\n[H1] Circulating advanced glycation end products (AGEs) that rise with chronological age act through RAGE to induce mitochondrial dysfunction, oxidative stress, and senescence-like phenotypes in vascular and stromal cells. Reducing AGE burden or blocking RAGE will reverse these cellular phenotypes even when chronological age is unchanged. Mechanism: AGE–RAGE ligation activates NADPH oxidase and NF-κB, elevating ROS, impairing mitochondrial respiration, and locking cells into a damaged, pro-fibrotic state. Prediction: Aged serum will induce ROS, mtDNA damage, and senescence markers in young endothelial cells in a RAGE-dependent manner; RAGE antagonists or AGE-cleaving interventions will abolish transfer of the phenotype while leaving other aged-plasma factors intact.\n\n[H2] Circulating GDF15 and related TGF-β superfamily ligands that accumulate with age causally impose a catabolic, mitochondrial-stress, and fibrotic cellular phenotype that contributes to organismal ageing burden. Pharmacologic antagonism of GDF15/GFRAL or TGF-β signaling will reverse these phenotypes in cells and tissues previously exposed to aged plasma. Mechanism: Chronic GDF15–GFRAL and TGF-β–SMAD signaling reprograms metabolism toward energy conservation and fibrosis, suppressing regenerative stem-cell function and reinforcing a systemic ageing milieu. Prediction: Neutralizing GDF15 or blocking GFRAL/TGF-β receptors will prevent aged-plasma induction of mitochondrial stress transcripts, collagen programs, and reduced colony-forming capacity in young progenitors, distinguishing this axis from cytokine- or AGE-driven alternatives.\n\n[H3] Sex-dimorphic midlife shifts in circulating sex steroids and gonadotropins (declining estradiol/testosterone with rising FSH/LH) causally accelerate tissue ageing phenotypes differently in women and men. Restoring midlife hormonal set-points will reverse sex-specific cellular ageing signatures induced by aged plasma. Mechanism: Loss of estrogen receptor and androgen receptor tone plus elevated FSH signaling alters mitochondrial biogenesis, DNA repair, and inflammatory set-points in a sex-dependent manner across bone, adipose, and vascular beds. Prediction: Aged female plasma will more strongly induce senescence and inflammatory programs in estrogen-responsive cells than age-matched male plasma; estradiol repletion or FSH neutralization will selectively reverse female-plasma effects without equivalent rescue of male-plasma effects.\n\n[H4] Age-accumulated circulating SASP cytokines (IL-6, IL-1β, TNF-α, and CXCL chemokines) causally drive secondary senescence and inflammatory gene programs in otherwise young cells. Neutralizing or clearing these factors in midlife will reverse induction of senescence markers and restore proliferative capacity in exposed tissues. Mechanism: Paracrine and endocrine SASP signaling engages NF-κB and JAK/STAT pathways in distant cells, spreading a senescence-like state and amplifying inflammaging. Prediction: Exposing young primary cells or young mice to aged plasma depleted of these SASP cytokines (or treated with neutralizing antibodies) will fail to induce p16/p21, SA-β-gal, and SASP gene expression relative to intact aged plasma, whereas re-adding the purified cytokine mix will restore the phenotype.\n\n[H5] Age-enriched circulating extracellular vesicles carrying pro-senescent microRNAs and damaged mitochondrial cargo actively transfer ageing phenotypes to young recipient cells. Blocking EV uptake or depleting aged EVs from plasma will prevent and reverse EV-driven cellular ageing. Mechanism: Aged EVs deliver miR-34a, miR-21, and oxidized mtDNA that repress SIRT1/PGC-1α and activate cGAS–STING, imposing a senescence-associated transcriptional state on recipient cells. Prediction: EV-depleted aged plasma will lose most of its capacity to induce senescence markers in young fibroblasts, whereas purified aged EVs alone will recapitulate the phenotype; inhibiting EV endocytosis will block transfer.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5424, "promptSha256": "136d4a9ef501c73a3dd2815fda30ec97fc356b2d3e29d7612e4567987891cd0c" } ] }, { "task": "R42642521", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nThe gut microbiome changes with age and is associated with immune dysregulation, chronic low-grade inflammation and functional decline. Microbiome composition also varies substantially among individuals and populations, making it difficult to distinguish consequential changes from incidental biomarkers of ageing. Animal studies suggest that manipulating gut microbial communities can influence age-related physiology, but the responsible organisms and molecular mediators have remained poorly defined. Establishing causality requires showing that a defined microbial intervention improves ageing phenotypes and identifying a functional mechanism that reproduces those effects.\n\nRESEARCH QUESTION\nCan a specific age-depleted gut microbe and one of its metabolites causally suppress inflammaging and improve healthspan in old animals?\n\nHYPOTHESES\n[H1] An age-depleted tryptophan-metabolizing microbe restores production of indole derivatives (e.g., indole-3-acetic acid or indole-3-aldehyde) that activate aryl hydrocarbon receptor (AhR) in gut epithelium and innate lymphoid cells, thereby restraining inflammaging and improving healthspan in old animals. The purified indole metabolite is necessary and sufficient. Mechanism: Microbial indoles ligate AhR, inducing IL-22 and antimicrobial/barrier programs and limiting chronic type-1 inflammatory signaling that drives inflammaging. Prediction: Metabolite or microbe treatment raises AhR-target gene expression (Cyp1a1, Il22), lowers systemic inflammatory markers, and improves healthspan; epithelial or ILC AhR deletion, or an AhR antagonist, blocks benefit while leaving unrelated SCFA pathways intact.\n\n[H2] Loss of an age-depleted bile-acid–transforming bacterium depletes secondary bile acids (e.g., isoalloLCA or DCA species) that agonize TGR5/FXR; restoring the microbe or the secondary bile acid metabolite suppresses inflammaging and improves healthspan in aged hosts. Mechanism: Secondary bile acids activate TGR5 on myeloid cells and FXR in epithelium/liver, reducing NLRP3 inflammasome activity and chronic cytokine output while improving metabolic resilience. Prediction: Treatment restores the secondary bile-acid pool, lowers inflammasome-dependent cytokines (IL-1β/IL-18), and improves frailty and metabolic healthspan measures; TGR5 or FXR knockout, or a non-agonist bile-acid analog, abolishes the phenotype while barrier and butyrate readouts remain unchanged.\n\n[H3] An age-depleted polyamine-producing gut microbe restores putrescine/spermidine availability; exogenous spermidine alone suppresses inflammaging and extends healthspan in old animals by inducing autophagy in immune and tissue cells. Mechanism: Microbial polyamines promote autophagic clearance of inflammasome components and damaged organelles, lowering chronic inflammatory tone and supporting tissue maintenance. Prediction: Microbe or spermidine treatment increases tissue autophagy flux (LC3-II, p62 turnover), reduces inflammaging cytokines, and improves healthspan; autophagy-deficient hosts (e.g., Atg5/Atg7 conditional knockouts) lose the benefit despite intact barrier and AhR pathways, isolating autophagy as the causal effector.\n\n[H4] An age-depleted butyrate-producing gut bacterium restores colonic butyrate levels in old hosts; exogenous butyrate alone recapitulates suppression of inflammaging and improved healthspan. Butyrate acts as an HDAC inhibitor that expands regulatory T cells and dampens myeloid inflammatory tone. Mechanism: Butyrate inhibits histone deacetylases in intestinal and circulating immune cells, increasing Foxp3+ Treg frequency and reducing pro-inflammatory cytokine transcription. Prediction: Butyrate (or the producer) elevates colonic/serum butyrate, increases Treg proportions, lowers inflammaging cytokines, and improves healthspan metrics; an HDAC-resistant butyrate analog or HDAC-knockout immune cells abolish the effect, separating HDAC-dependent from receptor-only SCFA signaling.\n\n[H5] Colonization of aged mice with an age-depleted mucin-specialist bacterium (e.g., Akkermansia muciniphila) restores mucus-layer integrity and reduces systemic LPS leakage, thereby suppressing inflammaging and extending healthspan. A purified outer-membrane protein or vesicle component from that microbe is sufficient to reproduce the benefit without live colonization. Mechanism: Microbe-driven mucin turnover and barrier reinforcement limit translocation of microbial products that chronically stimulate TLR4/NF-κB; the metabolite/protein signal reinforces tight-junction and goblet-cell programs. Prediction: Old colonized or protein-treated animals show lower serum LPS/endotoxin activity, reduced circulating IL-6/TNF-α, improved gut permeability assays, and better frailty/physical-performance scores relative to vehicle; germ-free or barrier-disrupted controls lose the benefit, distinguishing barrier repair from generic immune stimulation.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5555, "promptSha256": "d18923f05047ab26ce221f2d9326ee1569cbc286e0396b06bf3e1bca6d3f1959" } ] }, { "task": "R42647119", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 1 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular reprogramming offers a potential way to replace neurons lost through injury or neurodegenerative disease. Most regenerative strategies have been developed and validated in young experimental animals, although advanced age is the principal risk factor for many neurological disorders. Aging can alter both the plasticity of resident cells and the tissue response to injury. It was therefore unclear whether neuronal reprogramming would remain effective in aged neural tissue and which age-associated processes might limit it.\n\nRESEARCH QUESTION\nHow does aging affect injury-induced neuronal reprogramming in the retina, and what mechanisms account for any age-related loss of regenerative capacity?\n\nHYPOTHESES\n[H1] Aging reduces injury-induced neuronal reprogramming in the retina because chronic low-grade inflammation progressively impairs Müller glial competence to activate neurogenic programs after injury. Suppressing age-associated inflammatory signaling in old retina should restore reprogramming efficiency toward youthful levels. Mechanism: Persistent innate immune activation (inflammaging) elevates NF-κB/STAT-driven glial reactivity that antagonizes Ascl1 and related neurogenic gene networks required for Müller glia-to-neuron conversion after injury. Prediction: Aged retinas will show higher baseline and post-injury inflammatory cytokine signatures coincident with fewer reprogrammed neurons; neutralizing key inflammatory mediators (e.g., IL-6/TNF or microglial depletion) will increase reprogrammed neuron yield in old but not young animals, whereas adding the same cytokines to young tissue will reduce yield.\n\n[H2] Aging limits retinal neuronal reprogramming by locking Müller glia into a more rigid epigenetic state that resists injury-triggered fate conversion. Restoring youthful chromatin accessibility at neurogenic loci in aged Müller glia will rescue reprogramming. Mechanism: Age-dependent accumulation of repressive chromatin marks and reduced pioneer-factor accessibility at Ascl1 targets and neuronal gene loci prevents injury cues from opening the neurogenic program in Müller glia. Prediction: Aged Müller glia will exhibit reduced chromatin accessibility and higher H3K27me3/DNA methylation at neurogenic loci after injury relative to young glia; transient epigenetic remodeling (e.g., HDAC or EZH2 inhibition timed with injury) will preferentially increase reprogrammed neurons in aged retina and reopen accessibility at those loci.\n\n[H3] Aging impairs injury-induced neuronal reprogramming because mitochondrial and NAD+-linked metabolic decline in Müller glia cannot meet the bioenergetic demands of fate conversion. Boosting NAD+ or mitochondrial function in aged Müller glia will rescue reprogramming. Mechanism: Age-related NAD+ depletion and mitochondrial dysfunction reduce ATP and redox capacity needed for chromatin remodeling, proliferation, and neuronal differentiation after injury. Prediction: Aged Müller glia will show lower NAD+/ATP and impaired oxidative metabolism after injury alongside fewer reprogrammed neurons; NAD+ precursors or mitochondrial enhancers will raise reprogramming efficiency in old retina and normalize metabolic signatures, while metabolic inhibition in young retina will phenocopy the age-related deficit.\n\n[H4] Aging diminishes retinal neuronal reprogramming by altering microglia–Müller glia crosstalk so that injury no longer delivers the transient, correctly timed trophic and cytokine signals that license neurogenic conversion. Reinstating a youthful microglial injury response in aged retina will restore reprogramming. Mechanism: Age-reprogrammed microglia mount a prolonged, less resolved inflammatory response and underproduce pro-neurogenic injury signals (e.g., specific growth factors or acute cytokine pulses) that Müller glia require to enter a neurogenic state. Prediction: Transcriptomic and cytokine profiling will show that aged microglia after injury lack youthful acute pro-reprogramming signals and sustain unresolved inflammation; replacing aged microglia with young microglia (or transferring young microglial secretome) will increase reprogrammed neuron numbers in old hosts, whereas aged microglia in young hosts will suppress reprogramming.\n\n[H5] Age-related accumulation of senescent cells in the retina creates a SASP milieu that blocks survival or maturation of newly reprogrammed neurons after injury. Clearing senescent cells in aged animals will restore regenerative output. Mechanism: Senescent Müller glia, RPE, or immune cells secrete SASP factors that enforce cell-cycle arrest, promote gliosis, and create a non-permissive niche for newborn neuron integration. Prediction: Aged injured retinas will show elevated senescence markers (p16Ink4a, SA-β-gal, SASP) correlating with failed reprogramming; senolytic treatment before or at injury will increase numbers of mature reprogrammed neurons in old retina while having little effect in young retina lacking senescence burden.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5632, "promptSha256": "7b4b19453734f8f15765d49e4b662bcf6af062813d6160dfdc4e2a96e964c595" } ] }, { "task": "R42647635", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by progressive molecular damage, impaired tissue maintenance, and declining physiological function. Genetic studies in laboratory organisms have identified processes that can influence lifespan and cellular senescence. However, findings from small-animal models do not always translate directly to humans because of major differences in physiology, metabolism, and lifespan. A large-mammal model is therefore valuable for testing whether a proposed source of molecular damage can directly produce systemic ageing phenotypes.\n\nRESEARCH QUESTION\nDoes experimentally increasing somatic mitochondrial DNA mutation burden cause premature ageing and shortened lifespan in a large mammal?\n\nHYPOTHESES\n[H1] Experimentally elevating the somatic mtDNA mutation rate in a large mammal will accelerate multi-tissue functional decline and shorten median and maximum lifespan relative to isogenic controls with a wild-type mtDNA polymerase proofreading capacity. Mechanism: Proofreading-deficient mtDNA polymerase increases the load of random somatic mtDNA mutations, impairing oxidative phosphorylation, elevating ROS and bioenergetic failure in post-mitotic and stem-cell niches, and thereby driving systemic ageing phenotypes. Prediction: Mutator animals will show dose-dependent earlier onset of sarcopenia, anemia, fertility loss, and cardiac dysfunction together with reduced lifespan, with these traits correlating quantitatively with measured tissue mtDNA mutation burden and respiratory-chain deficiency.\n\n[H2] Experimentally increased somatic mtDNA mutation burden will not produce a true premature-ageing syndrome in a large mammal if nuclear DNA integrity, proteostasis, and endocrine ageing clocks remain intact; any lifespan reduction will reflect organ-specific mitochondrial disease rather than accelerated systemic ageing. Mechanism: Large-mammal ageing is dominated by nuclear genomic instability, epigenetic drift, and systemic signaling; mtDNA mutations primarily cause tissue-restricted energetic disease (e.g., myopathy, neuropathy) without advancing organism-wide ageing biomarkers. Prediction: Mutator animals will develop mitochondrial myopathy or neurodegeneration and may die earlier from organ failure, yet epigenetic clocks, telomere attrition rates, senescence marker distributions across non-OXPHOS-limited tissues, and multi-morbidity patterns will remain similar to age-matched controls.\n\n[H3] Somatic mtDNA mutation burden shortens lifespan by inducing a chronic innate immune and inflammatory state (inflammaging) secondary to mitochondrial damage-associated molecular patterns, independent of direct OXPHOS insufficiency as the proximal cause of organ failure. Mechanism: Mutant mitochondria release mtDNA fragments and oxidized lipids that activate cGAS–STING and NLRP3 pathways, producing systemic cytokine elevation that drives tissue fibrosis, metabolic dysfunction, and organismal frailty. Prediction: Mutator animals will exhibit elevated circulating mtDNA, type-I interferon signatures, and NLRP3-dependent cytokines before major OXPHOS failure; genetic or pharmacologic blockade of cGAS–STING or NLRP3 will extend lifespan and delay ageing phenotypes despite unchanged mtDNA mutation load.\n\n[H4] Elevated somatic mtDNA mutations cause premature ageing only when mutation load exceeds a tissue-specific heteroplasmy threshold that collapses respiratory-chain capacity; subthreshold loads will be phenotypically silent for lifespan. Mechanism: Because of intracellular and intercellular complementation and mitochondrial quality control, moderate increases in mutation frequency are buffered until a critical fraction of mtDNA molecules are compromised, after which ATP production and metabolite homeostasis fail abruptly. Prediction: Lifespan and ageing-trait severity will show a nonlinear (threshold) relationship with measured mutation frequency and COX-negative fiber/cell fraction, with little phenotype below the threshold and sharp acceleration above it across multiple organs.\n\n[H5] Increased somatic mtDNA mutations cause premature ageing primarily by depleting adult stem-cell pools and impairing tissue regenerative capacity, rather than by uniform bioenergetic failure in differentiated cells. Mechanism: Heteroplasmic mutant mtDNA reaches a threshold in stem and progenitor cells that triggers apoptosis, senescence, or differentiation block, leading to progressive failure of tissue maintenance while differentiated cells remain relatively functional until late stages. Prediction: Tissues with high turnover (blood, gut, skin, muscle satellite cells) will show earlier clonal mtDNA mutation expansion, stem-cell depletion, and regenerative failure than low-turnover tissues, and stem-cell transplantation from wild-type donors will partially rescue ageing phenotypes without correcting mutations in differentiated parenchyma.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5526, "promptSha256": "d75ef7e8d087fc171cf4a00885ce6e8243f730839c7e1dfb85a7b1fa1415c897" } ] }, { "task": "R42663085", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing commonly impairs the cyclical regeneration of hair follicles, contributing to progressive hair thinning and alopecia. Hair growth depends on the orderly transition of follicles from a resting phase into a proliferative growth phase. With age, this transition becomes less efficient as regenerative cells lose functional capacity. Whether this decline can be reversed by directly restoring an intrinsic molecular control of follicle regeneration remained unresolved.\n\nRESEARCH QUESTION\nCan an intrinsic molecular regulator be enhanced to reactivate quiescent hair follicles and restore hair regeneration, and through what mechanism?\n\nHYPOTHESES\n[H1] Enhancing Wnt/β-catenin signaling in aged hair follicle stem cells is sufficient to drive quiescent follicles into anagen and restore regenerative cycling. Age-related decline in intrinsic Wnt pathway activity is a primary cause of failed resting-to-growth transition. Mechanism: Increased nuclear β-catenin and Wnt target gene expression overcome elevated inhibitory niche cues, reactivating bulge stem cell proliferation and initiating the hair growth cycle. Prediction: Pharmacologic or genetic upregulation of β-catenin in aged bulge cells will increase anagen entry and hair shaft production even when surrounding dermal niche BMP levels remain high, whereas Wnt inhibition will block regeneration despite other interventions.\n\n[H2] Reversing age-associated epigenetic silencing of regenerative gene programs in hair follicle stem cells—via enhanced chromatin accessibility at key anagen loci—reactivates quiescent follicles and restores hair growth. Intrinsic epigenetic drift is a causal barrier to regeneration. Mechanism: Increased histone acetylation or reduced DNA methylation at Wnt, cell-cycle, and progenitor-specification loci restores transcriptional competence of aged stem cells to execute the resting-to-growth transition. Prediction: Targeted epigenetic remodeling (e.g., HDAC inhibition or locus-specific demethylation) in aged HFSCs will restore regenerative gene expression and hair cycling without requiring changes in circulating hormones or systemic niche composition; blocking chromatin opening will eliminate benefits of pathway agonists.\n\n[H3] Enhancing autocrine or paracrine FGF (e.g., FGF7/FGF10) signaling within aged follicles overcomes niche-imposed quiescence and restores cyclical hair regeneration. Age-related loss of intrinsic FGF tone keeps follicles locked in resting phase. Mechanism: Restored FGF receptor signaling activates MAPK/PI3K cascades that promote stem cell activation and progenitor expansion, counteracting inhibitory BMP and elevating anagen competence. Prediction: Local delivery or transgenic overexpression of FGF ligands in aged skin will increase anagen entry and hair regrowth; concurrent FGFR blockade will prevent regeneration that would otherwise occur after Wnt or quiescence-factor interventions.\n\n[H4] Reducing the activity of the quiescence-maintaining transcription factor Nfatc1 (or Foxc1) in aged follicle stem cells reactivates dormant follicles and restores hair regeneration. Persistent high Nfatc1 activity with age locks stem cells in a non-cycling state. Mechanism: Lowered Nfatc1 relieves transcriptional repression of cell-cycle and anagen-entry genes, allowing aged stem cells to exit prolonged telogen and re-enter the proliferative growth phase. Prediction: Conditional Nfatc1 knockdown or calcineurin pathway modulation in aged HFSCs will accelerate telogen-to-anagen transition and increase hair density, while ectopic Nfatc1 expression will prevent regeneration even when Wnt or growth-factor pathways are stimulated.\n\n[H5] Restoring mTORC1 activity in aged hair follicle stem cells reactivates quiescent follicles by correcting age-impaired metabolic and translational capacity needed for anagen entry. Intrinsic mTOR decline limits regenerative competence independently of external niche signals. Mechanism: Elevated mTORC1 increases protein synthesis, mitochondrial biogenesis, and biosynthetic readiness, enabling aged stem cells to mount the proliferative burst required for follicle regeneration. Prediction: Transient, stem-cell-targeted mTORC1 activation will restore anagen frequency and hair growth in aged skin, whereas mTOR inhibition will abolish the regenerative benefit of other pathway enhancers such as Wnt agonists.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5011, "promptSha256": "61b8880691a8faa2b4958683a008b2b6854d7e9b1605c5000b286d947c927bae" } ] }, { "task": "R42664348", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOsteoarthritis is a common age-related disorder characterized by progressive joint deterioration, inflammation, pain, and loss of mobility. Obesity substantially increases osteoarthritis risk, including in joints that do not bear additional body weight, suggesting that mechanical loading alone cannot explain the association. Adipose tissue can influence distant organs through circulating signals, but the molecular basis of its contribution to joint degeneration remained unclear. Identifying the responsible signals and downstream processes could reveal targets for preventing or treating obesity-associated osteoarthritis.\n\nRESEARCH QUESTION\nBy what causal molecular mechanism does excess adiposity promote osteoarthritis progression, and can disrupting that mechanism reduce joint pathology?\n\nHYPOTHESES\n[H1] Obesity accelerates osteoarthritis through adipose secretion of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) that circulate to the joint, activate NF-κB and MAPK pathways in chondrocytes and synovial fibroblasts, and sustain low-grade synovitis and cartilage matrix loss. Disrupting adipose cytokine production or joint cytokine receptors should reduce pathology independent of weight. Mechanism: Adipose-derived TNF-α/IL-6/IL-1β activate NF-κB/MAPK in joint tissues, amplifying inflammation and matrix catabolism. Prediction: Obese individuals or models show elevated adipose and serum TNF-α/IL-6 that correlate with synovial NF-κB activity and OA severity; adipose-specific cytokine knockout, systemic cytokine blockade, or joint Tnfr/Il6r deletion attenuates OA while leptin or EV cargo remain elevated, distinguishing cytokine drive from adipokine or vesicle mechanisms.\n\n[H2] Excess adiposity promotes osteoarthritis by elevating circulating leptin, which acts on articular chondrocytes and synoviocytes via LEPR–JAK2–STAT3 signaling to upregulate matrix-degrading proteases (MMP13, ADAMTS5) and inflammatory mediators, accelerating cartilage breakdown. Blocking leptin signaling or reducing adipose leptin production should therefore slow joint pathology even when body mass is held constant. Mechanism: Adipose-derived leptin activates LEPR–STAT3 in joint cells, driving catabolic enzyme expression and synovitis. Prediction: In diet-induced obese animals or humans, joint LEPR–STAT3 activity and MMP13/ADAMTS5 rise with leptin; cartilage- or synovium-specific Lepr deletion, leptin neutralization, or STAT3 inhibition reduces OA scores without reducing mechanical load, whereas other adipokine or EV interventions do not rescue the phenotype to the same degree.\n\n[H3] Excess adiposity promotes osteoarthritis by releasing adipose-derived extracellular vesicles whose cargo (specific miRNAs and proteins) is taken up by chondrocytes and synovial cells, reprogramming them toward a catabolic, inflammatory state. Interrupting EV biogenesis, release, or uptake should therefore lessen joint degeneration despite persistent obesity. Mechanism: Adipose EVs deliver regulatory miRNAs/proteins that suppress anabolic gene programs and induce proteases and cytokines in joint cells. Prediction: Serum or synovial fluid EVs from obese donors transfer OA-promoting activity in vitro and in lean recipients; adipose-specific Rab27a/nSMase2 disruption or EV uptake blockade reduces OA severity while circulating leptin and classical cytokines are unchanged, separating EV transfer from soluble adipokine/cytokine models.\n\n[H4] Excess adiposity drives osteoarthritis by priming a circulating myeloid program (e.g., CCR2+ monocytes) that infiltrates synovium, differentiates into inflammatory macrophages, and sustains synovitis and secondary cartilage destruction. Depleting these cells or blocking their adipose-to-joint recruitment should reduce joint pathology independent of mechanical load. Mechanism: Adipose-derived chemokines and metabolic cues expand and recruit inflammatory monocytes that seed synovial macrophages driving OA. Prediction: Obesity increases synovial CCR2+ macrophage burden that correlates with OA; Ccr2 blockade, adipose chemokine (e.g., CCL2) deletion, or macrophage depletion reduces synovitis and cartilage loss while chondrocyte-autonomous leptin/FFA/EV pathways remain intact, distinguishing immune recruitment from direct chondrocyte signaling.\n\n[H5] Obesity promotes osteoarthritis via elevated circulating free fatty acids that induce lipotoxicity in chondrocytes through TLR4 and/or PPAR-linked metabolic stress, increasing ROS, ceramide accumulation, and catabolic gene expression. Lowering adipose lipolysis or blocking joint TLR4/FFA sensing should reduce cartilage damage without requiring weight loss. Mechanism: Adipose-released FFAs trigger TLR4/metabolic stress in chondrocytes, driving ROS, ceramides, and matrix-degrading programs. Prediction: Obese models show joint enrichment of saturated FFAs, TLR4 activation, and ceramides that track OA severity; adipose Atgl inhibition, joint Tlr4 deletion, or FFA-scavenging interventions protect cartilage while leptin, EV miRNA profiles, and bulk cytokine levels remain high, favoring lipotoxicity over other systemic signals.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5765, "promptSha256": "1a5b61c440a8bf8925a8f4e3837b3b8175955a7601d3015055130f78bd814e46" } ] }, { "task": "R42665751", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian function declines earlier than the function of many other organs, reducing fertility and altering endocrine health. Age-related deterioration of cellular quality, tissue communication and inflammatory homeostasis has been implicated in this process. Mitochondrial dysfunction is common in ageing reproductive tissues, but whether it directly initiates ovarian decline rather than merely accompanying it has remained uncertain. The molecular signals linking mitochondrial stress to dysfunction across the ovarian follicle were unknown.\n\nRESEARCH QUESTION\nHow does age-associated mitochondrial dysfunction initiate and propagate inflammatory signaling that causes ovarian functional decline?\n\nHYPOTHESES\n[H1] Impaired mitochondrial calcium buffering in aged granulosa cells elevates cytosolic Ca2+, activating CaMKII–NF-κB and promoting expression of adhesion molecules and chemokines that recruit inflammatory monocytes into the ovarian stroma. Mechanism: Ca2+ leak from dysfunctional mitochondria sustains CaMKII–NF-κB activity, upregulating VCAM1/CCL2 and driving monocyte infiltration that amplifies tissue inflammation and follicle atresia. Prediction: Restoring mitochondrial Ca2+ uptake (e.g., MCU gain-of-function in granulosa) or inhibiting CaMKII will reduce stromal monocyte accrual and follicle atresia with age without necessarily lowering cytosolic mtDNA or IL-1β to the same degree as STING/NLRP3 interventions.\n\n[H2] Mitochondrial proteostatic failure in ageing oocytes activates the integrated stress response via OMA1–DELE1–HRI, inducing ATF4-dependent cytokines (e.g., GDF15, CXCL10) that remodel the follicular niche and suppress gonadotropin responsiveness. Mechanism: ISR-driven ATF4 programs secrete stress cytokines that alter cumulus–oocyte communication and dampen FSH/LH signaling in granulosa cells, linking organelle stress to endocrine failure. Prediction: Oocyte-specific HRI or ATF4 deletion will blunt age-associated cytokine induction and restore FSH-stimulated estradiol and ovulation, whereas STING or NLRP3 deletion will leave ATF4 targets and this endocrine defect largely intact.\n\n[H3] Age-associated mitochondrial DNA damage in oocytes and granulosa cells releases oxidized mtDNA into the cytosol, which activates cGAS–STING and thereby initiates type-I interferon and NF-κB inflammatory programs that impair follicle survival and steroidogenesis. Mechanism: Cytosolic mtDNA sensing by cGAS–STING drives interferon and NF-κB transcription in follicular cells, creating a local inflammatory milieu that reduces oocyte competence and granulosa endocrine function. Prediction: Ovary-specific cGAS or STING deletion (or mtDNA packaging rescue) will reduce follicular inflammatory transcripts and preserve ovulation and estradiol output with age, whereas parallel inflammasome blockade alone will not fully rescue the same endpoints.\n\n[H4] Age-related decline in mitophagy (PINK1/Parkin) allows accumulation of damaged mitochondria that shed extracellular vesicles enriched in mitochondrial DAMPs; these EVs are taken up by immune and stromal cells, propagating inflammatory signaling beyond the originating follicle. Mechanism: Failed mitophagy increases EV release of mtDAMPs that activate TLR9/cGAS in recipient macrophages and stromal cells, spreading inflammation ovary-wide and accelerating multi-follicle functional decline. Prediction: Enhancing mitophagy (Parkin overexpression or USP30 inhibition) will reduce mtDAMP+ EVs in follicular fluid, limit distant stromal inflammation, and preserve fertility more effectively than blocking only cell-intrinsic cGAS in the same cells that retain high EV output.\n\n[H5] Mitochondrial ROS from ageing theca and granulosa cells oxidize cardiolipin and other lipids, priming NLRP3 inflammasome assembly; IL-1β and IL-18 then act on neighboring follicles to propagate inflammatory decline across the ovary. Mechanism: ROS-dependent NLRP3 activation produces mature IL-1β/IL-18 that diffuse through follicular fluid and interstitial spaces, recruiting immune cells and suppressing follicle maturation in bystander follicles. Prediction: Granulosa/theca-restricted NLRP3 or caspase-1 knockout will lower ovarian IL-1β, reduce macrophage influx, and slow age-related follicle loss more than antioxidant treatment that does not block inflammasome assembly.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4974, "promptSha256": "d97c02fb0742bb417132f96e7cc022eb4d2ce67ae82ebbb54f31f5e2cb7f9a01" } ] }, { "task": "R42689491", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson-Gilford progeria syndrome is a rare genetic disorder characterized by accelerated, multisystem features of ageing. Progressive skeletal abnormalities are a prominent component of the disease in both patients and experimental models. These abnormalities involve impaired bone formation, remodeling, and mechanical integrity. It remained unclear whether established skeletal pathology could be meaningfully reversed in vivo and how strongly therapeutic efficacy would depend on the age at treatment.\n\nRESEARCH QUESTION\nCan in vivo correction of the HGPS-causing mutation rescue molecular, cellular, and structural defects in bone, and how does treatment timing affect efficacy?\n\nHYPOTHESES\n[H1] Established skeletal pathology in HGPS can be substantially reversed in adults by mutation correction because residual remodeling capacity continuously replaces defective bone once progerin is cleared from the osteoblast–osteocyte lineage. Mechanism: Ongoing bone turnover replaces progerin-damaged matrix and osteocytes; post-correction osteoblasts deposit normal collagen and mineral, gradually remodeling cortical and trabecular compartments toward wild-type architecture. Prediction: Adult-onset correction improves bone formation markers, reduces osteocyte death and microcrack density, and measurably increases BMD and biomechanical strength over months, with efficacy scaling with residual remodeling rate rather than chronological age alone.\n\n[H2] Therapeutic efficacy of mutation correction on bone depends on cell-autonomous rescue of osteoblasts and osteocytes, with little contribution from corrected hematopoietic or vascular compartments. Mechanism: Progerin in osteolineage cells directly causes defective matrix secretion, impaired mechanotransduction, and osteocyte senescence; correcting only those cells restores formation and integrity even if other tissues retain mutant alleles. Prediction: Lineage-restricted correction in osteoprogenitors rescues molecular, cellular, and structural bone phenotypes to a similar degree as ubiquitous correction, whereas correction confined to hematopoietic or endothelial cells yields negligible skeletal improvement.\n\n[H3] Late correction rescues molecular and cellular bone defects but fails to restore structural and mechanical integrity because accumulated extracellular matrix defects and altered bone geometry become largely irreversible after peak accrual. Mechanism: Chronic progerin exposure produces abnormal collagen cross-linking, reduced cortical thickness, and altered trabecular topology that persist after cells are genetically corrected; cellular health recovers while tissue-level architecture does not. Prediction: Adult-treated animals show normalized osteoblast gene expression, reduced senescence markers, and improved formation rates, yet cortical geometry, mineralization quality, and whole-bone strength remain significantly below wild-type and early-treated cohorts.\n\n[H4] In vivo correction of the HGPS-causing LMNA mutation before a critical developmental window fully restores osteoblast differentiation, bone matrix deposition, and adult bone mechanical integrity because early progerin toxicity primarily impairs formation rather than locking in irreversible structural damage. Mechanism: Progerin-driven nuclear lamina dysfunction and DNA-damage signaling in osteoprogenitors disrupt Runx2/Osterix programs during peak bone accrual; removing progerin early reopens normal lineage progression and mineralization before cortical architecture is permanently compromised. Prediction: Correction in juvenile animals normalizes osteoblast transcriptomes, mineral apposition rate, cortical thickness, and fracture toughness to wild-type levels, whereas identical correction after skeletal maturity leaves residual deficits in geometry and strength despite molecular normalization.\n\n[H5] Mutation correction improves bone primarily by restoring osteoclast–osteoblast coupling and reducing inflammatory/senescent signaling that secondarily suppresses formation, so efficacy tracks systemic inflammatory and senescence burden at the time of treatment more than local osteoblast genotype alone. Mechanism: Progerin-driven SASP and chronic inflammation uncouple remodeling; clearing progerin lowers circulating and local inflammatory mediators, rebalances RANKL/OPG signaling, and permits coordinated formation even when some mutant cells persist briefly. Prediction: Correction efficacy correlates with pre-treatment SASP/inflammatory signatures and RANKL/OPG ratios across ages; anti-inflammatory or senolytic co-treatment enhances structural rescue after late correction beyond genetic correction alone.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5322, "promptSha256": "9520d222e1a274ab28645f54b4a5016609764a46f1c7e8f8ffa6e78d0e2aa776" } ] }, { "task": "R42696595", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSeeds progressively lose viability during storage, limiting crop propagation and the preservation of genetic resources. Longevity varies substantially among rice varieties and is influenced by both environmental conditions and inherited traits. Although several genomic regions associated with seed longevity had been identified, the causal genes and regulatory mechanisms underlying this variation remained poorly understood. It was also unclear whether naturally occurring longevity alleles could improve seed survival without compromising agronomic performance.\n\nRESEARCH QUESTION\nWhat genetic and molecular mechanism causes natural variation in seed longevity among rice varieties?\n\nHYPOTHESES\n[H1] Natural polymorphisms in a major antioxidant enzyme gene (e.g., a seed-expressed peroxidase or glutathione S-transferase) cause differential ROS scavenging capacity during dry storage, producing the observed longevity QTL. The protective allele maintains lower lipid peroxidation and higher embryo viability after accelerated aging. Mechanism: Higher constitutive or aging-inducible antioxidant activity limits reactive oxygen species accumulation and membrane/protein oxidation in quiescent seeds. Prediction: Seeds of the longevity haplotype will show higher enzyme activity, lower MDA/carbonyls after identical aging treatments, and genetic complementation by the protective cDNA will extend longevity of a short-lived parent; ROS scavenger chemicals will phenocopy the allele in short-lived lines.\n\n[H2] Natural alleles of a seed-coat cuticle/wax biosynthesis gene alter testa impermeability to oxygen and water vapor, changing the rate of oxidative aging during storage. The longevity allele thickens or densifies the cuticular barrier and slows viability loss. Mechanism: Reduced O2 and moisture flux into the embryo lowers oxidative and hydrolytic damage during storage. Prediction: Longevity NILs will differ in cuticle thickness/composition (GC-MS of cuticular waxes), O2 permeability, and aging rate under controlled RH; mechanical scarification or cuticle mutants will abolish the longevity advantage of the protective allele.\n\n[H3] Natural allelic variation in a rice IAA-amido synthetase (OsGH3-family) gene alters free auxin homeostasis in developing seeds, changing seed-coat structure and thereby storage longevity. Accessions carrying a high-activity longevity allele conjugate more IAA, produce a less permeable coat, and retain higher germination after aging. Mechanism: Auxin conjugation reduces free IAA during late seed maturation, remodeling testa cell-wall and cuticle deposition and slowing oxidative aging. Prediction: Near-isogenic lines that differ only at the OsGH3 longevity QTL will show correlated differences in free IAA, seed-coat permeability (tetrazolium uptake), and post-aging germination; CRISPR knockout of the high-longevity allele will shorten longevity without changing primary yield components when auxin is restored chemically.\n\n[H4] Functional polymorphism in an ABA biosynthesis or signaling gene (e.g., NCED or ABI-related) deepens primary dormancy and slows after-ripening/aging-related viability loss among varieties. The longevity allele maintains higher ABA or stronger ABA responsiveness through late maturation and early storage. Mechanism: Stronger ABA signaling programs a more stress-tolerant quiescent state and delays metabolic reactivation that accelerates deterioration. Prediction: Longevity and dormancy depth will cosegregate; ABA content or sensitivity will be higher in the longevity haplotype; fluridone (ABA biosynthesis inhibitor) or ABA mutants will erase the longevity difference, while exogenous ABA during maturation will extend longevity of the short-lived allele.\n\n[H5] Allelic variation at a raffinose-family oligosaccharide (RFO) biosynthetic locus (e.g., raffinose synthase) changes accumulation of membrane-stabilizing sugars in mature seeds and thus storage life. The longevity allele elevates raffinose/stachyose relative to sucrose at maturity. Mechanism: Elevated RFOs vitrify and protect membranes and proteins against desiccation and aging damage in the dry state. Prediction: Metabolite profiling will show higher RFO:sucrose ratios cosegregating with longevity; transgenic overexpression of the longevity allele will raise RFOs and improve aged germination, while sugar-composition rescue by exogenous oligosaccharides will partially equalize longevity between alleles.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5094, "promptSha256": "e916999bf9863b4011858aa32632152fa1bc95c2caedd3fbfb51b042fcbd92c7" } ] }, { "task": "R42698274", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 1 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAndrogenetic alopecia is a common, progressive form of hair loss associated with genetic susceptibility and heightened follicular responses to dihydrotestosterone. Androgen exposure progressively impairs the cells that support follicle growth, contributing to follicular miniaturization and a shortened growth phase. Mitochondrial dysfunction, oxidative stress, inflammation and cellular senescence have been implicated in this deterioration. However, the molecular mechanism connecting androgen signaling to these pathogenic cellular changes remained incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism exacerbates dihydrotestosterone-induced mitochondrial dysfunction, oxidative stress and senescence during androgenetic alopecia?\n\nHYPOTHESES\n[H1] DHT impairs PINK1/Parkin-mediated mitophagy in androgen-sensitive follicles, so damaged mitochondria accumulate, leak ROS and oxidized mtDNA, and drive senescence. The key lesion is failed clearance rather than increased damage generation alone. Mechanism: AR signaling suppresses PINK1 stabilization or Parkin recruitment to depolarized mitochondria, blocking autophagosome engulfment of dysfunctional organelles. Prediction: Parkin overexpression or a mitophagy inducer (e.g., urolithin A) will clear dysfunctional mitochondria and reverse DHT-driven senescence without restoring NOX or PGC-1α to baseline; mitophagy reporter flux will fall under DHT and recover with AR antagonism.\n\n[H2] DHT-AR signaling induces NOX1/NOX4-derived superoxide that damages mitochondria and locks dermal papilla cells into a ROS–senescence feed-forward loop. Mitochondrial dysfunction is therefore secondary to plasma-membrane NADPH oxidase activity rather than a primary AR target. Mechanism: AR-driven NOX upregulation generates cytosolic ROS that oxidizes mitochondrial proteins/lipids, impairing ETC complexes and triggering p53/p21 senescence. Prediction: NOX-selective inhibitors or NOX4 knockdown will prevent DHT-induced mtROS, ΔΨm loss, and senescence even when PGC-1α remains repressed; scavenging only mitochondrial ROS will be less protective than NOX blockade.\n\n[H3] DHT-stressed mitochondria release mtDNA into the cytosol, activating cGAS–STING and an IFN/NF-κB inflammatory program that amplifies oxidative stress and locks cells into senescence. Innate immune sensing of mitochondrial damage is the exacerbating link between androgen exposure and follicle deterioration. Mechanism: AR-induced mitochondrial outer-membrane permeabilization or VDAC opening releases mtDNA; cGAS–STING then induces SASP cytokines and further ROS. Prediction: cGAS or STING knockout/inhibition will blunt DHT-induced ISG expression, IL-6/IL-8 SASP, and senescence despite persistent mitochondrial depolarization; DNase treatment of cytosol or VDAC inhibitors will phenocopy STING loss.\n\n[H4] Dihydrotestosterone-bound androgen receptor transcriptionally represses PGC-1α in dermal papilla cells, collapsing mitochondrial biogenesis and antioxidant capacity. The resulting electron-transport inefficiency elevates ROS, which accelerates cellular senescence and shortens anagen. Mechanism: AR-dependent transcriptional downregulation of the PGC-1α–NRF1/TFAM biogenesis axis, with secondary loss of SOD2/GPX activity. Prediction: Forced PGC-1α expression or AR DNA-binding blockade will restore mtDNA copy number and oxygen consumption and reduce SA-β-gal/p16 under DHT, whereas NOX or inflammasome inhibitors will not fully rescue biogenesis markers.\n\n[H5] DHT-AR upregulates TXNIP, which both inhibits thioredoxin antioxidant buffering and activates NLRP3 inflammasome–IL-1β signaling in dermal papilla cells. Combined redox collapse and inflammasome-driven inflammation exacerbate mitochondrial injury and senescence beyond AR’s direct transcriptional effects on growth factors. Mechanism: AR-dependent TXNIP induction sequesters TRX, raises ROS, and licenses NLRP3 assembly; caspase-1/IL-1β then reinforce mitochondrial damage and p16-linked senescence. Prediction: TXNIP knockdown or NLRP3/caspase-1 inhibition will reduce DHT-evoked mtROS, IL-1β release, and SA-β-gal positivity more than TGF-β or DKK1 neutralization alone; TXNIP ChIP will show AR occupancy at the TXNIP locus after DHT.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4873, "promptSha256": "4ff3b079110de320bd57d609c6e471c9e27be8411e732ce9cf219b964395b04a" } ] }, { "task": "R42717261", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence can develop in immune populations and alter tissue function through persistent inflammatory and dysfunctional states. Such immunosenescence has been associated with chronic inflammatory disorders, but whether senescent immune cells directly cause disease progression has remained uncertain. Metabolic disruption and mitochondrial damage are recognized triggers of senescence, including through the abnormal release of mitochondrial components into the cytosol. The causal sequence connecting these processes to intestinal inflammation and treatment resistance was unresolved.\n\nRESEARCH QUESTION\nWhat mechanism induces pathogenic immune-cell senescence in ulcerative colitis, and does this senescence causally exacerbate the disease?\n\nHYPOTHESES\n[H1] Defective mitophagy in colonic macrophages of UC patients allows accumulation of damaged mitochondria, elevating ROS that stabilize p53/p21 and induce macrophage senescence; senescent macrophages then sustain IL-1β/IL-6–rich inflammation that causally worsens barrier failure and steroid resistance. Mechanism: Impaired mitophagy → ROS → p53/p21 macrophage senescence → proinflammatory SASP → barrier injury and treatment resistance Prediction: Restoring mitophagy (e.g., Parkin/PINK1 gain-of-function or urolithin A) in macrophages will clear damaged mitochondria, reduce ROS and senescence burden, decrease mucosal IL-1β/IL-6, and restore steroid responsiveness in colitis models; macrophage-specific senescence ablation will phenocopy this benefit.\n\n[H2] In UC, mitochondrial outer-membrane permeabilization in regulatory T cells releases cytochrome c and mtDAMPs that both impair Treg suppression and induce Treg senescence; loss of functional Tregs plus senescent Treg SASP together remove mucosal tolerance and causally accelerate flare severity and treatment failure. Mechanism: MOMP in Tregs → mtDAMPs + Treg senescence → loss of tolerance + SASP → flare amplification and therapy failure Prediction: Treg-specific protection of mitochondrial integrity (e.g., Bcl-xL overexpression or Bax/Bak deletion) will preserve Treg numbers and function, reduce senescence markers within the Treg compartment, lower flare frequency, and improve response to standard UC therapies; adoptive transfer of senescent Tregs will worsen colitis relative to equal numbers of non-senescent Tregs.\n\n[H3] Persistent IFN-γ and TNF signaling in UC creates a feed-forward loop that forces DNA-damage responses in mucosal NK and CD8+ cells, locking them into a senescent, hypofunctional state whose SASP (including chemokines and proteases) recruits neutrophils and destroys crypt architecture, thereby causally escalating disease severity. Mechanism: Chronic IFN-γ/TNF → DNA damage → NK/CD8 senescence → chemokine/protease SASP → neutrophil-driven tissue destruction Prediction: Neutralizing IFN-γ/TNF early will prevent acquisition of senescence markers in NK/CD8 cells and limit neutrophil influx; once senescence is established, senolytic clearance of these cells will reduce protease activity and crypt damage even if cytokine levels remain partially elevated, distinguishing senescence causality from cytokine effects alone.\n\n[H4] Dysbiotic microbiota in UC produce excess secondary bile acids or short-chain fatty acid imbalances that rewire CD4+ T-cell metabolism toward glycolytic mitochondrial overload, triggering senescence; these senescent T cells then drive pathogenic Th17 persistence and resistance to anti-TNF therapy. Mechanism: Microbiota metabolite imbalance → T-cell metabolic overload → senescence → Th17 persistence and anti-TNF resistance Prediction: Germ-free or metabolite-normalized gnotobiotic mice will show fewer senescent CD4+ cells and milder colitis; transfer of metabolite-conditioned senescent T cells into healthy hosts will induce colitis-like inflammation and blunt anti-TNF efficacy, whereas metabolite rescue without altering senescence will not fully restore drug response.\n\n[H5] In ulcerative colitis, chronic metabolic stress damages mitochondria in lamina propria T cells, releasing mtDNA into the cytosol; cytosolic mtDNA activates cGAS–STING, which drives a senescence program that produces a SASP that amplifies mucosal inflammation and impairs epithelial repair. Mechanism: Mitochondrial damage → cytosolic mtDNA → cGAS–STING → immune-cell senescence → SASP-driven colitis exacerbation Prediction: Selective blockade or genetic deletion of cGAS or STING in T cells will reduce senescence markers (p16, SA-β-gal), lower SASP cytokines in the mucosa, and improve histological colitis scores even when upstream mitochondrial stress persists; exogenous cytosolic mtDNA will recapitulate senescence and worsen disease in a STING-dependent manner.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5375, "promptSha256": "03b5886114996afed280ed615659a37d6f0663d167a59bac564577ee9408b6a3" } ] }, { "task": "R42723546", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nChronic ultraviolet exposure causes skin photoaging characterized by impaired barrier function, collagen loss, cellular senescence, and persistent inflammation. Damaged cells can accumulate dysfunctional organelles and release intracellular danger signals that sustain sterile inflammatory responses. Regenerative cell-free therapies have shown potential for repairing aged or injured tissues, but their activity can involve many distinct biological processes. The causal mechanism by which such therapies might suppress photoaging-associated senescence and inflammation remained unresolved.\n\nRESEARCH QUESTION\nCan a cell-free regenerative treatment alleviate UV-induced skin photoaging, and which causal intracellular mechanism mediates its protective effects?\n\nHYPOTHESES\n[H1] The therapy’s benefit is mediated by extracellular vesicle or soluble factor delivery of antioxidant enzymes and NRF2 agonists that quench UV-driven ROS before they trigger senescence and danger-signal release. Mechanism: NRF2 nuclear translocation and catalase/SOD enrichment neutralize oxidative stress, preventing DNA damage foci and secondary mitochondrial injury. Prediction: NRF2 knockout skin will retain high 8-oxo-dG, γH2AX, and SASP despite therapy, whereas forced NRF2 activation without the full preparation will phenocopy the anti-photoaging effect on inflammation and senescence markers.\n\n[H2] A cell-free regenerative preparation alleviates UV-induced photoaging by restoring mitophagy in keratinocytes and fibroblasts, which clears dysfunctional mitochondria and thereby reduces mitochondrial danger-signal release that drives senescence and sterile inflammation. Mechanism: Enhanced PINK1/Parkin-dependent mitophagy lowers mtDNA and ROS leakage, interrupting NLRP3 inflammasome activation and SASP maintenance. Prediction: Pharmacologic or genetic blockade of mitophagy will abolish the therapy’s anti-senescence and anti-inflammatory benefits even when barrier and collagen markers partially recover; mitophagy flux reporters and circulating mtDNA will normalize only in treated, mitophagy-competent skin.\n\n[H3] Cell-free factors suppress photoaging by reactivating SIRT1–AMPK signaling that deacetylates and represses p53/p16 senescence programs while limiting inflammasome priming. Mechanism: NAD+-dependent SIRT1 and AMPK restore metabolic fitness, lower acetyl-p53 and p16INK4a, and dampen NF-κB transcriptional output. Prediction: SIRT1 or AMPK inhibition will erase therapy-induced declines in SA-β-gal+ cells and SASP cytokines while leaving mitophagy markers unchanged relative to vehicle, distinguishing this pathway from organelle-clearance mechanisms.\n\n[H4] Protective effects arise because the cell-free treatment restores endoplasmic reticulum calcium homeostasis and UPR balance, preventing ER stress–driven CHOP/XBP1 signaling that couples photoaging to inflammasome activation and collagen matrix collapse. Mechanism: Normalized SERCA activity and BiP/ATF6 signaling reduce ER Ca2+ leak and terminate chronic UPR that feeds NLRP3 and MMP induction. Prediction: Thapsigargin or SERCA inhibition will reinstate ER stress, senescence, and MMP-1 elevation in treated skin despite intact mitophagy and NRF2 responses, and ER-Ca2+ imaging plus CHOP knockdown epistasis will show ER homeostasis is necessary and partially sufficient for the phenotype.\n\n[H5] The protective effect is caused by therapy-driven autophagic degradation of damaged lysosomes and aggregated proteins that otherwise sustain cGAS–STING and NF-κB signaling in photoaged epidermis. Mechanism: Upregulated macroautophagy and lysosomal biogenesis remove cytosolic DNA and protein aggregates that chronically activate innate immune sensors. Prediction: ATG5/ATG7 knockdown or chloroquine co-treatment will specifically abolish reductions in cGAMP, phospho-STING, and IL-6/IL-1β without equivalent loss of collagen synthesis rescue by alternative anabolic stimuli.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4573, "promptSha256": "2bb65494ce5f5a91c327ce4e07a1f17375c355a64a74279414b68232b6534419" } ] }, { "task": "R42725837", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence is a stable stress response that contributes to tissue dysfunction, chronic inflammation, and multiple age-related diseases. Senescent cells accumulate with age, and experimentally reducing their abundance or activity can improve health-related outcomes in animal models. Transmembrane proteins can regulate intracellular signaling networks involved in stress responses and cell-fate decisions, but many remain poorly characterized in ageing. Identifying upstream regulators that causally control senescence could reveal therapeutic targets for age-associated disorders.\n\nRESEARCH QUESTION\nDoes the transmembrane protein investigated in this study causally regulate cellular senescence and age-related tissue pathology, and through what signaling mechanism?\n\nHYPOTHESES\n[H1] The transmembrane protein causally suppresses senescence by restraining chronic DNA-damage checkpoint signaling through facilitation of ATM/ATR resolution and p53 turnover. Its age-dependent decline therefore permits persistent γH2AX foci, p53/p21 activation, and progressive tissue dysfunction. Mechanism: Membrane-proximal regulation of DNA-damage response kinases or p53 stability that limits sustained checkpoint activation under genotoxic stress. Prediction: Protein overexpression will reduce persistent γH2AX and p53 levels after sublethal DNA damage and delay senescence markers, whereas ATM or p53 inhibition will phenocopy protein gain-of-function and abolish the difference between wild-type and knockout cells.\n\n[H2] The transmembrane protein causally regulates senescence by modulating mitochondrial ROS production through localized NOX or mitochondrial–ER contact control, such that excess ROS activates p38 MAPK and irreversible cell-cycle arrest. Reducing the protein’s activity therefore lowers oxidative stress and age-associated tissue damage. Mechanism: Membrane localization that concentrates ROS-generating enzymes or alters mitochondria–ER contacts, elevating ROS–p38–senescence signaling. Prediction: Loss of the protein will decrease mitochondrial ROS and phospho-p38 without changing TGF-β/SMAD or DNA-damage marker kinetics, and antioxidants or p38 inhibitors will phenocopy the anti-senescence effect of knockout.\n\n[H3] The transmembrane protein causally promotes cellular senescence by amplifying TGF-β receptor signaling at the plasma membrane, thereby driving SMAD-dependent transcription of cyclin-dependent kinase inhibitors and SASP factors. Loss of this protein therefore delays senescence onset and reduces age-related tissue pathology in vivo. Mechanism: Scaffolding or co-receptor activity that potentiates TGF-β/SMAD2/3 signaling, elevating p21/p16 and inflammatory SASP output. Prediction: Genetic or pharmacologic loss of the protein will specifically blunt TGF-β–induced SMAD phosphorylation and p21 induction without altering baseline MAPK or PI3K activity, and tissue pathology will be rescued by SMAD inhibition to a similar degree as protein loss.\n\n[H4] The transmembrane protein causally accelerates senescence and age-related pathology by inhibiting PI3K/AKT–mTOR pro-survival and autophagy flux, locking cells into a stable arrested state. Restoring AKT/mTOR tone downstream of the protein will reverse senescence phenotypes even when the protein remains present. Mechanism: Negative regulation of PI3K/AKT–mTOR signaling that impairs autophagy and favors irreversible arrest and SASP persistence. Prediction: Knockout will increase phospho-AKT/mTOR and autophagic flux and reduce senescence markers; constitutively active AKT will rescue senescence in protein-overexpressing cells, whereas SMAD or ATM pathway blockade will not fully reverse the phenotype.\n\n[H5] The transmembrane protein causally drives senescence and age-related pathology by coupling to integrin–FAK–NF-κB signaling that sustains a pro-inflammatory SASP loop. Blocking this axis will reduce senescent-cell burden and improve tissue function independently of cell-cycle CDK inhibitors. Mechanism: Outside-in integrin/FAK activation that maintains NF-κB–dependent SASP transcription and paracrine senescence reinforcement. Prediction: Knockout will lower phospho-FAK and nuclear NF-κB, reduce SASP cytokines with only modest effects on p16/p21, and NF-κB or FAK inhibitors will mimic knockout rescue of tissue pathology while TGF-β pathway inhibitors will not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5008, "promptSha256": "ffd2c52b1dae71e8288e27c175a570a231f2405387b108738b7f771ea252ba73" } ] }, { "task": "R42736449", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAlzheimer's disease involves progressive neuronal dysfunction accompanied by broad molecular changes in the brain. Conventional genome annotation does not capture every translated product, leaving potentially functional proteins uncharacterized. Disease-associated changes in these overlooked products may occur independently of established proteins encoded at the same genomic loci. It remained unclear whether any such product contributes directly to cellular dysfunction in Alzheimer's disease.\n\nRESEARCH QUESTION\nCan an unannotated protein product that is altered in Alzheimer's disease causally regulate cellular function relevant to disease pathology?\n\nHYPOTHESES\n[H1] An unannotated microprotein upregulated in Alzheimer-affected neurons impairs synaptic vesicle recycling by binding and inhibiting a SNARE-complex accessory factor, thereby reducing neurotransmitter release independently of the annotated protein from the same locus. Mechanism: Disease-driven translation of a cryptic ORF yields a short peptide that sterically occludes a SNARE regulatory site, decoupling vesicle fusion efficiency from the locus’s canonical gene product. Prediction: Selective knockdown or CRISPR deletion of only the cryptic ORF (leaving the annotated ORF intact) will restore vesicle recycling rates and evoked release in patient iPSC neurons, whereas modulating the annotated protein alone will not.\n\n[H2] A locus-independent unannotated transmembrane microprotein enriched in Alzheimer microglia disrupts TREM2 signaling by occupying DAP12, thereby suppressing phagocytic clearance of amyloid plaques. Mechanism: The cryptic ORF encodes a short ITAM-like peptide that sequesters DAP12 away from TREM2, reducing SYK phosphorylation and downstream phagocytosis without altering annotated TREM2 or DAP12 coding sequences. Prediction: Microglia with cryptic-ORF knockout will show restored TREM2–DAP12 co-immunoprecipitation, SYK activation, and plaque uptake in AD-model co-cultures, whereas annotated-gene knockdown will produce a different phagocytic phenotype.\n\n[H3] An Alzheimer’s-elevated unannotated protein product hyperactivates the integrated stress response by competing with eIF2B for eIF2α-P binding, causing chronic translational repression that impairs memory-related protein synthesis. Mechanism: The cryptic peptide mimics a domain of a known ISR modulator and locks eIF2B in an inactive state, sustaining ATF4 induction without requiring changes in the annotated locus product. Prediction: Neurons engineered to express only the cryptic product will show persistent p-eIF2α signaling and ATF4 targets; mutating the peptide’s eIF2B-contact residues will abolish ISR hyperactivation while annotated-protein levels remain unchanged.\n\n[H4] A cryptic ORF product downregulated in Alzheimer’s disease normally buffers toxic amyloid-β oligomers by direct binding; its loss therefore amplifies Aβ-driven mitochondrial calcium overload and neuronal death. Mechanism: The unannotated peptide acts as a stoichiometric sink for soluble Aβ oligomers at mitochondrial contact sites, limiting PTP opening; reduced peptide levels remove this buffer. Prediction: Re-expressing the cryptic peptide (but not the annotated isoform) in Aβ-challenged neurons will reduce mitochondrial Ca2+ spikes and caspase activation even when annotated-locus expression is held constant.\n\n[H5] An unannotated nuclear peptide depleted in Alzheimer’s disease normally promotes clearance of phosphorylated tau by recruiting a ubiquitin ligase to tau aggregates; its loss therefore accelerates tau propagation between neurons. Mechanism: The cryptic peptide scaffolds a specific E3 ligase onto phospho-tau, driving proteasomal turnover; disease-associated downregulation of the peptide removes this clearance route independently of the annotated locus protein. Prediction: Forced expression of the cryptic peptide (but not the annotated product) will reduce insoluble phospho-tau load and limit seed-competent tau transfer in neuron–neuron assays, and this rescue will require an intact ligase-binding motif on the peptide.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4730, "promptSha256": "d511ee67809c4862962ede0ba75425827529b1c869df690d969d704d9921ba2d" } ] }, { "task": "R42744804", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAmyotrophic lateral sclerosis is a progressive neurodegenerative disease characterized by motor-neuron loss, neuromuscular denervation and premature death. Inherited SOD1 mutations cause some forms of ALS and are widely used to model disease progression in mice. Degeneration in these models involves interactions between vulnerable neurons and surrounding cells, but it remained unclear which responses actively cause neuronal death rather than merely accompany it. Identifying causal mechanisms could reveal ways to preserve neuromuscular function and extend survival.\n\nRESEARCH QUESTION\nWhat disease-associated mechanism actively eliminates motor neurons and accelerates mortality in SOD1G93A mice?\n\nHYPOTHESES\n[H1] In SOD1G93A mice, complement component C1q tags motor-neuron synapses and somata, recruiting microglia that strip synapses and phagocytose still-viable neurons, thereby eliminating motor neurons and shortening survival. Blocking C1q–microglia coupling should therefore spare motor neurons and extend lifespan. Mechanism: Complement C1q opsonization drives microglial synaptic stripping and phagoptosis of motor neurons Prediction: Genetic or antibody blockade of C1q (or CR3) reduces motor-neuron loss and prolongs survival more than anti-inflammatory treatments that leave complement tagging intact\n\n[H2] Chronic microglial activation via the NLRP3 inflammasome and IL-1β/TNF release creates a neurotoxic inflammatory milieu that actively kills motor neurons and accelerates death in SOD1G93A mice. Inhibiting NLRP3 or neutralizing key cytokines should therefore slow motor-neuron loss and extend survival beyond what is achieved by broadly suppressing glial reactivity. Mechanism: NLRP3 inflammasome–driven microglial cytokine toxicity eliminates motor neurons Prediction: NLRP3 knockout or IL-1β/TNF blockade reduces motor-neuron degeneration and prolongs lifespan more than general CSF1R microglial depletion alone\n\n[H3] Mutant SOD1 in astrocytes causes them to release soluble toxic factors that trigger motor-neuron death; this non-cell-autonomous toxicity is a primary driver of neurodegeneration and early mortality in SOD1G93A mice. Selectively removing mutant SOD1 from astrocytes or neutralizing the secreted toxin should preserve motor neurons and extend survival. Mechanism: Astrocyte-derived soluble neurotoxins kill neighboring motor neurons Prediction: Astrocyte-restricted SOD1G93A excision or conditioned-medium neutralization markedly reduces motor-neuron death and mortality, whereas neuron-only interventions of similar magnitude do not\n\n[H4] Mutant SOD1 triggers RIPK1-dependent necroptosis in motor neurons (and/or surrounding glia), releasing DAMPs that amplify inflammation and drive further neuronal loss, thereby hastening mortality. Pharmacologic or genetic RIPK1/MLKL inhibition should therefore preserve motor neurons and extend lifespan. Mechanism: RIPK1/MLKL necroptotic death of motor neurons with secondary inflammatory amplification Prediction: RIPK1 kinase inhibition or MLKL deletion reduces spinal necroptotic markers, motor-neuron loss, and mortality more effectively than apoptosis-selective interventions (e.g., caspase blockade alone)\n\n[H5] CD8+ T cells infiltrate the SOD1G93A spinal cord and directly kill MHC-I–expressing motor neurons via perforin/granzyme pathways, accelerating neuromuscular failure and death. Depleting CD8+ T cells or blocking MHC-I recognition should spare motor neurons and improve survival. Mechanism: Cytotoxic CD8+ T cell–mediated killing of MHC-I+ motor neurons Prediction: CD8 depletion or β2-microglobulin/MHC-I loss reduces motor-neuron death and extends survival, while CD4 depletion does not produce a comparable rescue\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4351, "promptSha256": "37bd996f5e27c422b324db95925e241e5c7d75036d9b5186c87e43d2464c4349" } ] }, { "task": "R42749700", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson–Gilford progeria syndrome is a rare genetic disorder characterized by accelerated ageing and markedly shortened lifespan. Cells affected by the disease develop nuclear abnormalities, loss of chromatin organization, and premature senescence. Senescent cells can reinforce tissue dysfunction by releasing pro-inflammatory factors collectively known as the senescence-associated secretory phenotype. The molecular mechanisms connecting altered nuclear architecture to this secretory state remained incompletely understood, limiting the development of mechanism-based treatments.\n\nRESEARCH QUESTION\nWhat molecular mechanism links disrupted chromatin regulation to cellular senescence in Hutchinson–Gilford progeria syndrome, and can targeting that mechanism ameliorate disease phenotypes and extend lifespan?\n\nHYPOTHESES\n[H1] Progerin-induced reorganization of higher-order chromatin creates de novo enhancers at SASP genes that depend on BRD4 and related chromatin readers; this enhancer rewiring, rather than simple loss of repression, drives the secretory phenotype. BRD4 inhibition or enhancer disruption will selectively collapse SASP transcription, delay senescence, and ameliorate organismal aging phenotypes. Mechanism: Pathogenic enhancer remodeling via BET bromodomain proteins installs active SASP transcription programs. Prediction: H3K27ac and BRD4 occupancy will rise at SASP enhancers in HGPS cells; BRD4 blockade will suppress SASP more strongly than global DNA-damage or interferon pathway inhibitors at equivalent toxicity.\n\n[H2] In HGPS, progerin-driven loss of lamina-associated heterochromatin causes leakage of nuclear DNA into the cytoplasm, which activates the cGAS–STING pathway and thereby induces a type-I interferon and SASP program that locks cells into senescence. Pharmacologic or genetic blockade of cGAS or STING will therefore reduce senescence burden, improve tissue function, and extend lifespan in HGPS models. Mechanism: Cytoplasmic chromatin sensing via cGAS–STING couples nuclear architectural failure to innate immune SASP induction. Prediction: HGPS cells and tissues will show elevated cytoplasmic DNA and STING pathway activation; cGAS/STING inhibition will suppress SASP and extend lifespan more than interventions that restore nuclear shape without reducing cytoplasmic DNA.\n\n[H3] Disrupted chromatin and chronic DNA damage hyperactivate PARP1, depleting NAD+ and impairing SIRT1-dependent deacetylation needed to maintain heterochromatin and repress inflammatory genes, creating a feed-forward loop into senescence. NAD+ repletion or PARP1 moderation will restore SIRT1 activity, reinstate chromatin repression of SASP genes, improve tissue phenotypes, and extend lifespan in HGPS. Mechanism: PARP1-driven NAD+ exhaustion disables SIRT1, linking chromatin damage to progressive loss of silencing and senescence. Prediction: HGPS cells will show elevated PARP activity, low NAD+/NADH, and reduced SIRT1-dependent H4K16/H3K9 deacetylation at inflammatory loci; NAD+ precursors will reverse these marks and extend lifespan more than STING inhibition when PARP hyperactivation remains high.\n\n[H4] Chronic replication stress and DNA breaks caused by disrupted chromatin topology persistently activate ATM–NEMO–NF-κB signaling, which transcriptionally installs the SASP and reinforces senescence in HGPS. Selective inhibition of this ATM–NF-κB axis will attenuate SASP, improve cardiovascular and musculoskeletal phenotypes, and extend lifespan. Mechanism: Persistent DNA-damage–response signaling through ATM/NEMO hyperactivates NF-κB as the master SASP driver. Prediction: NF-κB inhibition will reduce SASP and extend lifespan even when heterochromatin marks remain low, whereas restoring nuclear morphology alone without lowering NF-κB activity will not fully reverse secretory senescence.\n\n[H5] Progerin depletes H3K9me3 and HP1 at lamina-associated domains, derepressing normally silent inflammatory and senescence gene clusters and thereby driving premature senescence. Restoring H3K9 methylation (for example by boosting SUV39H1 activity or inhibiting H3K9 demethylases) will reinstate heterochromatin, dampen SASP, and prolong survival. Mechanism: Loss of constitutive heterochromatin (H3K9me3/HP1) directly derepresses senescence and SASP loci. Prediction: Genome-wide H3K9me3 ChIP-seq will show selective loss at SASP and inflammatory loci preceding senescence marker induction, and H3K9me3 restoration will reverse those expression changes without requiring reduced DNA damage signaling.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5181, "promptSha256": "d9352da7f57f2c4850faa4df7477bb0c083cad16886958cc3aec153a0493180e" } ] }, { "task": "R42758848", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 4 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by a progressive weakening of adaptive immune responses, which reduces protection against infections and cancer. Effective immunity requires resting immune cells to preserve metabolic competence while remaining ready for rapid activation. Age-related changes in chromatin regulation and cellular metabolism have both been implicated in immune dysfunction. However, the mechanism that establishes this latent metabolic readiness and how ageing disrupts it remained unclear.\n\nRESEARCH QUESTION\nWhat developmentally established epigenetic mechanism preserves metabolic readiness for rapid immune activation, and how is it disrupted during ageing?\n\nHYPOTHESES\n[H1] A developmentally established NAD+-dependent SIRT1/SIRT6 chromatin circuit maintains deacetylation balance that keeps metabolic loci poised rather than fully repressed or constitutively active in resting lymphocytes. Age-related NAD+ decline disables this circuit, causing inappropriate H3K9/H3K56 hyperacetylation drift and loss of coordinated metabolic readiness. Mechanism: Sirtuin activity, fueled by developmental NAD+ set points, fine-tunes acetylation at metabolic chromatin; NAD+ depletion with age impairs sirtuins, scrambling the poised acetylation landscape needed for rapid, ordered activation. Prediction: Aged resting T cells will show elevated H3K9/H3K56ac at metabolic loci yet delayed inducible transcription; NAD+ precursor supplementation or SIRT1/SIRT6 activation will restore both the resting acetylation pattern and rapid post-stimulation metabolic flux, whereas boosting NAD+ in young cells will have minimal further effect, distinguishing this from non-sirtuin chromatin ageing models.\n\n[H2] Developmentally timed deposition of histone variant H3.3 at metabolic gene bodies and promoters creates a labile nucleosome state that facilitates rapid Pol II recruitment upon immune activation. Ageing shifts turnover toward canonical H3, stabilizing chromatin and slowing metabolic gene induction. Mechanism: H3.3-enriched nucleosomes are more dynamic and permissive for rapid transcription; replacement by canonical H3 with age increases chromatin stability and raises the activation energy for metabolic gene expression. Prediction: H3.3 ChIP-seq occupancy at metabolic genes will decline with age while canonical H3 rises; H3.3 knockdown in young cells will phenocopy aged delayed metabolic activation, and H3.3 overexpression or chaperone (HIRA) restoration in aged cells will selectively accelerate induction of glycolytic/OXPHOS genes.\n\n[H3] Pioneer factors such as TCF1 and FOXO1, installed during lymphocyte lineage commitment, continuously occupy metabolic gene enhancers in resting cells to maintain nucleosome-depleted readiness. Ageing reduces pioneer factor protein levels and chromatin occupancy, collapsing the latent metabolic program. Mechanism: Lineage pioneer TFs hold metabolic enhancers open and recruit basal chromatin remodelers; their age-related decline allows nucleosome re-occupation and loss of inducible coactivator recruitment. Prediction: CUT&RUN will show age-dependent loss of TCF1/FOXO1 at metabolic enhancers coincident with reduced ATAC-seq signal; forced re-expression of these factors in aged naïve T cells will reopen the same enhancers and accelerate post-activation ATP and lactate production, whereas overexpression of non-pioneer lineage TFs will not.\n\n[H4] A developmental DNA hypomethylation program at metabolic readiness enhancers is established in hematopoietic progenitors and inherited by naïve lymphocytes, permitting rapid enhancer–promoter looping upon activation. With age, remethylation of these enhancers by DNMT3A/3B silences the readiness state and blunts metabolic burst capacity. Mechanism: CpG hypomethylation at metabolic enhancers preserves chromatin accessibility and TF binding potential; age-associated de novo methylation closes these enhancers and blocks inducible looping. Prediction: Bisulfite and Hi-C profiling will show age-specific remethylation and lost looping at metabolic enhancers; DNMT3A/3B inhibition or CRISPR demethylation of those sites in aged T cells will restore early glycolytic and OXPHOS gene induction more than global hypomethylating agents acting on non-metabolic loci.\n\n[H5] During T cell development, thymic selection deposits H3K4me3 and H3K27ac at promoters and enhancers of glycolytic and mitochondrial biogenesis genes, creating a poised chromatin state that enables rapid metabolic reprogramming upon TCR stimulation. Ageing erodes this priming through progressive loss of these activating marks, delaying metabolic activation and impairing effector function. Mechanism: Developmentally deposited activating histone marks keep metabolic gene loci in a latent open state in resting naïve T cells; age-dependent histone demethylase/deacetylase activity or failed mark maintenance removes the poised configuration. Prediction: Young naïve T cells will show high H3K4me3/H3K27ac occupancy at metabolic loci before stimulation and rapid glycolytic flux after activation; aged cells will lack these marks at the same loci, show delayed induction of glycolytic enzymes, and restoring the marks (e.g., via HDAC inhibition or H3K4 methyltransferase gain-of-function) will rescue activation speed specifically in aged cells without altering unrelated gene programs.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5991, "promptSha256": "d348facb61b270fa03204c88471c64dd72d9cda70a4988da2270c4cd84a4d393" } ] }, { "task": "R42759510", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nWomen show a disproportionate increase in cognitive and systemic vulnerability during midlife despite their longer average lifespan. Ageing is accompanied by mitochondrial dysfunction, cellular senescence, and altered communication between peripheral tissues and the brain. Circulating regulatory signals can influence brain physiology, but the mechanisms responsible for the female-biased transition from resilience to vulnerability remain poorly understood. It was also unclear whether this transition is reversible or contributes causally to age-related neurodegenerative phenotypes.\n\nRESEARCH QUESTION\nWhat molecular mechanism drives peripheral-to-brain signaling that promotes senescence, mitochondrial dysfunction, and cognitive vulnerability during female midlife?\n\nHYPOTHESES\n[H1] Midlife ovarian failure reduces circulating levels of the anti-aging hormone α-klotho produced by kidney and choroid-related circuits under estrogenic tone; loss of peripheral-to-brain klotho signaling derepresses FGF23– and Wnt-driven pathways that promote neuronal mitochondrial fragmentation, senescence, and synaptic failure. Mechanism: Estrogen-dependent peripheral klotho production falls → reduced circulating klotho → unchecked FGF23/Wnt signaling in brain → mitochondrial fragmentation and senescence. Prediction: Restoring circulating α-klotho to premenopausal levels in midlife females should reverse brain mitochondrial and cognitive deficits without needing estradiol replacement, whereas klotho neutralization in young females should phenocopy the midlife vulnerability state.\n\n[H2] Menopause-driven adipose remodeling elevates circulating long-chain ceramides (e.g., C16:0, C18:0) that enter the brain, inhibit neuronal complex IV and promote mitochondrial outer-membrane permeabilization, thereby accelerating neuronal senescence and midlife cognitive vulnerability in females. Mechanism: Ovarian hormone loss → adipose ceramide overproduction → circulating ceramides → neuronal ETC inhibition and senescence. Prediction: Pharmacologic or genetic reduction of circulating ceramide species in midlife females should improve brain mitochondrial function and cognition even with persistent hypoestrogenism; elevating the same ceramides in young females should induce comparable mitochondrial and cognitive deficits, while male midlife animals with lower ceramide trajectories should be relatively spared.\n\n[H3] The perimenopausal decline in circulating 17β-estradiol specifically impairs estrogen receptor–dependent mitochondrial quality control in metabolically active peripheral tissues, increasing release of circulating mitochondrial damage-associated molecular patterns (mtDAMPs) that activate TLR9/cGAS–STING in microglia and thereby induce neuroinflammation, neuronal senescence, and cognitive vulnerability. Mechanism: E2 loss → peripheral mitophagy failure → circulating mtDAMPs → microglial TLR9/STING → neuroinflammation and cognitive decline. Prediction: Clearing circulating mtDAMPs or inhibiting brain cGAS–STING in midlife females should restore cognition and reduce brain senescence markers independently of restoring estradiol; males or premenopausal females with experimentally elevated circulating mtDAMPs should show similar brain phenotypes.\n\n[H4] Menopause-associated loss of ovarian estradiol removes repression of peripheral cellular senescence, causing adipose and endothelial cells to release senescence-associated extracellular vesicles enriched in damaged mitochondrial DNA and miRNAs (e.g., miR-34a, miR-146a) that are taken up by neurons and glia, thereby propagating mitochondrial dysfunction and senescence in the brain. Mechanism: Estradiol withdrawal → peripheral senescence → EV cargo (mtDNA/miRNAs) → neuronal/glial uptake → brain mitochondrial failure and senescence. Prediction: Depleting circulating EVs or blocking EV uptake in the brain of midlife females should prevent transfer of the senescence phenotype and cognitive decline despite low estradiol, whereas transferring midlife-female EVs into young ovariectomized females should recapitulate brain mitochondrial and cognitive deficits.\n\n[H5] The midlife rise in circulating follicle-stimulating hormone (FSH), secondary to ovarian follicular depletion, acts on FSH receptors in adipose and vascular tissues to induce mitochondrial ROS production and cellular senescence; the resulting circulating SASP factors and oxidized lipids then cross or signal across the blood–brain barrier to drive hippocampal senescence, mitochondrial dysfunction, and cognitive vulnerability. Mechanism: Elevated FSH → peripheral FSHR activation → mitochondrial ROS and senescence → circulating SASP/oxidized lipids → brain senescence and cognitive decline. Prediction: Neutralizing circulating FSH or blocking peripheral FSHR in midlife females should reduce circulating SASP markers, restore brain mitochondrial respiration, and preserve cognition even if estradiol remains low; the same interventions should have little effect in age-matched males or in females before the FSH surge.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5697, "promptSha256": "cc2c68e91db11e178b94be949ff33415e79e80f8075636b7c08e3e39faa07d84" } ] }, { "task": "R42775695", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 4 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCardiac function progressively deteriorates with age, increasing susceptibility to heart failure and other cardiovascular disorders. Defective mitochondrial quality control is considered an important contributor to this decline. Selective removal of damaged mitochondria must remain properly balanced, because disruption at multiple stages of the process can impair cellular homeostasis. The upstream causes of this age-associated defect and whether it can be therapeutically reversed were not well established.\n\nRESEARCH QUESTION\nWhat causes defective mitochondrial quality-control flux in the aging heart, and how can restoring mitochondrial homeostasis reverse cardiac aging?\n\nHYPOTHESES\n[H1] Chronic low-grade inflammation in the aging heart represses transcription of mitophagy receptors (BNIP3, NIX, FUNDC1) and ATG genes via NF-κB/cytokine signaling, starving the QC pathway of receptor capacity. Anti-inflammatory restoration of receptor expression restarts mitochondrial homeostasis and reverses cardiac aging. Mechanism: Persistent TNF-α/IL-1β–NF-κB activity downregulates receptor-mediated (Parkin-independent) mitophagy and general autophagy genes, reducing cargo recognition even when lysosomes and Parkin remain partially functional. Prediction: Aged myocardium will show reduced BNIP3/FUNDC1 protein with elevated inflammatory transcripts; blocking NF-κB or key cytokines will restore receptor levels and mitophagic flux and improve function in a receptor-dependent manner, distinguishable from pure NAD+ or Parkin rescue.\n\n[H2] Progressive NAD+ depletion with age suppresses SIRT1/SIRT3 activity, causing hyperacetylation of mitochondrial and autophagy-regulatory proteins that stalls both mitophagy and mitochondrial biogenesis. Replenishing NAD+ restores sirtuin-dependent mitochondrial homeostasis and reverses cardiac aging. Mechanism: Low NAD+ reduces SIRT3 deacetylation of OXPHOS and QC proteins and SIRT1-dependent FOXO/ATG gene programs, simultaneously impairing selective removal and renewal of mitochondria. Prediction: NAD+ precursors will raise cardiac NAD+, lower mitochondrial protein acetylation, increase mitophagic and biogenic markers together, and improve energetics; SIRT3 knockout will abolish these benefits while Parkin overexpression alone will not fully phenocopy them.\n\n[H3] Age-associated imbalance of mitochondrial dynamics—insufficient DRP1-mediated fission relative to fusion—prevents segregation of damaged mitochondrial fragments needed for selective mitophagy. Restoring fission–fusion balance re-enables QC flux and reverses cardiac aging. Mechanism: Impaired DRP1 recruitment or excessive OPA1/MFN activity keeps damaged regions tethered within elongated networks, so they are not packaged into mitophagosomes and continue to poison the reticulum. Prediction: Aged cardiomyocytes will show hyperfused mitochondria with mixed membrane potential; modest DRP1 activation will increase mitophagy of depolarized fragments and improve function, whereas forcing further fusion will worsen QC failure.\n\n[H4] Aging impairs lysosomal acidification and autophagosome–lysosome fusion in the heart, creating a late-stage block in mitochondrial quality-control flux even when upstream tagging remains intact. Correcting lysosomal function restores complete mitophagic turnover and reverses cardiac aging phenotypes. Mechanism: Age-related loss of v-ATPase activity and SNARE-mediated fusion leaves mitochondria trapped in undegraded autophagosomes, so net QC flux collapses despite preserved early mitophagy signaling. Prediction: Aged hearts will show elevated LC3-II and p62 with uncleared mitochondrial cargo and failed quenching of mt-Keima red signal; lysosomal re-acidification (e.g., TFEB activation) will clear the backlog and improve function without needing to increase Parkin levels.\n\n[H5] Age-dependent decline of PINK1/Parkin signaling in cardiomyocytes reduces selective tagging and clearance of depolarized mitochondria, allowing damaged organelles to accumulate and impair contractile and bioenergetic function. Restoring Parkin-dependent mitophagy flux re-establishes mitochondrial quality and reverses age-related cardiac decline. Mechanism: Reduced PINK1 stabilization and Parkin E3-ligase recruitment on damaged mitochondria lowers ubiquitination of OMM proteins, so damaged mitochondria escape autophagosome engulfment and accumulate ROS-producing organelles that drive cardiomyocyte dysfunction. Prediction: Cardiomyocyte-specific Parkin or PINK1 reactivation in aged hearts will increase mitophagic flux (mt-Keima/mt-pHluorin), lower mtDNA mutation load and ROS, and improve diastolic function more than interventions that only boost biogenesis without enhancing selective clearance.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5379, "promptSha256": "f628df62776782be18e3c47d8beb11c1e3a987ffb57326ccfb326857b3412d56" } ] }, { "task": "R42775698", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIntestinal structure and barrier integrity commonly deteriorate with age, contributing to altered nutrient handling, inflammation, and systemic metabolic dysfunction. Ageing is also accompanied by changes in circulating metabolites and intestinal gene expression. Observational studies have linked these features, but such associations cannot establish whether age-related changes in the intestinal ecosystem actively cause host dysfunction. The mechanisms connecting donor age-associated biological states to impaired intestinal physiology therefore remained unclear.\n\nRESEARCH QUESTION\nCan age-associated differences in the human gut microbial community causally reprogram intestinal barrier function, systemic metabolism, and mucosal gene expression, and what mediators contribute to these effects?\n\nHYPOTHESES\n[H1] Transplantation of gut microbiota from older human donors into germ-free or antibiotic-treated young recipient animals causally impairs intestinal epithelial barrier integrity relative to microbiota from young donors. This effect is driven by enrichment of age-associated taxa that reduce mucus thickness and tight-junction protein expression. Mechanism: Age-enriched mucin-degrading and pro-inflammatory taxa deplete mucus and downregulate occludin, claudin-1, and ZO-1, increasing paracellular permeability. Prediction: Older-donor microbiota recipients show higher FITC-dextran flux and lower tight-junction protein levels than young-donor recipients; co-colonization or selective depletion of candidate mucin degraders abolishes the barrier defect while matched metabolite profiles without those taxa do not.\n\n[H2] Older human gut microbial communities causally induce a mucosal gene-expression program enriched for inflammatory and innate immune pathways (NF-κB, TLR, interferon) and depleted for epithelial differentiation and nutrient-transport genes. Mechanism: Age-associated microbial PAMPs and metabolites chronically activate TLR/MyD88 and inflammasome pathways in the epithelium and lamina propria, remodeling the mucosal transcriptome. Prediction: RNA-seq of ileum/colon from older-donor recipients recapitulates age-linked human mucosal signatures; MyD88 or TLR4 deficiency in recipients blocks the inflammatory transcriptional shift while barrier and metabolic phenotypes remain partially intact.\n\n[H3] Microbiota-derived tryptophan metabolites (especially reduced indole derivatives and elevated kynurenine-pathway products) mediate age-associated barrier failure and metabolic dysfunction after older-donor colonization. Mechanism: Loss of bacterial tryptophanase/indole producers and gain of host–microbe kynurenine flux impair AhR-dependent IL-22 and regenerative signaling while promoting aryl-hydrocarbon-independent inflammatory tone. Prediction: Older-donor recipients have lower fecal/serum indoles and higher kynurenine; dietary indole or AhR agonism restores barrier and metabolic readouts in older-donor animals, whereas tryptophan restriction worsens young-donor outcomes to older-donor levels.\n\n[H4] Age-associated microbiota causally increase intestinal permeability and systemic low-grade inflammation through elevated microbial lipopolysaccharide bioavailability and impaired epithelial alkaline-phosphatase detoxification, linking barrier breach to metabolic endotoxemia. Mechanism: Older communities raise LPS load and suppress host intestinal alkaline phosphatase, allowing LPS translocation that activates TLR4 in adipose and liver, driving cytokine production and insulin resistance. Prediction: Older-donor recipients show higher portal and circulating LPS, lower intestinal alkaline-phosphatase activity, and elevated TNF-α/IL-6; LPS neutralization, TLR4 blockade, or alkaline-phosphatase supplementation selectively reverse metabolic inflammation without fully normalizing mucus or SCFA profiles.\n\n[H5] Age-associated human gut microbiota causally reprogram host systemic metabolism by elevating circulating secondary bile acids and reducing short-chain fatty acids, producing insulin resistance and altered lipid profiles independent of caloric intake. Mechanism: Shifted microbial bile-salt hydrolase and 7α-dehydroxylation activity plus diminished butyrate/propionate producers change FXR/TGR5 and GPR41/43 signaling in liver and adipose tissue. Prediction: Older-donor recipients exhibit higher serum deoxycholate, lower butyrate, worsened glucose tolerance, and hepatic steatosis; restoring young-like SCFA or bile-acid pools (or FXR antagonism) rescues metabolic phenotypes without restoring the full young microbiota.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5219, "promptSha256": "8e7f289a02f5c42dbc912158f86c90fab11dea5c68ff8ca5dcacd1b6bc395a7f" } ] }, { "task": "R42786310", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing involves coordinated deterioration across metabolic, immune and organ systems, accompanied by changes in host-associated microbial communities. Microbiome composition correlates with biological age and age-related physiological states, but such associations do not establish whether individual microorganisms can modify the ageing process. Some microbial interventions alter host metabolism and longevity in experimental models, although causal effects often depend on organism viability, microbial products and host context. It therefore remained unclear whether systematic integration of diverse human biological measurements could identify a microorganism with experimentally reproducible geroprotective activity.\n\nRESEARCH QUESTION\nCan a commensal microorganism predicted from integrated human ageing profiles causally extend lifespan and healthspan and shift age-associated molecular and microbial states toward younger configurations?\n\nHYPOTHESES\n[H1] Cell-surface or secreted immunoregulatory molecules from the predicted microorganism engage host pattern-recognition and Treg pathways, lowering inflammageing and thereby extending healthspan and lifespan. Mechanism: Microbial PAMPs or secreted proteins induce IL-10 and Foxp3+ regulatory T cells while reducing chronic innate immune activation, reversing age-associated inflammatory tone without requiring major metabolic shifts. Prediction: Benefits will persist with heat-killed or purified surface-component preparations, require intact host TLR/NOD or IL-10 signalling, and be accompanied by expanded Treg frequencies and reduced inflammasome activity; metabolically inert mutants that retain surface immunogens will still extend lifespan.\n\n[H2] The microorganism improves host mitochondrial and metabolic efficiency via bile-acid or other signalling metabolites that activate AMPK/SIRT pathways, delaying molecular ageing clocks and extending lifespan. Mechanism: Microbial transformation of host bile acids or production of NAD+-related cofactors activates energy-sensing pathways, enhances oxidative phosphorylation, and slows epigenetic and transcriptomic ageing signatures. Prediction: Colonized hosts will show shifted bile-acid pools, elevated AMPK/SIRT activity, younger epigenetic clock estimates, and longer lifespan; genetic or pharmacological blockade of AMPK/SIRT or of microbial bile-acid transforming enzymes will abolish geroprotection while leaving immune markers relatively unchanged.\n\n[H3] A human gut commensal identified by integrative ageing-profile association produces short-chain fatty acids that restore intestinal barrier integrity, thereby reducing systemic inflammation and extending host lifespan and healthspan. Mechanism: Microbial fermentation yields SCFAs (especially butyrate) that reinforce tight junctions, dampen NF-κB-driven inflammatory signalling, and recalibrate metabolic set-points toward a youthful state. Prediction: Gnotobiotic or aged hosts colonized with the viable strain will show elevated faecal and circulating SCFAs, lower plasma inflammatory markers, improved barrier assays, and longer median lifespan relative to heat-killed or SCFA-deficient mutant controls; these benefits will be phenocopied by exogenous SCFA supplementation and abolished by antibiotic depletion of the strain.\n\n[H4] Geroprotective effects require ongoing colonization by a live, metabolically active strain whose continuous production of multiple bioactive products jointly shifts host molecular and microbial states toward younger configurations; dead cells or single purified products are insufficient. Mechanism: Sustained in situ synthesis of a suite of metabolites and immunomodulators, plus niche occupancy, is necessary to maintain youthful multi-omic host states and suppress age-associated dysbiosis over time. Prediction: Only repeated or persistent colonization with viable wild-type organisms will extend lifespan, reverse age-associated multi-omic signatures, and stabilize a younger microbiome; single metabolites, heat-killed cells, or transient exposure will produce incomplete or transient molecular shifts without durable lifespan extension.\n\n[H5] The predicted commensal extends lifespan by remodelling the host gut microbiota toward a younger community structure, with secondary taxa mediating metabolic and immune rejuvenation. Mechanism: The colonizer occupies ecological niches, produces antimicrobial or cross-feeding metabolites that suppress age-associated pathobionts and enrich youth-associated taxa, shifting the overall microbiome composition and function. Prediction: Colonization will significantly alter beta-diversity toward younger reference profiles, and transplant of the remodeled community (without the original strain) into aged germ-free hosts will partially recapitulate lifespan and molecular rejuvenation, whereas colonization of hosts that cannot support secondary community change will yield weaker or null effects.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5595, "promptSha256": "c4932cdac949834e8adc7b95455da1f15562ba4812c8cd144c0f0566da0732ca" } ] }, { "task": "R42805954", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 4 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is associated with declining thermogenic capacity in adipose tissue, impaired energy expenditure, and increased susceptibility to metabolic dysfunction. Subcutaneous white adipose tissue can acquire heat-producing adipocytes in response to environmental stimuli, but this capacity diminishes with age. Communication between the nervous system and adipose tissue helps regulate this adaptive response. The mechanisms responsible for its age-related deterioration remained incompletely understood.\n\nRESEARCH QUESTION\nWhat causal mechanism contributes to the age-related decline of thermogenic adipocytes in subcutaneous white adipose tissue?\n\nHYPOTHESES\n[H1] Pathologically elevated TGF-β/SMAD signaling in aging subcutaneous adipose tissue actively represses the PRDM16–PGC-1α thermogenic program in adipocyte progenitors. Inhibiting TGF-β signaling would therefore reverse age-related loss of inducible beige adipocytes. Mechanism: Age-increased TGF-β ligands and SMAD2/3 activity transcriptionally and epigenetically silence beige identity genes and blunt β-adrenergic responsiveness of progenitors. Prediction: Pharmacologic or genetic TGF-β/SMAD inhibition in aged mice will restore cold- and β3-agonist–induced UCP1+ adipocytes and energy expenditure; chromatin at Ucp1/Ppargc1a loci will regain permissive marks, whereas restoring sympathetic tone alone will not fully reopen these loci if TGF-β remains high.\n\n[H2] Age-related loss of sympathetic innervation density and norepinephrine release in subcutaneous white adipose tissue causally impairs β3-adrenergic recruitment of thermogenic (beige) adipocytes. Restoring local catecholaminergic tone would therefore rescue cold- or agonist-induced browning in aged animals. Mechanism: Progressive sympathetic axon rarefaction and reduced vesicular norepinephrine availability lower β3-AR–cAMP–PKA signaling in adipocyte progenitors and mature adipocytes, preventing UCP1 induction and beige differentiation. Prediction: Aged scWAT will show reduced tyrosine hydroxylase+ fiber density and lower tissue norepinephrine; local β3-agonist delivery or chemogenetic reactivation of adipose-projecting sympathetic neurons will restore UCP1+ beige adipocytes and cold-induced energy expenditure without requiring systemic endocrine rescue.\n\n[H3] Senescent PDGFRα+/CD81+ beige adipocyte progenitors accumulate with age and, via a senescence-associated secretory phenotype, both lose differentiation competence and suppress neighboring progenitors. Clearing these senescent cells would restore thermogenic adipocyte formation. Mechanism: p16Ink4a/p21-driven senescence depletes the inducible beige progenitor pool and releases SASP factors (e.g., IL-6, TGF-β ligands) that lock remaining progenitors in a non-thermogenic state. Prediction: Senolytic treatment or genetic ablation of p16+ cells in aged mice will increase cold-inducible UCP1+ adipocytes and progenitor differentiation ex vivo more than equivalent β3-agonist dosing alone, and SASP blockade will phenocopy part of that rescue.\n\n[H4] Age-associated shift of adipose-resident macrophages toward a pro-inflammatory phenotype suppresses beige adipogenesis through cytokine-mediated inhibition of the thermogenic transcriptional program. Reprogramming or depleting these macrophages would restore browning capacity. Mechanism: Elevated TNF-α, IL-1β, and related cytokines from aged adipose macrophages repress Ppargc1a/Ucp1 and antagonize β-adrenergic–driven beige differentiation in progenitors and mature white adipocytes. Prediction: Macrophage-specific interruption of inflammatory cytokine production (or adoptive transfer of young macrophages into aged scWAT) will restore cold-induced UCP1 expression even when sympathetic innervation remains age-typical, distinguishing immune suppression from primary denervation.\n\n[H5] Age-dependent stiffening and fibrotic remodeling of the scWAT extracellular matrix create a biomechanical niche that blocks beige adipocyte emergence. Softening or degrading the aged matrix would reinstate thermogenic adipocyte induction. Mechanism: Increased collagen cross-linking and integrin–YAP/TAZ mechanotransduction in aged fat divert progenitor fate away from the beige lineage and limit vascular–nerve co-recruitment needed for sustained thermogenesis. Prediction: Enzymatic or pharmacologic reduction of matrix stiffness in aged scWAT will increase beige adipocyte formation under cold challenge without raising circulating catecholamines or FGF21, and progenitors plated on young- versus aged-derived matrix will show matrix-dependent UCP1 induction.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5237, "promptSha256": "d43797401503a28703ecf497062c5ac14b5e30a1887d28f6be733c94b0b1ba21" } ] }, { "task": "R42810392", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is strongly influenced by conserved systems that coordinate cellular metabolism with nutrient and energy availability. Genetic studies have shown that altering metabolic regulation can affect lifespan in several model organisms. Pharmacological studies, however, often use compounds with multiple targets, making it difficult to attribute longevity effects to a specific mechanism. It therefore remained unclear whether selective engagement of a single conserved metabolic target could directly produce longevity benefits across species.\n\nRESEARCH QUESTION\nCan direct pharmacological activation of a conserved metabolic target extend lifespan across evolutionarily diverse organisms and induce longevity-associated changes in mammals?\n\nHYPOTHESES\n[H1] AMPK-driven longevity across species requires inhibition of mTORC1 as an obligatory downstream effector. Without mTORC1 suppression, AMPK activation will not produce lifespan extension or mammalian longevity-associated remodeling. Mechanism: Activated AMPK phosphorylates TSC2 and Raptor, lowering mTORC1 activity, which reduces protein synthesis and enhances autophagy—shared anti-aging outputs conserved from worms to mammals. Prediction: Genetic or pharmacological locking of mTORC1 in an active state will abolish lifespan extension by the AMPK agonist in invertebrates and block longevity-linked autophagy and metabolic shifts in mammalian tissues despite intact AMPK activation.\n\n[H2] Cross-species lifespan extension from activating a conserved metabolic target depends on FOXO/DAF-16 orthologs. AMPK (or the analogous sensor) extends life by stabilizing or activating FOXO-dependent stress-resistance and detoxification programs. Mechanism: AMPK phosphorylates and promotes nuclear FOXO/DAF-16 activity, inducing antioxidant, proteostasis, and stress-response genes that are causal for longevity in invertebrates and for healthspan-related gene programs in mammals. Prediction: Loss of FOXO/DAF-16 orthologs will eliminate lifespan gains from the selective agonist in worms/flies, and mammalian FOXO-deficient tissues will fail to show the longevity-associated transcriptional signature despite AMPK engagement.\n\n[H3] Selective pharmacological activation of AMPK is sufficient to extend lifespan in evolutionarily distant invertebrates and to induce longevity-associated physiological and molecular signatures in mammals. The longevity benefit is caused by AMPK itself rather than off-target pharmacology of multi-target drugs. Mechanism: Direct AMPK activation increases catabolic programs (fatty-acid oxidation, autophagy, mitochondrial biogenesis) and dampens anabolic growth signaling, shifting cells into a conserved energy-sparing, stress-resistant state that slows aging. Prediction: A highly selective AMPK agonist will extend lifespan in C. elegans and Drosophila and, in mice, raise AMPK activity, improve metabolic healthspan markers, and induce transcriptomic/proteomic aging-delay signatures, whereas chemically related inactive analogs will not.\n\n[H4] Pharmacological activation of the conserved metabolic target extends invertebrate lifespan primarily by improving mitochondrial quality and biogenesis via PGC-1α/ERR-like coactivators; the same axis drives longevity-associated metabolic remodeling in mammalian liver and muscle. Mechanism: AMPK phosphorylates PGC-1α (and related regulators), increasing mitochondrial biogenesis, oxidative capacity, and mitophagy, thereby reducing bioenergetic failure and oxidative damage that accelerate aging. Prediction: Blocking PGC-1α (or invertebrate orthologs) will prevent lifespan extension by the agonist and abolish increased mitochondrial content, OCR, and mitochondrial gene programs in treated mammals, while other AMPK outputs remain intact.\n\n[H5] Direct activation of the conserved metabolic target produces true longevity benefits in mammals only when it induces tissue-specific metabolic remodeling (improved insulin sensitivity, reduced ectopic lipid, enhanced autophagy) that parallels genetic longevity models; invertebrate lifespan extension alone is insufficient evidence of a conserved anti-aging mechanism. Mechanism: Systemic AMPK activation rewires nutrient handling in liver, adipose, and skeletal muscle, lowering chronic nutrient-sensing stress and aligning mammalian physiology with states seen in calorie restriction and long-lived mutants. Prediction: Treated mammals will show measurable longevity-associated changes—improved glucose homeostasis, CR-like hepatic and muscle transcriptomes, and delayed aging biomarkers—correlated with on-target engagement; compounds that extend worm/fly lifespan without these mammalian changes will be classified as non-conserved or off-pathway.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5367, "promptSha256": "eb1c7bdb36783eb667772cba56931ac9416d0c7b96e30afaaf778c737fc6ad1a" } ] }, { "task": "R42811497", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nLocalized scleroderma is characterized by excessive extracellular-matrix deposition and progressive skin fibrosis. Cellular senescence can promote persistent tissue remodeling and fibrotic disease through altered cell function and inflammatory signaling. Disturbances in organelle homeostasis have also been associated with both senescence and fibrosis. The causal molecular mechanisms connecting these processes in localized scleroderma, and whether they can be therapeutically reversed, remained incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism drives cellular senescence and fibrosis in localized scleroderma, and can pharmacological disruption of that mechanism alleviate the disease phenotype?\n\nHYPOTHESES\n[H1] Expanded mitochondria–ER contact sites (MERCS) in scleroderma fibroblasts dysregulate IP3R–VDAC–MCU calcium transfer, producing mitochondrial Ca2+ overload, ROS, and senescence while amplifying TGF-β–SMAD signaling at ER-associated scaffolds. Disrupting excessive MERCS pharmacologically should decouple senescence from fibrosis. Mechanism: Hyperconnected MERCS → Ca2+ overload and ROS → DNA damage senescence; local Ca2+/kinase scaffolds enhance SMAD nuclear activity and collagen transcription Prediction: Knockdown or pharmacologic disruption of tethering proteins (e.g., FUNDC1/IP3R–VDAC linkers) will normalize mitochondrial Ca2+, lower p21 and COL1A1, and shrink lesion thickness; merely scavenging ROS without altering contacts will reduce senescence markers less effectively than MERCS disruption.\n\n[H2] Chronic ER stress and unresolved UPR (PERK–ATF4–CHOP and IRE1–XBP1) in dermal fibroblasts of localized scleroderma couple translational repression and oxidative stress to senescence while transcriptionally upregulating collagen and fibronectin genes. Pharmacologic UPR modulators that restore ER proteostasis should alleviate both phenotypes. Mechanism: ER calcium/proteostasis failure → sustained PERK/IRE1 signaling → CHOP-linked senescence and XBP1/ATF4-driven ECM gene expression Prediction: Selective PERK or IRE1 inhibitors will reduce CHOP, SA-β-gal, and dermal hydroxyproline in scleroderma models without broadly suppressing TGF-β receptors; forcing ER stress in healthy fibroblasts will recapitulate senescence-plus-fibrosis, supporting UPR as causal over pure mitochondrial ROS.\n\n[H3] Impaired autophagic flux and lysosomal acidification in scleroderma fibroblasts cause accumulation of damaged organelles, which triggers p53/p21-dependent senescence and persistent TGF-β–driven fibrogenesis. Restoring autophagy with mTORC1 inhibition or lysosomal re-acidification should reverse senescence and fibrosis. Mechanism: Lysosomal/autophagy failure → uncleared damaged mitochondria and protein aggregates → genotoxic and proteotoxic stress → p53/p21 senescence → TGF-β/SMAD ECM program Prediction: Low-dose rapamycin or a lysosomal acidification enhancer will increase LC3-II flux, reduce p16 and collagen I/III in lesional skin, and outperform pure senolytics on fibrosis scores if autophagy restoration is the causal node.\n\n[H4] Senescent dermal cells in localized scleroderma sustain fibrosis through a PDGF/TGF-β–rich SASP that feeds forward via PDGFR–PI3K–Akt–mTOR to reinforce senescence and myofibroblast differentiation; dual disruption of SASP signaling and mTOR should regress established lesions better than targeting either arm alone. Mechanism: Senescent cell SASP (TGF-β, PDGF, IL-6) → PDGFR/TGFBR–PI3K–Akt–mTOR → myofibroblast conversion, ECM deposition, and further senescence Prediction: Combined senolytic clearance plus mTOR or PDGFR inhibition will reduce α-SMA+ myofibroblasts and dermal thickness more than senolytics or antifibrotics alone, and conditioned medium from treated senescent cells will lose fibrogenic activity on naïve fibroblasts.\n\n[H5] In localized scleroderma, mitochondrial dysfunction in dermal fibroblasts elevates ROS and releases mtDNA into the cytosol, activating cGAS–STING and thereby locking cells into a senescent, SASP-secreting state that drives collagen deposition. Pharmacologic inhibition of STING or clearance of dysfunctional mitochondria should reduce both senescence markers and dermal fibrosis. Mechanism: Damaged mitochondria → cytosolic mtDNA → cGAS–STING → NF-κB/IRF3-dependent SASP → paracrine fibroblast activation and ECM overproduction Prediction: STING knockout or STING inhibitor treatment in patient-derived fibroblasts and in a localized scleroderma mouse model will lower SA-β-gal, p16/p21, SASP cytokines, and dermal collagen thickness more than TGF-β receptor blockade alone, whereas restoring STING after mitochondrial damage will re-induce the fibrotic phenotype.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5328, "promptSha256": "8c3eea846304f632a64aef4a75384f062a7b6b6271eeeff4c50ece7b2a5f36ca" } ] }, { "task": "R42821663", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOsteoarthritis is a common degenerative disease whose incidence and severity increase with age. Mechanical damage and age-associated changes in joint tissues create susceptibility to progressive cartilage loss. Systemic metabolic disorders, including hypertension, have been associated with greater osteoarthritis risk and severity. However, it was unclear whether elevated blood pressure actively promotes joint degeneration through a defined biological mechanism rather than merely sharing risk factors with osteoarthritis.\n\nRESEARCH QUESTION\nThrough what causal mechanism does hypertension accelerate osteoarthritis in joints predisposed by aging or mechanical injury?\n\nHYPOTHESES\n[H1] Hypertension accelerates osteoarthritis by chronically elevating subchondral bone interstitial fluid pressure, which dysregulates osteocyte–chondrocyte signaling and drives cartilage matrix catabolism in joints already weakened by aging or injury. Mechanism: Sustained high arterial pressure transmits through the subchondral vascular bed, raising intraosseous fluid pressure; osteocytes then release catabolic mediators (e.g., RANKL, sclerostin, PGE2) that increase chondrocyte MMP and ADAMTS activity and impair matrix synthesis. Prediction: In aged or injury-primed joints, experimentally lowering subchondral intraosseous pressure (without changing systemic inflammatory markers or RAAS activity) will reduce cartilage proteoglycan loss and MMP expression relative to hypertensive controls with matched systemic blood pressure elsewhere.\n\n[H2] Hypertension accelerates osteoarthritis by amplifying low-grade systemic and synovial inflammation (IL-6, TNF-α, CRP), which primes synoviocytes and chondrocytes for exaggerated catabolic responses after aging or mechanical insult. Mechanism: Hypertensive vascular inflammation elevates circulating and synovial pro-inflammatory cytokines that sensitize joint cells; subsequent injury or age-related microdamage then triggers disproportionate MMP/ADAMTS induction and synovial hyperplasia. Prediction: Cytokine neutralization (e.g., anti–IL-6 or anti–TNF) in hypertensive animals will reduce OA severity in predisposed joints to levels similar to normotensive controls despite persistent hypertension, whereas equal pressure reduction without cytokine reduction will be less protective.\n\n[H3] Hypertension accelerates osteoarthritis by stiffening and remodeling subchondral bone via altered vascular tone and mechanotransduction, creating an overly rigid support that concentrates shear stress on overlying cartilage after aging or injury. Mechanism: Chronic high pressure and pulsatile load remodel subchondral trabeculae (increased bone volume fraction and plate-like architecture), raising cartilage contact stresses and accelerating fibrillation and proteoglycan loss in mechanically vulnerable joints. Prediction: Hypertensive, predisposed joints will exhibit earlier increases in subchondral bone mineral density and stiffness that temporally precede cartilage thinning; interventions that normalize subchondral compliance without lowering systemic pressure will reduce cartilage damage more than vasodilators that lower pressure but leave bone stiff.\n\n[H4] Hypertension accelerates osteoarthritis through local activation of the renin–angiotensin system in synovium and cartilage, where angiotensin II signaling directly promotes chondrocyte senescence and extracellular-matrix degradation. Mechanism: Elevated systemic angiotensin II and upregulated joint ACE/AT1R increase NF-κB and TGF-β/Smad signaling in chondrocytes and synoviocytes, upregulating collagenases and aggrecanases while suppressing type II collagen and aggrecan synthesis. Prediction: Joint-targeted AT1R blockade or ACE inhibition will slow cartilage degeneration in hypertensive, injury- or age-predisposed animals even when systemic blood pressure remains high via a non-RAAS pressor, outperforming pressure-matched controls without RAAS blockade.\n\n[H5] Hypertension accelerates osteoarthritis by inducing synovial and subchondral microvascular rarefaction and endothelial dysfunction, causing chronic cartilage hypoxia and oxidative stress that amplify age- or injury-driven matrix failure. Mechanism: Hypertensive endothelial damage and capillary loss reduce oxygen and nutrient delivery to avascular cartilage; HIF-1α and ROS then activate MMPs, impair autophagy, and accelerate chondrocyte apoptosis in predisposed joints. Prediction: Hypertensive joints with age or mechanical priming will show reduced synovial/subchondral capillary density, lower cartilage pO2, and higher oxidative damage markers preceding lesion progression; restoring microvascular density or scavenging ROS will attenuate OA more than blood-pressure reduction alone when perfusion is not restored.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5426, "promptSha256": "6241d1cb96ccadbfedd99e9286c1e7ea7e043257c7b02e77c54075e9bd634a17" } ] }, { "task": "R42822442", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSolid tumors create metabolically stressful microenvironments in which rapidly proliferating malignant and immune cells compete for limited nutrients. Adoptively transferred immune cells often lose function and fail to persist under these conditions, limiting therapeutic efficacy. Cellular senescence can produce durable functional decline in immune cells, but the metabolic signals that initiate this state within tumors have remained incompletely understood. Identifying the causal signaling events could reveal ways to preserve therapeutic immune-cell activity.\n\nRESEARCH QUESTION\nHow does nutrient scarcity in the solid-tumor microenvironment cause senescence and loss of persistence in adoptively transferred antitumor immune cells?\n\nHYPOTHESES\n[H1] Chronic nutrient competition depletes NAD+ in adoptively transferred antitumor cells, impairing SIRT1 activity and allowing hyperacetylated p53 to drive a senescence transcriptional program that abolishes long-term persistence. Mechanism: NAD+-consuming stress pathways and limited salvage precursors lower NAD+/NADH; reduced SIRT1 fails to deacetylate p53, potentiating p53-dependent senescence gene expression and durable functional decline. Prediction: NAD+ precursors (e.g., NMN/NR) or SIRT1 activation in transferred cells should lower acetyl-p53, senescence markers, and improve persistence in nutrient-scarce tumors, with little benefit if p53 is deleted.\n\n[H2] Nutrient scarcity lowers acetyl-CoA availability in adoptively transferred immune cells, causing histone hypoacetylation that epigenetically locks in a senescence gene program and prevents persistence even after nutrient restoration. Mechanism: Reduced glycolytic and TCA-derived acetyl-CoA decreases histone acetyltransferase activity at proliferation loci while permitting repressive chromatin at effector genes, converting reversible metabolic stress into stable senescence. Prediction: Histone deacetylase inhibition or acetate supplementation that restores histone acetylation should reverse senescence markers and persistence failure after nutrient stress more effectively than acute nutrient repletion alone, distinguishing epigenetic locking from purely signaling-based hypotheses.\n\n[H3] Nutrient scarcity forces adoptively transferred T cells into inefficient mitochondrial metabolism that elevates ROS, causing DNA damage responses that initiate irreversible senescence and loss of persistence. Mechanism: Substrate limitation and electron-transport inefficiency increase mitochondrial ROS; ROS-induced double-strand breaks activate ATM/ATR–p53–p21 and p16INK4a pathways, establishing stable senescence. Prediction: Mitochondria-targeted antioxidants or SOD2 overexpression in transferred cells should reduce DDR foci and senescence markers and improve persistence under nutrient stress, whereas AMPK or GCN2 inhibition alone would not fully phenocopy this rescue if ROS is the dominant driver.\n\n[H4] Depletion of glutamine and other amino acids in solid tumors activates the GCN2–ATF4 integrated stress response in adoptively transferred immune cells, driving a senescence-associated secretory and growth-arrest phenotype that limits persistence. Mechanism: Uncharged tRNAs activate GCN2, phosphorylating eIF2α and inducing ATF4; sustained ATF4 programs upregulate cell-cycle inhibitors and SASP factors, locking cells into senescence rather than reversible quiescence. Prediction: GCN2-null or ATF4-deficient transferred cells should resist senescence and persist longer in amino-acid-poor tumors, with rescue by exogenous glutamine restoring function only in GCN2-intact cells.\n\n[H5] Glucose scarcity in the tumor microenvironment activates AMPK in adoptively transferred T cells, which stabilizes p53 and induces a p21-dependent senescence program that curtails proliferation and persistence. Mechanism: Low ATP/AMP ratios from glucose competition trigger AMPK; AMPK phosphorylates p53 (Ser15), upregulating CDKN1A/p21 and enforcing durable cell-cycle arrest characteristic of senescence. Prediction: Pharmacologic or genetic AMPK blockade in transferred T cells should reduce p21 and senescence markers (SA-β-gal, γH2AX) and restore persistence specifically under glucose-limited but not nutrient-replete conditions, more than interventions targeting amino-acid sensors alone.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4951, "promptSha256": "948d3f95b3e4d03129f34e69ffc891f82e08c23924d68eb4cb2bb27511d18008" } ] }, { "task": "R42826184", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nThree-dimensional genome organization helps regulate transcription by partitioning chromosomes into domains and controlling contacts between regulatory elements and gene promoters. Ageing is accompanied by widespread transcriptional dysregulation, including chronic inflammation and impaired immune function. Changes in chromatin structure have been observed during ageing, but whether they actively drive age-related gene-expression programs rather than merely accompany them has remained unclear. The molecular mechanisms connecting altered genome topology to physiological decline are also poorly understood.\n\nRESEARCH QUESTION\nWhat causal molecular mechanism remodels three-dimensional genome organization during ageing and thereby promotes age-associated inflammatory and activation-related transcription?\n\nHYPOTHESES\n[H1] Age-dependent depletion or impaired loading of cohesin and CTCF erodes topologically associating domain (TAD) boundaries at inflammatory and immune-activation loci, permitting ectopic enhancer–promoter contacts that drive chronic inflammatory transcription. Mechanism: Reduced cohesin–CTCF loop extrusion fidelity with chronological age weakens insulating boundaries, allowing distal enhancers to ectopically contact promoters of NF-κB/STAT target genes and lock in an inflammatory expression program. Prediction: Restoring cohesin loading (e.g., NIPBL/MAU2 overexpression or CTCF repletion) in aged cells should re-establish TAD insulation at inflammatory hubs and selectively downregulate age-associated activation genes without broadly reversing unrelated ageing chromatin marks such as LAD detachment.\n\n[H2] Age-associated loss of Polycomb/H3K27me3 repression and gain of H3K27ac at poised inflammatory enhancers decompacts chromatin and enables new loop extrusion or hub contacts that activate age-related inflammatory transcription. Mechanism: Decline in PRC2 activity and redistribution of acetylation open enhancer chromatin at immune loci, lowering the energetic barrier to cohesin-mediated looping and permitting promoter engagement that was blocked in youth. Prediction: Restoring H3K27me3 (e.g., EZH2 reactivation) or blocking p300/CBP at those enhancers in aged cells should collapse the novel contacts and suppress inflammatory transcription without correcting lamina defects or global cohesin levels, separating epigenetic unlocking from structural lamina or cohesin primary causes.\n\n[H3] Age-elevated NF-κB and related inflammatory transcription factors recruit cohesin and Mediator to their binding sites, thereby constructing self-reinforcing 3D enhancer hubs that propagate chronic inflammatory and activation gene expression. Mechanism: Increased nuclear NF-κB occupancy with age scaffolds architectural protein complexes at cytokine and activation loci, building multi-enhancer hubs whose topology both depends on and amplifies inflammatory transcription. Prediction: Acute NF-κB blockade in aged tissue should rapidly dismantle the inflammatory hubs and their specific long-range contacts before bulk TAD structure or lamina integrity recovers, whereas cohesin restoration without NF-κB inhibition would leave hub-centric contacts intact.\n\n[H4] Persistent DNA damage signaling in ageing and senescent cells actively recruits chromatin remodelers and cohesin to inflammatory gene neighborhoods, forging new long-range loops that sustain activation-related transcription. Mechanism: Chronic ATM/ATR and γH2AX signaling at unresolved lesions concentrates remodelers (e.g., SWI/SNF) and architectural factors at nearby inflammatory enhancers, creating de novo enhancer–promoter loops that drive inflammageing programs. Prediction: Inhibiting ATM/ATR or clearing senescent cells should dissolve the age-specific inflammatory loops and reduce activation transcription even when global CTCF levels remain low, distinguishing damage-driven looping from passive boundary erosion.\n\n[H5] Progressive nuclear lamina dysfunction (reduced lamin A/C integrity and altered lamina-associated domain architecture) releases heterochromatic inflammatory and interferon-response genes from the nuclear periphery into a transcriptionally permissive interior compartment during ageing. Mechanism: Age-related lamina weakening remaps LADs, relocating repressed immune-activation loci away from the nuclear envelope into A-compartment hubs where they gain enhancer contacts and become chronically transcribed. Prediction: Stabilizing lamin A/C or experimentally tethering inflammatory loci back to the lamina in aged cells should re-silence those genes and reduce SASP-like transcription, whereas restoring cohesin alone would not reverse their radial repositioning.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5326, "promptSha256": "9a94b40bebbe49f2bf2b65057b3b4e35a5298e43822276c40b4cf48a410aaaad" } ] }, { "task": "R42839094", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 2 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by widespread changes in metabolism and cellular composition. Lipids support membrane organization, signaling and energy storage, and age-associated lipid disturbances have been observed across many tissues and organisms. Some lipid changes correlate with age-related disease and physiological decline, but their functional importance remains uncertain. A central unresolved question is whether conserved lipid remodeling actively drives ageing or merely reflects it.\n\nRESEARCH QUESTION\nDoes a conserved form of lipid remodeling actively constrain lifespan, and what molecular regulator controls it?\n\nHYPOTHESES\n[H1] Age-associated loss of ether-linked phospholipids (plasmalogens), caused by declining peroxisomal alkylglycerone phosphate synthase (AGPS) activity, constrains lifespan by increasing membrane oxidative susceptibility and impairing vesicle trafficking. Restoring AGPS or ether-lipid levels extends life. Mechanism: Reduced AGPS lowers plasmalogen content in membranes, weakening antioxidant buffering at sn-1 vinyl-ether bonds and disrupting synaptic and autophagic membrane fusion, thereby accelerating functional decline. Prediction: AGPS overexpression or dietary alkylglycerol supplementation that specifically restores plasmalogens will extend lifespan and improve oxidative-stress resistance without normalizing ceramides or triglyceride stores; AGPS loss-of-function will shorten life and occlude other lipid interventions that act through ether lipids.\n\n[H2] A conserved age-dependent rise in long-chain ceramides, driven by elevated serine palmitoyltransferase (SPT) activity, actively shortens lifespan by impairing insulin/IGF signaling and mitochondrial respiratory capacity. Genetic or pharmacological reduction of SPT or ceramide synthases therefore extends lifespan across taxa. Mechanism: SPT-dependent de novo sphingolipid synthesis increases membrane and circulating ceramides that dampen IIS/AKT and promote mitochondrial outer-membrane permeabilization and ROS, accelerating physiological decline. Prediction: Tissue-specific SPT knockdown or myriocin treatment that lowers ceramides will extend lifespan and restore youthful IIS/mitochondrial markers even when other age-linked lipid classes remain altered; restoring ceramides will abolish the benefit.\n\n[H3] Age-driven upregulation of ALCAT1-mediated pathological cardiolipin remodeling (enrichment in polyunsaturated acyl chains) destabilizes mitochondrial electron-transport chain supercomplexes and elevates ROS, actively constraining lifespan. Suppressing ALCAT1 or preserving tafazzin-dependent mature cardiolipin extends life. Mechanism: ALCAT1 replaces mature tetralinoleoyl-cardiolipin with PUFA-rich species that are peroxidation-prone, disrupting cristae architecture and Complex I/III efficiency, which feeds forward into further oxidative damage and energy failure. Prediction: ALCAT1 knockout or cardiolipin-stabilizing interventions will preserve youthful cardiolipin acyl composition, improve ETC efficiency, and extend lifespan independently of bulk ceramide or MUFA changes; ALCAT1 overexpression will shorten life and reverse longevity from mitochondrial protectants that act via cardiolipin.\n\n[H4] Declining lysosomal acid lipase (LIPA/lipl-4) activity with age causes undegraded neutral lipids and lipofuscin to accumulate, which actively constrains lifespan by impairing autophagy–lysosome flux and inducing chronic lipotoxicity. Restoring lysosomal lipolysis extends lifespan. Mechanism: Insufficient lysosomal hydrolysis of cholesteryl esters and triglycerides generates indigestible lipid aggregates that clog lysosomes, reduce autophagic clearance of damaged organelles, and release toxic free fatty acids into the cytosol. Prediction: Tissue-specific LIPA/lipl-4 overexpression or lysosome-targeted lipase activation will clear lipofuscin, restore autophagic flux, and extend lifespan without requiring correction of plasma membrane sphingolipid or plasmalogen composition; lipase inhibition will shorten life and abolish benefits of fasting or autophagy inducers that depend on lysosomal lipolysis.\n\n[H5] Progressive age-dependent repression of stearoyl-CoA desaturase (SCD/fat-5/6/7) reduces monounsaturated fatty acid (MUFA) production, stiffening membranes and limiting stress-resilient lipid remodeling, thereby actively constraining lifespan. Sustained SCD activity or MUFA supplementation extends life. Mechanism: Lower SCD activity depletes oleate and related MUFAs needed for fluid, signaling-competent membranes and for lipid-droplet buffering of lipotoxicity, increasing ER stress and reducing proteostatic capacity with age. Prediction: SCD overexpression or oleate feeding that elevates MUFAs will extend lifespan and improve membrane fluidity metrics even when sphingolipid and ether-lipid profiles stay aged; SCD inhibition will shorten life and block MUFA-dependent longevity pathways.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5573, "promptSha256": "cd7399ef4b7536dd50ab7836bbf247beef283fac49a745585d29042b01345ab6" } ] }, { "task": "R42841227", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 4 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOlder individuals are more susceptible to severe influenza and often mount less effective antiviral immune responses. Ageing also alters the composition and metabolic activity of the gut microbiota, potentially affecting immune function at distant organs. Microbial metabolites are known to influence host immunity and gene regulation, but their contribution to age-related loss of antiviral protection remains poorly understood. It was therefore unclear whether altered microbial metabolism during ageing directly contributes to defective responses against respiratory viral infection.\n\nRESEARCH QUESTION\nDo age-related changes in gut microbial metabolism causally impair antiviral defense during influenza infection, and through what host mechanism can this deficit be counteracted?\n\nHYPOTHESES\n[H1] Age-associated remodeling of gut bile-acid metabolism reduces secondary bile acids that signal through FXR/TGR5, thereby impairing alveolar macrophage antiviral competence. Replenishing secondary bile acids will restore macrophage interferon readiness and limit influenza severity in aged hosts. Mechanism: Secondary bile acids tone macrophage metabolic and interferon programs via FXR/TGR5; their age-related loss leaves alveolar macrophages hyporesponsive to viral sensing. Prediction: Secondary-bile-acid or TGR5-agonist treatment will selectively restore alveolar-macrophage IFN competence and early viral control in aged animals without normalizing systemic SCFA or AHR-ligand pools.\n\n[H2] Age-related gut dysbiosis elevates inhibitory microbial metabolites (for example, certain pathobiont-derived amines or LPS fragments) that systemically suppress antiviral immunity; blocking their production or sensing will reverse defective influenza defense in aged hosts. Mechanism: Accumulated inhibitory metabolites engage innate sensors or metabolic checkpoints that dampen IFN and effector lymphocyte function distal to the gut. Prediction: Selective depletion or receptor blockade of the inhibitory metabolite class will restore antiviral responses in aged colonized mice, whereas adding beneficial metabolites alone will be less effective if inhibitors remain high.\n\n[H3] Decline of specific Clostridium-associated metabolites such as desaminotyrosine (DAT) with ageing removes a key amplifier of type I interferon signaling in the lung, causally weakening intrinsic antiviral resistance. DAT restoration will counteract age-related influenza susceptibility independent of broad microbiota transfer. Mechanism: DAT amplifies IFNAR signaling and ISG expression in airway epithelium and innate immune cells; age-related loss of DAT-producing taxa removes this tonic boost. Prediction: DAT supplementation in aged mice will elevate early lung ISG expression and reduce viral titers even when overall SCFA, bile-acid, and tryptophan-metabolite profiles remain aged-like.\n\n[H4] Ageing depletes microbiota-derived tryptophan metabolites that activate the aryl hydrocarbon receptor (AHR), weakening dendritic-cell priming of antiviral CD8+ T cells. Supplementing AHR agonists will counteract age-related defective influenza control. Mechanism: Loss of microbial indoles and related AHR ligands impairs AHR-dependent antigen-presenting cell function and subsequent effector T-cell differentiation in lung-draining lymph nodes. Prediction: Aged AHR-ligand-replete mice will show rescued virus-specific CD8+ T-cell expansion and protection even when SCFA levels remain low, whereas SCFA supplementation alone will not fully restore adaptive antiviral responses.\n\n[H5] Age-related decline in gut microbial short-chain fatty acid (SCFA) production, especially butyrate, causally impairs pulmonary type I interferon responses during influenza infection. Restoring SCFAs in aged hosts will rescue antiviral defense by reactivating interferon-stimulated gene programs in lung epithelial and innate immune cells. Mechanism: Reduced microbial fermentation lowers circulating butyrate, relieving HDAC inhibition and thereby dampening epigenetic priming of antiviral IFN/ISG loci at distant mucosal sites. Prediction: Oral butyrate or HDAC-inhibitor treatment of aged mice will restore early lung IFN/ISG induction and improve viral clearance without requiring restoration of other microbial metabolites such as AHR ligands or secondary bile acids.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4969, "promptSha256": "f35f23d1b3ed135de6adeb6fed98238a9091c4dc9c26f9f13e0bd22708eb18ec" } ] }, { "task": "R42842666", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson-Gilford progeria syndrome is a premature-ageing disorder caused by an LMNA mutation and is characterized by severe, early-onset vascular disease. Its vascular pathology includes extracellular-matrix abnormalities, fibrosis, collagen accumulation and inflammation. Blood-vessel models have often examined individual vascular compartments in isolation, limiting understanding of how interactions among the vessel wall layers produce disease. The cellular origins of the distinct pathological features and the extent to which they depend directly on the causal mutation remained unresolved.\n\nRESEARCH QUESTION\nHow do the different cellular compartments of the vascular wall causally contribute to distinct features of Hutchinson-Gilford progeria vascular pathology?\n\nHYPOTHESES\n[H1] Progerin expression specifically in vascular smooth muscle cells is sufficient to cause medial VSMC depletion and collagen-rich extracellular-matrix accumulation, independently of endothelial or adventitial progerin. Mechanism: Cell-autonomous nuclear lamina disruption in VSMCs triggers DNA damage responses, senescence and apoptosis, while dysregulating matrix gene programs that favor collagen deposition and medial remodeling. Prediction: Mice or vessel organoids with VSMC-restricted LMNA G609G (or equivalent) will reproduce medial VSMC loss and collagen accumulation, whereas endothelium- or adventitia-restricted progerin will not.\n\n[H2] Adventitial fibroblasts expressing progerin are the main cellular source of adventitial fibrosis and vessel stiffening in HGPS, acting through excessive collagen synthesis and myofibroblast differentiation. Mechanism: Progerin alters fibroblast mechanotransduction and TGF-β/SMAD signaling, converting adventitial fibroblasts into collagen-secreting myofibroblasts that thicken and stiffen the outer wall. Prediction: Adventitia-restricted progerin will cause adventitial thickening and elevated collagen I/III without requiring medial VSMC loss, whereas clearing or genetically rescuing adventitial fibroblasts will reduce fibrosis despite persistent medial pathology.\n\n[H3] Progerin in endothelial cells is the primary driver of vascular wall inflammation in HGPS, through upregulation of leukocyte-adhesion molecules and inflammatory cytokines that recruit immune cells into the vessel wall. Mechanism: Endothelial nuclear envelope dysfunction activates NF-κB and related stress pathways, increasing ICAM-1/VCAM-1 and cytokine release that promote leukocyte extravasation and chronic inflammation. Prediction: Endothelium-restricted progerin will produce inflammatory infiltrates and adhesion-molecule upregulation even when medial and adventitial cells are wild-type, while VSMC-restricted progerin will produce little inflammation without endothelial involvement.\n\n[H4] Distinct HGPS vascular features segregate by compartment: medial VSMC loss and calcification require VSMC-intrinsic progerin, while intimal inflammation requires endothelial progerin, and adventitial fibrosis requires fibroblast progerin, implying limited interchangeability of cell-autonomous effects. Mechanism: Each mural lineage has a distinct transcriptional and stress response to progerin, so the same laminopathy maps onto different effector programs (apoptosis/calcification in VSMCs, adhesion/inflammation in endothelium, matrix deposition in fibroblasts). Prediction: In a panel of lineage-restricted progerin models, each pathological feature will appear only when the corresponding compartment expresses progerin, and combining compartments will additively recreate the full HGPS vascular phenotype.\n\n[H5] Progerin-bearing endothelial cells secondarily induce medial VSMC dysfunction and ECM abnormalities via paracrine loss of nitric oxide and gain of inflammatory mediators, so some medial pathology is non-cell-autonomous. Mechanism: Endothelial progerin impairs eNOS activity and elevates IL-6/TNF-α and other factors that promote neighboring VSMC senescence, apoptosis and matrix dysregulation across the intima–media interface. Prediction: Co-culture or chimeric vessels with progerin endothelium and wild-type VSMCs will show VSMC stress markers and collagen changes that are rescued by NO donors or cytokine blockade, whereas VSMC-only progerin will not fully account for the same inflammatory ECM signature.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4976, "promptSha256": "745c782f428ea9455bedcce2d16e73b3b8cadb89fa74b7f2ba5fb33f45adacf5" } ] }, { "task": "R42844664", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCardiovascular ageing is characterized by hypertension, arterial stiffening, endothelial dysfunction, and maladaptive cardiac remodeling. Chronic inflammation, impaired tissue barriers, and regulated inflammatory cell death can accelerate these changes. Dietary patterns can influence age-related cardiovascular health, but causal chains connecting specific eating schedules to vascular protection remain incompletely understood. Identifying the necessary and sufficient mediators of such protection is important for developing non-pharmacological strategies against cardiovascular decline.\n\nRESEARCH QUESTION\nThrough what causal mechanism does time-restricted feeding protect against accelerated cardiovascular ageing?\n\nHYPOTHESES\n[H1] Time-restricted feeding slows cardiovascular ageing by elevating circulating β-hydroxybutyrate during the fasting window, which directly inhibits vascular NLRP3 activity and epigenetic drivers of arterial stiffening. Ketone signaling is necessary and sufficient for the schedule’s protective effect. Mechanism: Hepatic ketogenesis during the daily fast raises β-hydroxybutyrate, which inhibits NLRP3 and acts as an HDAC inhibitor to maintain elastin/collagen balance and eNOS expression in the arterial wall, thereby reducing inflammation-linked stiffening and endothelial dysfunction. Prediction: TRF’s rise in β-hydroxybutyrate will correlate with reduced vascular inflammasome activity and PWV; clamping ketones at ad libitum levels during TRF (e.g., HMGCS2 knockdown or exogenous glucose to suppress ketogenesis) will erase protection, while exogenous β-hydroxybutyrate infusion on an ad libitum schedule will recapitulate TRF’s vascular benefits.\n\n[H2] Time-restricted feeding protects against cardiovascular ageing by re-entraining peripheral circadian clocks in endothelial and cardiomyocyte cells, which restores diurnal nitric oxide bioavailability and blood-pressure dipping. Clock alignment, rather than total calorie reduction, is the necessary causal step. Mechanism: Consolidated feeding synchronizes BMAL1/CLOCK and PER/CRY rhythms in the vasculature; aligned clocks restore rhythmic eNOS phosphorylation, antioxidant enzyme expression, and nocturnal sympathetic withdrawal, reducing 24-hour hemodynamic load and age-related remodeling. Prediction: TRF will restore vascular Bmal1 amplitude and nocturnal BP dipping before structural benefits appear; endothelial- or cardiomyocyte-specific Bmal1 deletion will abolish TRF protection, whereas mistimed TRF (same fasting duration but inverted to the inactive phase) will fail to protect or worsen stiffening despite equal calories.\n\n[H3] Time-restricted feeding protects against accelerated cardiovascular ageing by restoring intestinal epithelial barrier integrity, thereby limiting chronic low-grade endotoxemia that drives endothelial dysfunction and arterial stiffening. The barrier restoration is necessary and sufficient for the vascular benefit under otherwise matched caloric intake. Mechanism: Extended daily fasting upregulates tight-junction proteins (e.g., occludin, claudin-1) and mucus production via circadian and AMPK-dependent pathways in enterocytes; reduced translocation of LPS and other microbial products lowers TLR4/NF-κB signaling in endothelium and vascular smooth muscle, slowing hypertension, stiffening, and maladaptive remodeling. Prediction: In aged or progeroid models, TRF that improves gut barrier markers and lowers plasma LPS will prevent arterial stiffening and endothelial dysfunction, whereas TRF combined with experimental barrier disruption (or chronic low-dose LPS infusion matched to ad libitum levels) will abolish protection despite preserved feeding-window compliance and body weight.\n\n[H4] Time-restricted feeding protects the ageing cardiovascular system by inducing endothelial and cardiomyocyte autophagy via AMPK activation and mTORC1 suppression during the fasting interval. Enhanced clearance of damaged organelles and inflammasome components is the causal mediator of reduced remodeling and dysfunction. Mechanism: Daily nutrient withdrawal activates AMPK and inhibits mTORC1 in endothelium and myocardium, increasing autophagic flux (LC3-II turnover, p62 clearance); removal of dysfunctional mitochondria and aggregated inflammasome platforms lowers ROS and chronic inflammatory tone, preserving endothelial function and limiting hypertrophic/fibrotic remodeling. Prediction: TRF will increase vascular and cardiac autophagic flux with concurrent improvement in endothelial-dependent dilation and reduced fibrosis; endothelial- or cardiomyocyte-specific Atg5/Atg7 deletion will abolish TRF benefits, while autophagy inducers given without TRF will partially phenocopy protection under matched calories.\n\n[H5] Time-restricted feeding protects vessels by suppressing NLRP3 inflammasome–dependent pyroptosis in endothelial and vascular smooth muscle cells. Reduction of this regulated inflammatory cell death is the causal mediator linking the feeding schedule to slower cardiovascular ageing. Mechanism: Daily fasting lowers mitochondrial ROS, oxidized lipids, and potassium efflux signals that prime and activate NLRP3; less caspase-1/GSDMD activity reduces IL-1β/IL-18 release and pyroptotic loss of barrier-competent endothelium, preserving nitric oxide signaling and limiting adventitial inflammation and stiffening. Prediction: TRF will reduce vascular GSDMD cleavage, IL-1β, and pyroptotic cell loss concurrent with improved pulse-wave velocity; genetic or pharmacologic NLRP3/GSDMD blockade will phenocopy TRF benefits in ad libitum animals, while constitutive NLRP3 activation confined to endothelium will eliminate TRF’s vascular protection.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 6337, "promptSha256": "8c19b3182d31cbeb8178c97c494a2dc9fe8dff8af20ab53752c689a2fdaf7ec2" } ] }, { "task": "R42853938", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nTherapy-induced cellular senescence can durably arrest the proliferation of cancer cells and contribute to treatment efficacy. Cancer cells can acquire resistance to treatments that normally induce this state, allowing continued growth and disease progression. Alternative splicing and epigenetic regulation are both frequently altered during cancer evolution, but their causal roles in suppressing treatment-induced senescence remain incompletely understood. Identifying the molecular mechanism responsible could reveal a way to restore therapeutic sensitivity.\n\nRESEARCH QUESTION\nWhat splicing-dependent mechanism enables resistance to CDK4/6 inhibition, and can disrupting it restore therapy-induced senescence?\n\nHYPOTHESES\n[H1] Resistance is caused by SF3B1-dependent production of an MDM4 splicing isoform that hyper-suppresses p53, thereby blocking the p53–p21 senescence arm downstream of CDK4/6 inhibition. Pharmacologic or genetic disruption of this SF3B1–MDM4 splicing axis restores p53 activity and therapy-induced senescence. Mechanism: Mutant or overactive SF3B1 alters 3' splice-site choice in MDM4, enriching an isoform that binds and inhibits p53 more potently; without p53/p21 reinforcement, CDK4/6i-arrested cells escape into reversible quiescence instead of senescence. Prediction: SF3B1 inhibitors or MDM4 splice-correcting ASOs will increase p53 transcriptional output and senescence only in resistant cells that accumulate the oncogenic MDM4 isoform, and this rescue will be abolished by TP53 knockout but not by RB1 knockout.\n\n[H2] Resistant cells produce a CDK6 splice isoform lacking the inhibitor-binding determinants yet retaining kinase activity, allowing continued Rb phosphorylation despite CDK4/6 drugs. Splice redirection to the drug-sensitive CDK6 isoform restores inhibition and senescence. Mechanism: Altered splicing (via hnRNP A1 or related factors) removes or rearranges exons encoding the CDK6 ATP-site/inhibitor interface; the isoform phosphorylates Rb but is poorly bound by palbociclib-class inhibitors. Prediction: Isoform-specific knockdown or ASOs forcing the canonical CDK6 isoform will re-sensitize cells to CDK4/6i-induced senescence, while forced expression of the resistant splice variant in parental cells will confer drug resistance without changing total CDK6 abundance.\n\n[H3] SRSF1-mediated alternative splicing of CDKN1A generates a truncated p21 isoform that cannot inhibit CDK2, so CDK4/6i-treated cells fail to commit to senescence and resume proliferation via residual CDK2 activity. Inhibiting SRSF1 or correcting CDKN1A splicing restores functional p21 and senescence. Mechanism: Elevated SRSF1 promotes inclusion or exclusion events in CDKN1A that remove or disrupt the CDK-inhibitory domain of p21; without intact p21, Rb remains partially phosphorylated by CDK2 after CDK4/6 blockade. Prediction: SRSF1 depletion will shift CDKN1A toward full-length p21, reduce CDK2 activity, and restore senescence in resistant models; ectopic expression of the truncated p21 isoform will confer resistance in otherwise sensitive cells, whereas full-length p21 will reverse resistance independent of SRSF1 levels.\n\n[H4] CDK4/6 inhibitor–resistant cells depend on PTBP1-driven exon skipping in RB1 that yields a hypomorphic Rb isoform unable to enforce durable G1 arrest and senescence. Blocking this PTBP1–RB1 splicing event restores full-length Rb and re-sensitizes tumors to therapy-induced senescence. Mechanism: PTBP1 binds RB1 pre-mRNA and promotes skipping of an exon required for Rb pocket-domain integrity; the resulting isoform fails to repress E2F targets after CDK4/6 inhibition, allowing cell-cycle re-entry. Prediction: PTBP1 knockdown or splice-switching oligos that force RB1 exon inclusion will restore senescence markers (SA-β-gal, SASP, durable colony suppression) specifically in resistant lines that express the skipped isoform, whereas restoring wild-type RB1 cDNA will phenocopy that rescue and RB1 exon-skipping mutants will recapitulate resistance in sensitive cells.\n\n[H5] EZH2-dependent H3K27me3 at intronic splicing enhancers near CDKN2A favors production of non-coding or truncated p16INK4a isoforms, removing the endogenous CDK4/6 brake and preventing senescence under pharmacologic CDK4/6 inhibition. Combined EZH2 inhibition and splice correction restores p16 and therapy-induced senescence. Mechanism: EZH2 deposits repressive chromatin at CDKN2A splicing regulatory elements, shifting spliceosome choice toward isoforms that lack CDK4/6-inhibitory function; loss of intact p16 weakens Rb pathway output below the senescence threshold. Prediction: EZH2 inhibitors will reopen chromatin at CDKN2A, increase full-length p16INK4a relative to truncated isoforms, and restore senescence only when the productive CDKN2A splice form is present; CDKN2A locus deletion will abolish rescue, distinguishing this from RB1- or p53-centric mechanisms.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5553, "promptSha256": "221f454e39144d820a82497101e1d6cd6ee98d9f42de5c267a832f26bef93f77" } ] }, { "task": "R42858183", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAging is accompanied by declining lysosomal activity, impaired autophagic clearance, and loss of protein homeostasis. These changes contribute to progressive functional deterioration and increase vulnerability to protein-aggregation disorders. Restoring cellular clearance systems can sometimes improve lifespan or healthspan in model organisms. However, interventions that preserve lysosomal competence during aging and the mechanisms through which they act remain incompletely understood.\n\nRESEARCH QUESTION\nCan a defined intervention preserve lysosomal function and protein homeostasis during aging, thereby extending lifespan and maintaining organismal function, and through what mechanism?\n\nHYPOTHESES\n[H1] Chronic low-dose Tor inhibition preserves lysosomal acidification and autophagic flux during aging, which sustains protein homeostasis and extends lifespan. The benefit depends on maintained lysosomal protease activity rather than reduced protein synthesis alone. Mechanism: Reduced mTORC1 signaling derepresses TFEB/HLH-30 nuclear translocation, upregulating lysosomal biogenesis and v-ATPase subunits, thereby keeping lumenal pH low and clearance competent with age. Prediction: Genetic or pharmacological blockade of TFEB/HLH-30 or v-ATPase will abolish lifespan extension and lysosomal pH preservation under Tor inhibition, while matching the translation-rate reduction without Tor inhibition will not restore lysosomal competence.\n\n[H2] Intermittent activation of the unfolded protein response of the ER (UPRER) in early adulthood programs a durable increase in lysosomal capacity that preserves proteostasis and longevity. The effect requires XBP1/IRE1 signaling to lysosomal gene networks. Mechanism: Transient XBP1s activity transcriptionally induces lysosomal and autophagy genes, establishing a lasting clearance set-point that buffers age-associated aggregate load. Prediction: Early-life, time-limited XBP1s activation will extend lifespan and preserve lysosomal function late in life even after the inducer is removed; loss of lysosomal gene targets of XBP1s will eliminate the longevity benefit while leaving acute ER stress resistance intact.\n\n[H3] Supplementing a defined lysosomal membrane lipid (e.g., bis(monoacylglycero)phosphate or specific sphingolipid species) during midlife preserves lysosomal membrane integrity and cathepsin maturation, delaying proteostasis collapse and extending healthspan. Mechanism: Age-related depletion of lysosome-enriched lipids destabilizes the limiting membrane and impairs hydrolase delivery; exogenous lipid restoration re-establishes membrane composition needed for acidification and cargo degradation. Prediction: Lipid supplementation will normalize lysosomal lipidomics, acidification, and insoluble protein burden without suppressing Tor activity; depleting the same lipid species will phenocopy age-related lysosomal failure even in young animals.\n\n[H4] Microbiota-derived metabolites that induce host lysosomal biogenesis (e.g., specific short-chain fatty acids or secondary bile acids) preserve systemic protein homeostasis and longevity; germ-free or metabolite-deficient conditions accelerate lysosomal aging. Mechanism: Defined microbial metabolites activate host nuclear receptors or AMPK–TFEB pathways in gut and distal tissues, sustaining lysosomal gene expression and clearance capacity during aging. Prediction: Colonizing aged hosts with a metabolite-producing consortium, or providing the purified metabolite, will restore lysosomal acidification and extend lifespan only when host TFEB/AMPK signaling is intact; non-producing isogenic microbes will not.\n\n[H5] Enhancing lysosomal Ca2+ release via TRPML1/MCOLN1 during aging restores autophagosome–lysosome fusion and cargo degradation, thereby maintaining neuronal and muscle function and extending lifespan. Mechanism: Age-dependent decline in lysosomal Ca2+ efflux impairs SNARE-mediated fusion; TRPML1 agonism re-enables fusion and hydrolase access to autophagic cargo. Prediction: TRPML1 agonists will rescue fusion defects, reduce p62/SQSTM1 and aggregate load, and extend lifespan in a TRPML1-dependent manner, whereas acidification-only interventions that do not restore Ca2+ release will fail to rescue fusion markers.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4899, "promptSha256": "f5530a651c72a3ea132a3f298d2a1fe06041506aae26683992b3a09a9f73b4e5" } ] }, { "task": "R42806945", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 1 }, { "id": "H4", "hypothesisIndex": 0 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is frequently accompanied by cognitive decline and chronic neuroinflammation. Cellular senescence and age-dependent changes in metabolic signaling can disrupt tissue homeostasis and contribute to functional deterioration in the brain. Although several circulating metabolic factors correlate with cognitive impairment, association alone does not establish which factors directly modify the ageing process. The molecular chain connecting a metabolic regulator to cellular dysfunction and cognitive outcomes therefore remained unresolved.\n\nRESEARCH QUESTION\nWhich metabolic regulator causally mitigates ageing-related cognitive impairment, and through what molecular mechanism does it suppress cellular senescence and inflammation?\n\nHYPOTHESES\n[H1] The ketone body β-hydroxybutyrate (BHB) causally mitigates ageing-related cognitive impairment by suppressing NLRP3 inflammasome activity and senescence-associated secretory phenotype in brain myeloid cells. Reduced BHB availability with age permits unchecked neuroinflammation and senescent cell accumulation. Mechanism: BHB inhibits NLRP3 inflammasome assembly and class I HDACs, elevates histone acetylation at anti-inflammatory loci, and lowers IL-1β maturation and SASP output from microglia and infiltrating macrophages. Prediction: Exogenous BHB or ketogenic interventions improve cognition and reduce inflammasome and senescence markers without elevating FGF21 or NAD+ to the same degree; NLRP3 knockout mimics BHB benefits and is non-additive with BHB, whereas HDAC overexpression blunts BHB’s anti-senescence effect.\n\n[H2] Age-related NAD+ depletion is a causal driver of cognitive decline; restoring NAD+ via precursors such as NMN or NR suppresses neuronal and microglial senescence and inflammation through SIRT1/SIRT3-dependent pathways. Mechanism: Elevated NAD+ activates SIRT1/SIRT3, deacetylates NF-κB p65 and PGC-1α, improves mitochondrial quality control, and transcriptionally represses p16INK4a and pro-inflammatory SASP genes. Prediction: NAD+ precursor treatment improves memory and reduces senescence/inflammation markers in aged brain even when FGF21 and Klotho remain low; SIRT1 or SIRT3 deletion in neurons/glia blocks these benefits despite restored NAD+ levels.\n\n[H3] The longevity factor α-Klotho causally protects cognition by limiting neuronal and glial cellular senescence through antagonism of IGF-1 and Wnt signaling. Declining circulating Klotho with age removes this brake, allowing senescence and chronic neuroinflammation to accumulate. Mechanism: Soluble Klotho inhibits IGF-1R and Wnt/β-catenin, reduces FOXO inactivation and cyclin-dependent kinase inhibitor expression, and dampens NLRP3 inflammasome priming in microglia. Prediction: Klotho supplementation or transgenic overexpression improves aged cognition and lowers hippocampal senescence and IL-1β/IL-6 without requiring FGF21 elevation; IGF-1R or Wnt pathway reactivation in the presence of Klotho abolishes the cognitive and anti-senescence effects.\n\n[H4] Circulating FGF21 causally mitigates ageing-related cognitive impairment by acting on hippocampal astrocytes and microglia to suppress senescence and neuroinflammation. Age-dependent decline in FGF21 signaling permits SASP-driven synaptic dysfunction that is reversed by restoring FGF21 levels. Mechanism: FGF21 engages FGFR1/β-Klotho, activates AMPK–SIRT1, represses NF-κB and p16INK4a/p21, and thereby lowers SASP cytokine release and senescent cell burden in the hippocampus. Prediction: Peripheral or CNS FGF21 restoration improves memory and reduces SA-β-gal+, p16+, and SASP markers in aged brain independently of systemic glucose changes, whereas FGFR1 or β-Klotho knockdown in glia abolishes these benefits while leaving other circulating factors intact.\n\n[H5] Circulating adiponectin causally counters ageing-related cognitive decline by activating AdipoR1/AMPK signaling in cerebrovascular and glial cells, thereby limiting cellular senescence and blood–brain barrier–linked neuroinflammation. Mechanism: Adiponectin–AdipoR1 activates AMPK, enhances eNOS and autophagy, reduces p53/p21-driven senescence in endothelial and glial cells, and lowers VCAM-1–dependent leukocyte recruitment and SASP amplification. Prediction: Adiponectin or AdipoRon treatment improves aged memory and reduces brain senescence and inflammatory markers when FGF21, Klotho, and NAD+ are held constant; endothelial or glial AdipoR1 knockout abolishes these effects and is not rescued by FGF21 or NMN alone.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5139, "promptSha256": "f0465ce2a2b3ffe34607988a989d66e12ae66cfc26b41898f25222b43dc025df" } ] }, { "task": "R42723144", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 0 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian function declines with age, eventually causing reproductive senescence and broader endocrine changes that affect female healthspan. The pace of this decline varies substantially among individuals, even when chronological age is similar. Both nuclear and non-nuclear inherited factors could contribute to this variation, but their causal roles are difficult to separate because genetic backgrounds commonly differ at many loci. The mechanisms connecting inherited variation to follicle depletion, tissue pathology and loss of ovarian function therefore remain poorly understood.\n\nRESEARCH QUESTION\nCan naturally occurring inherited genetic variation alter the rate of ovarian ageing on equivalent heterogeneous nuclear backgrounds, and what cellular mechanism mediates this effect?\n\nHYPOTHESES\n[H1] Naturally occurring cytoplasmic (mtDNA) variants alter ovarian ageing rate by changing NAD+/NADH balance and sirtuin-dependent maintenance of oocyte proteostasis and epigenetic marks required for prolonged dormancy. Mechanism: Haplotypes that chronically lower NAD+ reduce SIRT1/SIRT3 activity, impairing deacetylation of mitochondrial and nuclear targets, accelerating proteostatic failure and epigenetic drift in the primordial follicle pool. Prediction: Susceptible mtDNA ovaries will exhibit lower NAD+/NADH, hyperacetylated mitochondrial proteins, and earlier loss of H3K27me3/H3K9me3 at dormancy loci in oocytes; NAD+ precursor supplementation will slow follicle depletion selectively on the susceptible haplotype.\n\n[H2] Non-nuclear inherited variation accelerates ovarian ageing by impairing mitophagy and mitochondrial quality control in granulosa and theca cells, causing progressive stromal dysfunction that secondarily depletes follicles. Mechanism: mtDNA polymorphisms that reduce membrane potential or alter PINK1/Parkin recruitment cause accumulation of damaged mitochondria, chronic inflammasome activation, and fibrotic remodeling of the ovarian stroma that disrupts follicle survival niches. Prediction: Susceptible mtDNA lines will show age-dependent buildup of p62/LC3 aggregates and NLRP3/IL-1β in stroma, increased collagen deposition, and follicle loss that is mitigated by enhancing mitophagy (e.g., urolithin A or Parkin overexpression) more than by antioxidant scavenging alone.\n\n[H3] Inherited mtDNA haplotype variation changes the rate of ovarian ageing by modulating local ovarian inflammation and immune-cell infiltration that drives follicle burnout and tissue pathology on otherwise equivalent nuclear backgrounds. Mechanism: mtDNA-dependent differences in mitochondrial DAMP release (oxidized mtDNA, cardiolipin) chronically activate TLR9/cGAS–STING and recruit macrophages and T cells that secrete cytokines accelerating follicle activation and atresia. Prediction: Susceptible haplotype ovaries will show earlier elevation of circulating and local IL-6/TNF, increased CD68+ and CD3+ infiltrate, and detectable cytosolic oxidized mtDNA; TLR9 or STING blockade will slow reserve loss preferentially on that haplotype versus the resistant one.\n\n[H4] Inherited mtDNA variation modulates ovarian ageing by altering the threshold for DNA-damage checkpoint activation in primordial oocytes. Variants that impair mtDNA repair or increase mitochondrial mutational load sensitize oocytes to p63/CHK2-mediated atresia. Mechanism: Elevated mitochondrial ROS and mtDNA damage amplify nuclear genotoxic signaling in dormant oocytes, lowering the apoptotic threshold and depleting the follicle pool faster without requiring large changes in basal ATP. Prediction: Ovaries from the susceptible mtDNA background will accumulate more γH2AX and cleaved caspase-3 in primordial oocytes at mid-life, and genetic or pharmacological dampening of CHK2/p63 will preferentially rescue reserve on that mtDNA background relative to the resistant haplotype.\n\n[H5] Naturally occurring mitochondrial DNA haplotype variants alter the rate of ovarian ageing on matched heterogeneous nuclear backgrounds by changing oocyte and granulosa-cell oxidative phosphorylation efficiency. Haplotypes that reduce Complex I/III coupling accelerate primordial-follicle attrition and earlier loss of cyclicity. Mechanism: mtDNA-encoded respiratory-chain polymorphisms elevate electron leak and lower ATP supply in oocytes and supporting somatic cells, increasing ROS-driven DNA damage and premature follicle activation or atresia. Prediction: On identical heterogeneous nuclear backgrounds, conplastic or cybrid lines carrying the inefficient mtDNA haplotype will show earlier decline in ovarian reserve, higher oocyte ROS and lower ATP, and earlier anovulation than lines with the efficient haplotype; nuclear-swapped controls will reverse the phenotype with the mtDNA.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5398, "promptSha256": "376ba0d125a14cb90e0a1e2fc930b89203b4d7b5bda6132b12d3f0b7132f157e" } ] }, { "task": "R42808804", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 1 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAge-related hearing loss is a common progressive disorder associated with degeneration of cochlear structure and function. Maintenance of cochlear homeostasis depends on a specialized vascular barrier that controls exchange between the circulation and inner-ear tissues. Ageing can compromise this barrier, disturb the local microenvironment, and contribute to auditory dysfunction. However, the causal molecular events connecting cochlear ageing to barrier failure and hearing decline were not fully understood.\n\nRESEARCH QUESTION\nWhat causal mechanism links cochlear ageing to loss of blood-labyrinth barrier integrity and auditory dysfunction?\n\nHYPOTHESES\n[H1] Senescence of cochlear pericytes and loss of PDGFB–PDGFRβ signaling detach pericyte coverage from strial capillaries, weakening the BLB and triggering local hypoxia and oxidative stress that damage sensory epithelium and cause age-related hearing loss. Mechanism: Pericyte dropout and reduced PDGFRβ signaling compromise capillary stabilization and barrier support, producing microvessel rarefaction, hypoxia, and ROS accumulation that injure hair cells and spiral ganglion neurons. Prediction: Aged animals will exhibit reduced pericyte coverage and PDGFRβ expression on strial vessels preceding measurable ABR threshold shift; pericyte-specific PDGFB restoration will preserve BLB integrity and hearing more effectively than endothelial-only interventions.\n\n[H2] Decline of cochlear endothelial Wnt/β-catenin signaling with age fails to maintain expression of claudin-5 and VE-cadherin at the BLB, causing barrier disintegration, potassium recycling failure, and progressive sensorineural hearing loss. Mechanism: Age-dependent loss of Wnt ligands or Frizzled/LRP receptors in strial endothelium reduces nuclear β-catenin, lowering transcription of barrier genes and collapsing the electrochemical gradients required for mechanotransduction. Prediction: Aged strial endothelium will show reduced active β-catenin and barrier-gene transcripts; endothelium-restricted Wnt activation will restore BLB integrity and ABR thresholds, whereas Wnt inhibition in young animals will phenocopy age-related barrier leak and hearing loss.\n\n[H3] Ageing-driven decline of endothelial nitric oxide synthase (eNOS) activity in cochlear strial vessels reduces NO-dependent tight-junction maintenance, causing progressive blood-labyrinth barrier (BLB) leakiness that permits serum proteins and inflammatory mediators to enter the endolymphatic space and impair hair-cell transduction. Mechanism: Reduced endothelial NO signaling destabilizes occludin/claudin-5 complexes at strial capillaries, increasing BLB permeability and disrupting ionic and metabolic homeostasis of the organ of Corti. Prediction: Aged cochleae will show lower eNOS phosphorylation and NO metabolites specifically in strial endothelium, with BLB tracer extravasation and hearing thresholds rescued by endothelium-targeted eNOS restoration or NO donors but not by global anti-inflammatory treatment alone.\n\n[H4] Age-related accumulation of mitochondrial ROS in strial marginal and intermediate cells activates NLRP3 inflammasome signaling, which downregulates junctional proteins in adjacent endothelial cells and opens the BLB, allowing immune infiltration that accelerates cochlear ageing. Mechanism: Mitochondrial oxidative stress in the stria vascularis triggers NLRP3–IL-1β/IL-18 release that transcriptionally and post-translationally suppresses endothelial tight-junction components, creating a feed-forward inflammatory breach of the BLB. Prediction: Strial NLRP3 and IL-1β will rise with age before large threshold shifts; genetic or pharmacologic NLRP3 blockade will preserve BLB impermeability and hearing even when mitochondrial ROS remains elevated, distinguishing inflammasome causation from ROS alone.\n\n[H5] Ageing elevates circulating and local TGF-β1, which drives endothelial-to-mesenchymal transition (EndMT) in cochlear capillaries, replacing tight-junction endothelium with leaky mesenchymal-like cells and thereby destroying BLB selectivity and auditory function. Mechanism: Chronic TGF-β/Smad signaling induces EndMT in strial vessels, reducing endothelial identity markers and junctional integrity while increasing fibronectin deposition and permeability, disturbing the cochlear microenvironment. Prediction: Aged cochleae will co-express mesenchymal markers (α-SMA, SNAIL) with residual endothelial markers in strial vessels; TGF-β neutralization or Smad3 inhibition will limit EndMT, preserve BLB tracer exclusion, and slow hearing decline relative to antioxidants that do not block TGF-β.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5270, "promptSha256": "1ecffb6a73cfefec12438b77b392935dc2fa426412201c13fe288d2839308479" } ] }, { "task": "R42585340", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 3 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 4 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by a progressive loss of protein homeostasis and an accumulation of damaged or aggregation-prone proteins. Mild perturbations of cellular physiology can trigger adaptive responses that increase stress resistance and extend lifespan in several species. Effective removal of damaged proteins is thought to contribute to these benefits, but the responsible transcriptional programs and degradation machinery are incompletely understood. It also remains unclear which components are causally required to connect such adaptive stress responses to improved proteostasis and longevity.\n\nRESEARCH QUESTION\nWhich molecular mechanism enables mild cellular stress to preserve protein homeostasis during ageing and extend organismal lifespan?\n\nHYPOTHESES\n[H1] Mild cellular stress extends lifespan by transcriptionally inducing HSF-1, which upregulates a core chaperone set that prevents age-associated protein aggregation and thereby preserves proteostasis. Causality requires HSF-1 and specific chaperone effectors rather than general stress signaling. Mechanism: Transient stress activates HSF-1-driven expression of molecular chaperones that refold or sequester damaged proteins, reducing toxic aggregates during ageing. Prediction: Genetic ablation of HSF-1 or of a defined chaperone effector set abolishes both proteostasis preservation and lifespan extension under mild stress, while leaving autophagy and proteasome capacity intact; restoring only those chaperones rescues both phenotypes.\n\n[H2] Mild mitochondrial perturbation triggers mitohormesis via the mitochondrial UPR (ATFS-1/ATF5), which coordinately upregulates mitochondrial and cytosolic proteostasis programs that delay ageing. Retrograde mitochondrial stress signaling is the causal bridge from mild stress to organismal longevity. Mechanism: Transient mitochondrial dysfunction activates UPR^mt transcription factors that induce mitochondrial chaperones, proteases, and overlapping cytosolic quality-control genes, improving global proteostasis. Prediction: Loss of ATFS-1/ATF5 or other UPR^mt mediators abolishes lifespan extension and proteostasis benefits from mild stress that still activate cytosolic HSF-1 or autophagy; mitochondrial-stress-only interventions that engage UPR^mt suffice for both phenotypes.\n\n[H3] Mild stress extends lifespan by activating Nrf1/SKN-1-dependent transcription of proteasome subunits, elevating ubiquitin–proteasome capacity that removes damaged proteins. Enhanced proteasomal degradation is necessary and sufficient for the proteostasis and longevity effects. Mechanism: Stress sensors induce Nrf1/SKN-1, which increases expression of 26S proteasome components and ubiquitin ligases, accelerating turnover of damaged proteins. Prediction: Proteasome inhibition or Nrf1/SKN-1 loss blocks mild-stress longevity and proteostasis gains even when chaperones and autophagy are upregulated; proteasome hyperactivity without stress mimics both outcomes.\n\n[H4] Mild ER stress activates the IRE1–XBP1 branch of the UPR, which remodels secretory-pathway proteostasis and secondarily improves cytosolic protein quality control, thereby extending lifespan. XBP1-dependent remodeling of ER and secretory proteostasis is causally required. Mechanism: IRE1 splicing of XBP1 induces ER chaperones, ERAD components, and lipid/membrane programs that reduce secretory proteotoxic stress and couple to organismal stress resistance. Prediction: XBP1 or IRE1 loss abolishes mild-stress longevity and age-related proteostasis preservation under conditions where HSF-1, autophagy, and proteasome pathways remain inducible; constitutive XBP1 activity without external stress reproduces both benefits.\n\n[H5] Mild stress preserves proteostasis and extends lifespan by inhibiting TOR and activating AMPK–ULK1 signaling, which induces selective autophagy of damaged or aggregation-prone proteins. Autophagic clearance, not chaperone induction alone, is the causal effector. Mechanism: Stress-dependent TOR inhibition and AMPK activation increase autophagosome formation and lysosomal degradation of misfolded proteins, clearing proteotoxic load. Prediction: Blocking autophagy (e.g., ATG gene loss) eliminates stress-induced proteostasis benefits and longevity despite intact HSF-1/chaperone and proteasome induction; enhancing autophagy without the original stress cue phenocopies both benefits.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5022, "promptSha256": "6deee99880bbfde21fd98d08b6a405d975a13e853900d0c1eb867a49b493ae7d" } ] }, { "task": "R42669067", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence is an irreversible growth-arrest state that contributes to ageing and age-related pathology. Senescent cells undergo changes in genome organization and can activate normally repressed repetitive DNA elements. Such activation may compromise genome stability and provoke inflammatory signaling. The regulatory mechanisms that preserve repeat silencing and thereby limit senescence remained incompletely understood.\n\nRESEARCH QUESTION\nHow does SIRT1 regulate L1 retrotransposon activity, and does this regulation affect cellular senescence?\n\nHYPOTHESES\n[H1] SIRT1 maintains L1 silencing by deacetylating histone H3K9/H4K16 at L1 promoter and 5' UTR chromatin; decline of SIRT1 activity during senescence causes L1 transcriptional derepression that accelerates the senescence program. Mechanism: NAD+-dependent local chromatin deacetylation by SIRT1 preserves repressive chromatin at L1 loci; loss of this mark permits RNA polymerase II access and L1 mRNA production. Prediction: ChIP-seq will show increased H3K9ac/H4K16ac and reduced H3K9me3 specifically at L1 5' UTRs after SIRT1 knockdown or catalytic inhibition, preceding elevated L1 RNA and earlier SA-β-gal/p16 induction; a L1-promoter-targeted deacetylase tether will rescue silencing without restoring global SIRT1 activity.\n\n[H2] SIRT1 restrains L1 retrotransposition post-transcriptionally by deacetylating ORF1p (or ORF2p), reducing ribonucleoprotein assembly or reverse-transcriptase activity; senescence-associated SIRT1 decline therefore increases successful L1 insertions that trigger DNA-damage signaling and reinforce growth arrest. Mechanism: Acetylation of L1 ORF proteins enhances RNP formation or RT activity; SIRT1 reverses these acetyl marks and limits de novo insertions. Prediction: SIRT1 knockdown increases engineered L1 reporter insertion frequency more than steady-state L1 RNA; acetyl-mimic ORF1p mutants show higher transposition independent of SIRT1 status, and blocking reverse transcription (e.g., with reverse-transcriptase inhibitors) abolishes the senescence acceleration caused by SIRT1 loss.\n\n[H3] Age- or stress-driven NAD+ depletion lowers SIRT1 catalytic activity at L1 loci before SIRT1 protein levels fall, causing L1 derepression that feeds forward into senescence; restoring NAD+ or SIRT1 activity specifically at L1 chromatin is sufficient to delay senescence. Mechanism: Substrate-limited SIRT1 fails to maintain repressive chromatin or co-repressor states at L1 elements; L1 products then promote DNA damage and inflammatory signaling that establish irreversible arrest. Prediction: NAD+ boosters (e.g., NMN/NR) or SIRT1 activators reduce L1 RNA/cDNA and delay senescence in a SIRT1-dependent manner; catalytically inactive SIRT1 fails to rescue, and L1-locus-restricted SIRT1 recruitment restores silencing and extends proliferative lifespan under low-NAD+ conditions.\n\n[H4] SIRT1 suppresses cytoplasmic L1 cDNA sensing by limiting L1 reverse transcription and/or by deacetylating components of the cGAS–STING pathway; SIRT1 decline in senescence therefore amplifies interferon-stimulated gene (ISG) expression that locks in the senescence-associated secretory phenotype (SASP). Mechanism: Reduced SIRT1 permits accumulation of L1-derived cytoplasmic DNA that activates cGAS–STING–IRF3/NF-κB, producing chronic type-I interferon and SASP that maintain senescence. Prediction: SIRT1 depletion elevates cytoplasmic L1 DNA, cGAMP, and ISGs concurrent with senescence; co-depletion of cGAS or STING, or reverse-transcriptase inhibition, blocks ISG induction and partially reverses senescence phenotypes without restoring L1 RNA levels to baseline.\n\n[H5] SIRT1 deacetylates KAP1/TRIM28 (or an associated co-repressor), thereby enabling SETDB1/HP1 recruitment to L1 elements; without SIRT1, KAP1 hyperacetylation disables the repression complex and allows L1 reactivation that drives senescence-associated inflammation. Mechanism: SIRT1-dependent deacetylation of KAP1 stabilizes the KAP1–SETDB1–HP1 heterochromatin complex on L1 DNA, blocking transcription. Prediction: SIRT1 loss increases KAP1 acetylation, reduces KAP1/SETDB1 occupancy at L1 loci, and elevates L1 RNA; a non-acetylatable KAP1 mutant restores L1 silencing and delays senescence markers despite SIRT1 depletion, whereas an acetylation-mimic KAP1 does not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 4971, "promptSha256": "d38d2dd46e04432daca8f9caa00dfbb95255a218c95d646e76edeeacff971ffa" } ] }, { "task": "R42811065", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 1 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nChronic stress can disrupt bone remodeling and promote osteoporosis through sustained sympathetic nervous system activity. Cellular senescence within the bone marrow microenvironment can impair regenerative functions and contribute to reduced bone formation. Neural and endocrine signals are therefore plausible links between psychological stress and deterioration of skeletal health. However, the local mediator responsible for stress-induced senescence and the mechanism by which peripheral stimulation could restore osteogenesis were unresolved.\n\nRESEARCH QUESTION\nWhich local mechanism connects stress-induced sympathetic activity to cellular senescence and impaired osteogenesis, and can it be modulated non-invasively?\n\nHYPOTHESES\n[H1] Chronic psychological stress elevates bone-marrow norepinephrine from sympathetic terminals, which acts through β2-adrenergic receptors on mesenchymal stem/progenitor cells to drive p53/p21-dependent cellular senescence and thereby suppress osteogenic differentiation. Non-invasive peripheral neuromodulation that reduces local norepinephrine tone or blocks β2 signaling will reverse marrow senescence and restore bone formation. Mechanism: Sympathetic norepinephrine → β2-AR → cAMP/PKA → ROS/p53/p21 senescence program in osteoprogenitors Prediction: Marrow β2-AR knockout or selective β2 blockade will abolish stress-induced senescence markers (p16, SA-β-gal) and rescue osteogenesis even when circulating catecholamines remain high, whereas β1-selective blockade will not; peripheral nerve stimulation that lowers marrow NE will phenocopy β2 blockade.\n\n[H2] Stress-activated sympathetic fibers co-release neuropeptide Y into the marrow niche; NPY via Y1 receptors on stromal cells induces mitochondrial dysfunction and a senescence-associated secretory phenotype that impairs osteoblastogenesis. Non-invasive sensory or autonomic peripheral stimulation restores osteogenesis by suppressing NPY release or upregulating competing osteogenic neuropeptides such as CGRP. Mechanism: Sympathetic NPY → Y1R → mitochondrial ROS/SASP in marrow stroma → osteogenic failure Prediction: Y1 receptor antagonism or NPY deletion will prevent stress-induced senescence without normalizing norepinephrine levels, and peripheral stimulation efficacy will correlate with reduced marrow NPY and elevated CGRP rather than with β-adrenergic tone alone.\n\n[H3] Sustained sympathetic activity locally amplifies glucocorticoid receptor signaling in bone-marrow mesenchymal cells, synergizing with catecholamines to accelerate telomere attrition and irreversible senescence that blocks osteogenesis. Non-invasive peripheral stimulation restores bone formation by dampening sympathetic drive and thereby reducing local glucocorticoid potency in the niche. Mechanism: SNS-facilitated local glucocorticoid/GR signaling → DNA damage/telomere stress → senescence of osteoprogenitors Prediction: Marrow-restricted GR knockdown will protect against stress-induced senescence despite intact SNS catecholamine signaling, and the osteogenic benefit of peripheral stimulation will be lost if exogenous glucocorticoids are clamped high in marrow.\n\n[H4] Sympathetic hyperactivity polarizes marrow myeloid cells to release IL-6 and TNF-α, which act in a paracrine loop to induce senescence of osteoprogenitors and lock the niche into a SASP-dominated, low-formation state. Non-invasive peripheral neuromodulation restores osteogenesis by interrupting this myeloid–stromal inflammatory circuit. Mechanism: SNS → myeloid IL-6/TNF → paracrine SASP induction in osteoprogenitors Prediction: Marrow myeloid-specific β-adrenergic or IL-6 deletion will prevent stromal senescence under stress while leaving direct adrenergic effects on osteoprogenitors intact; peripheral stimulation will fail to rescue bone if recombinant IL-6 is continuously infused into marrow.\n\n[H5] Chronic sympathetic tone depletes NAD+ and SIRT1 activity in marrow osteoprogenitors, causing mitochondrial failure and senescence that impairs osteogenesis; non-invasive peripheral electrical or mechanical nerve stimulation restores osteogenesis by reactivating sensory afferent–autonomic reflexes that replenish NAD+/SIRT1 and clear senescent cells. Mechanism: SNS-driven NAD+/SIRT1 depletion → mitochondrial dysfunction → osteoprogenitor senescence; peripheral afferent stimulation reverses the metabolic deficit Prediction: Stress will lower marrow NAD+ and SIRT1 preceding senescence; NAD+ repletion or SIRT1 activation will rescue osteogenesis without requiring β-blockade, and peripheral stimulation will lose efficacy when NAD+ synthesis is pharmacologically blocked.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5279, "promptSha256": "b4705eaae3c0c51ac77769f01833c544d9e53287703b10f41efc856e3bf20c80" } ] }, { "task": "R42841610", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 3 }, { "id": "H2", "hypothesisIndex": 2 }, { "id": "H3", "hypothesisIndex": 0 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing commonly causes a progressive loss of skeletal muscle mass, strength and regenerative capacity known as sarcopenia. Mitochondrial respiratory dysfunction is a prominent feature of ageing muscle and is associated with cellular senescence. Senescent cells undergo extensive metabolic changes that may compromise tissue function. However, the causal metabolic processes connecting senescence to mitochondrial impairment and functional muscle decline remained incompletely understood.\n\nRESEARCH QUESTION\nWhat causal metabolic mechanism links cellular senescence to mitochondrial dysfunction and functional decline in ageing skeletal muscle, and can this mechanism be therapeutically reversed?\n\nHYPOTHESES\n[H1] Senescent muscle stem and stromal cells adopt a hyperglycolytic, OXPHOS-suppressed metabolic state that exports excess lactate and alters the extracellular NAD+/NADH redox couple, forcing neighboring myofibers into reductive stress that impairs TCA-cycle flux and ATP generation; correcting lactate export or senescent glycolysis reverses decline. Mechanism: Senescent Warburg-like metabolism floods the niche with lactate, shifting myofiber cytosolic redox toward NADH, inhibiting NAD+-dependent dehydrogenases and mitochondrial substrate oxidation needed for force and repair. Prediction: MCT1/MCT4 blockade or LDHA inhibition confined to senescent cells will normalize myofiber NADH/NAD+, raise oxygen consumption, and improve regeneration more than systemic lactate scavenging, and isotopic tracing will show senescent-derived lactate carbons entering myofiber TCA pools.\n\n[H2] Cellular senescence in muscle rewires sphingolipid metabolism toward ceramide and sphingosine-1-phosphate accumulation that permeabilizes mitochondrial membranes and inhibits complexes I–IV; inhibiting ceramide synthesis or senolytic removal of ceramide-rich senescent cells therapeutically reverses mitochondrial and functional decline. Mechanism: Senescent-cell serine palmitoyltransferase and acid sphingomyelinase elevate ceramides that insert into mitochondrial membranes, increase permeability transition, and suppress OXPHOS, with spillover to neighboring fibers via extracellular vesicles. Prediction: Pharmacologic SPT inhibition will lower muscle ceramides, restore state-3 respiration and fatigue resistance in aged muscle, and these benefits will be occluded in mice already cleared of senescent cells, indicating ceramides act downstream of senescence.\n\n[H3] In ageing skeletal muscle, senescent cells upregulate the NAD+-consuming ectoenzyme CD38, depleting local NAD+ and thereby impairing SIRT3/SIRT1-dependent mitochondrial quality control in neighboring myofibers; restoring NAD+ or inhibiting CD38 reverses mitochondrial respiratory failure and strength loss. Mechanism: Senescent-cell CD38-driven NAD+ drain lowers nuclear and mitochondrial NAD+, reducing deacetylation of OXPHOS and mitophagy regulators, which collapses respiratory capacity and regenerative competence. Prediction: Muscle-restricted CD38 deletion or senolytic clearance will raise intramuscular NAD+, restore complex I/III activity and force production, whereas equal NAD+ precursor dosing without lowering CD38 will be less effective in senescent-rich aged muscle than in young muscle.\n\n[H4] Senescent myogenic and fibroadipogenic cells secrete a SASP enriched in IL-6 and TNF-α that activates NF-κB/JNK in adjacent myofibers, inducing mitochondrial ROS and mtDNA damage that causally drive contractile and regenerative decline; blocking this cytokine axis or clearing senescent cells restores mitochondrial function. Mechanism: Paracrine SASP cytokines rewire myofiber signaling toward chronic inflammatory stress, elevating mitochondrial superoxide, damaging electron-transport chain complexes, and suppressing PGC-1α-driven biogenesis. Prediction: Neutralizing IL-6/TNF or deleting their receptors specifically on myofibers will improve mitochondrial respiration and grip strength in aged mice even when senescent-cell burden remains high, whereas antioxidant treatment alone will not fully rescue regeneration.\n\n[H5] Senescence disables PINK1/Parkin- and ULK1-dependent mitophagy in muscle-resident cells, causing accumulation of ROS-generating mitochondria that amplify SASP and damage satellite-cell niches; reactivating mitophagy or removing senescent cells breaks this loop and restores mitochondrial and contractile function. Mechanism: Persistent DNA-damage signaling and p16/p21 programs transcriptionally and post-translationally suppress mitophagy adaptors, allowing dysfunctional mitochondria to accumulate, leak ROS, and propagate metabolic failure across the tissue. Prediction: Inducible Parkin overexpression or a mitophagy-activating compound will clear damaged mitochondria, lower SASP transcripts, and improve specific force in aged muscle, with greater effect in senescence-high than senescence-low animals, and senolytics will phenocopy mitophagy restoration on mitochondrial proteome composition.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5640, "promptSha256": "cf6ecfadd5afe5618a6a7fe953df9bced7e3dfafd066d8de06001c8e1499136f" } ] }, { "task": "R42806003", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 2 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 4 }, { "id": "H4", "hypothesisIndex": 1 }, { "id": "H5", "hypothesisIndex": 3 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAdvanced maternal age is associated with placental dysfunction, impaired fetal growth, and increased risks to offspring health. Ageing tissues commonly exhibit metabolic disruption, chronic inflammation, and accumulation of senescent cells with a senescence-associated secretory phenotype. The placenta contains interacting maternal and fetal compartments whose metabolic state and inflammatory environment influence pregnancy outcomes. However, the causal processes through which maternal ageing induces placental senescence and developmental complications remained unclear.\n\nRESEARCH QUESTION\nWhat intercellular mechanism causes placental senescence during maternal ageing, and can disrupting this mechanism restore placental and offspring health?\n\nHYPOTHESES\n[H1] Maternal ageing elevates CD38 on decidual and circulating immune cells, depleting NAD+ in the shared placental microenvironment and thereby suppressing SIRT1/PARP activity in trophoblasts, which accelerates placental cellular senescence and metabolic failure. Restoring NAD+ or inhibiting maternal CD38 should reverse placental senescence and improve fetal growth. Mechanism: Maternal CD38-driven NAD+ depletion creates a metabolic niche that forces trophoblast senescence. Prediction: Placental NAD+ and SIRT1 activity fall with maternal age in parallel with CD38+ immune infiltration; CD38 inhibition or NAD+ precursors restore trophoblast NAD+/SIRT1, reduce senescence markers, and improve fetal outcomes even when maternal chronological age is unchanged.\n\n[H2] Advanced maternal age causes accumulation of senescent decidual stromal cells whose senescence-associated secretory phenotype (SASP) factors, especially IL-6, IL-8 and TGF-β, act in a paracrine manner on adjacent trophoblasts to trigger p16/p21-dependent placental senescence, impairing nutrient transport and fetal growth. Neutralizing key SASP cytokines or clearing decidual senescent cells should restore placental function and offspring outcomes. Mechanism: Paracrine SASP signaling from aged maternal decidual cells induces secondary senescence in fetal trophoblasts. Prediction: In aged pregnancies, decidual SASP factor levels and trophoblast senescence markers rise together; SASP neutralization or senolytic clearance of decidual cells reduces trophoblast senescence and improves fetal growth more than interventions targeting trophoblasts alone.\n\n[H3] Maternal vascular ageing increases oxidative ROS release at the maternal–fetal interface, oxidizing trophoblast membranes and DNA and activating ATM/ATR–p53 senescence programs that impair placental angiogenesis and nutrient exchange. Antioxidant interception of maternal ROS or strengthening trophoblast antioxidant defenses should break this intercellular oxidative relay and rescue placental and offspring health. Mechanism: Maternal vascular ROS act as an intercellular oxidative signal that triggers DNA-damage-driven trophoblast senescence. Prediction: Maternal uteroplacental vessels from aged dams show elevated ROS coincident with trophoblast 8-oxo-dG and senescence; scavenging maternal ROS (or endothelium-targeted antioxidants) lowers trophoblast senescence without requiring direct treatment of fetal cells, whereas trophoblast-only antioxidant overexpression is less effective if maternal ROS production remains high.\n\n[H4] Aged maternal cells release extracellular vesicles enriched for pro-senescence microRNAs and damaged mitochondrial DNA that are taken up by trophoblasts, activating DNA-damage and inflammatory sensors (cGAS–STING, p53) and locking the placenta into a senescent state. Blocking EV release or uptake should interrupt maternal-age-driven placental senescence and rescue offspring health. Mechanism: Maternal extracellular vesicles deliver pro-senescence nucleic-acid cargo that reprograms trophoblast fate toward senescence. Prediction: EVs from aged maternal serum or decidua induce trophoblast senescence in vitro and in young recipients in vivo; depleting EV biogenesis (e.g., Rab27a/nSMase2 inhibition) or blocking EV uptake specifically prevents placental senescence despite persistent maternal ageing.\n\n[H5] Advanced maternal age skews decidual macrophages toward a chronically activated, inflammasome-competent phenotype that secretes IL-1β and TNF-α, which engage trophoblast receptors to drive NF-κB–dependent senescence and barrier dysfunction. Depleting or reprogramming these maternal macrophages should prevent placental senescence and restore offspring health. Mechanism: Aged maternal macrophage–derived inflammasome cytokines induce trophoblast senescence via NF-κB. Prediction: Aged decidua shows increased NLRP3+ macrophages and IL-1β/TNF-α adjacent to senescent trophoblasts; macrophage depletion, NLRP3 inhibition, or IL-1 blockade reduces placental senescence and fetal growth restriction more effectively than systemic anti-inflammatory treatment that spares decidual macrophages.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5566, "promptSha256": "75bb247d498cb4c3be4f456482d402bf44505ebd1ecfee55160d232e901f4f13" } ] }, { "task": "R42806572", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 4 }, { "id": "H2", "hypothesisIndex": 0 }, { "id": "H3", "hypothesisIndex": 2 }, { "id": "H4", "hypothesisIndex": 3 }, { "id": "H5", "hypothesisIndex": 1 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSenescent cells accumulate with age and can promote tissue dysfunction through persistent inflammatory and remodeling signals. Experimental removal of these cells can improve several age-related phenotypes, supporting cellular senescence as a causal contributor to declining health. Immune-mediated senolysis offers a way to eliminate selected senescent cells, but differences between therapeutic and toxic exposure can complicate translation. A major open problem is whether an externally controllable treatment can achieve effective senolysis in both rodents and primates while providing a practical marker of emerging toxicity.\n\nRESEARCH QUESTION\nCan a dose-titratable immune engager safely eliminate senescent cells and alleviate age-related pathology across mice and non-human primates, and what measurement can guide its safe dosing?\n\nHYPOTHESES\n[H1] Age-related pathology will improve only when engager-mediated senolysis depletes senescent immune and stromal cells in key organs sufficiently to break a self-reinforcing SASP–inflammation loop; subtherapeutic clearance will leave the loop intact and produce little functional benefit despite measurable target engagement. Mechanism: Residual senescent niches continue to secrete inflammatory and remodeling factors that recruit and maintain dysfunction; crossing a clearance threshold collapses the loop and allows tissue repair. Prediction: Across mice and NHPs, functional gains (tissue histology, inflammatory panels, physical performance) will appear as a step function once senescent-cell burden falls below a quantified threshold, and that threshold dose will remain below the cytokine-defined toxicity ceiling when guided by the chosen safety marker.\n\n[H2] A dose-titratable bispecific immune engager that redirects T cells to a senescence-associated surface antigen will clear a therapeutically relevant fraction of senescent cells in aged mice and non-human primates at exposures below those that trigger systemic cytokine release. Circulating IL-6 and IFN-γ rise steeply only after the efficacious dose window, so their early kinetics can guide safe titration. Mechanism: Target engagement on senescent cells forms an immunological synapse that drives selective cytotoxicity; off-target or excess engagement expands systemic cytokine production once a threshold of T-cell activation is crossed. Prediction: In both species, intermediate engager doses will reduce senescence markers (p16INK4a, SA-β-gal, SASP factors) and improve tissue function without grade ≥2 cytokine release, while cytokine AUC will increase nonlinearly only at higher doses that do not further improve efficacy.\n\n[H3] Safe cross-species senolysis requires intermittent rather than continuous engager exposure so that waves of senescent-cell clearance reduce SASP-driven pathology without sustained effector activation that drives chronic inflammation and tissue injury. Mechanism: Pulsed engagement eliminates senescent reservoirs and allows immune resolution between doses; continuous engagement maintains cytokine and cytotoxic pressure that damages parenchyma. Prediction: Intermittent dosing schedules matched for cumulative exposure will outperform continuous infusion on pathology endpoints (fibrosis, grip strength, metabolic markers) while producing lower trough cytokines and less organ injury in both mice and primates.\n\n[H4] Circulating levels of a senescence-linked soluble factor released during cell death (for example cleaved GDF15 or a defined SASP peptide) will rise in proportion to on-target senolysis and plateau before toxic cytokine storm, providing a practical real-time marker to stop or hold dose escalation. Mechanism: On-target lysis liberates intracellular or membrane-proximal senescence cargo into blood earlier and more selectively than bystander cytokine amplification from over-activated T cells. Prediction: In dose-escalation studies, the soluble senolysis marker will increase with efficacious doses that improve age-related phenotypes, whereas IL-6/IFN-γ and clinical toxicity scores will diverge upward only after the marker has already plateaued.\n\n[H5] Therapeutic senolysis by a titratable immune engager depends on antigen density on senescent cells being higher than on essential non-senescent tissues; dosing that saturates high-density targets first will clear senescent cells and reverse age-related pathology before toxicity from low-density off-target killing emerges. Mechanism: Affinity- and avidity-dependent T-cell activation preferentially lyses high-antigen-density senescent cells; as free engager rises, low-density healthy cells become engaged and cause organ toxicity. Prediction: Pharmacodynamic models fitting antigen density will show a separable efficacy–toxicity window in mice and NHPs, and tissue histology will show senescent-cell clearance at doses where non-senescent target-expressing cells remain intact.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5548, "promptSha256": "b39bcf7844246d1d0ef52ae9052acd189aef67648786261c5e64f764261e3bcd" } ] }, { "task": "R42748238", "generator": "grok-4.5", "arm": "N", "mapping": [ { "id": "H1", "hypothesisIndex": 0 }, { "id": "H2", "hypothesisIndex": 1 }, { "id": "H3", "hypothesisIndex": 3 }, { "id": "H4", "hypothesisIndex": 2 }, { "id": "H5", "hypothesisIndex": 4 } ], "requests": [ { "protocol": "direct-confirmation-grok-v2", "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.", "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nMicrovascular function declines with age, impairing tissue perfusion, nutrient delivery, and waste clearance. Vascular deterioration is associated with dysfunction across multiple organs and with increased frailty and mortality. Cellular senescence and altered metabolic homeostasis are recognized contributors to age-related tissue decline. However, the molecular mechanism by which vascular aging can drive organism-wide aging and shorten lifespan remained unclear.\n\nRESEARCH QUESTION\nWhat molecular mechanism causes age-related vascular deterioration to promote systemic senescence and shorten lifespan?\n\nHYPOTHESES\n[H1] Age-related endothelial senescence causes systemic aging because senescent microvascular endothelial cells chronically secrete SASP cytokines (notably IL-1α, IL-6, and TNF) that circulate and induce secondary senescence in distant parenchymal cells. Blocking endothelial SASP production or neutralizing these circulating cytokines should therefore delay multi-organ senescence and extend lifespan even when local vascular structural damage remains. Mechanism: Endothelial SASP → circulating inflammatory cytokines → NF-κB/p38 activation and p16INK4a/p21 induction in remote tissues Prediction: Endothelium-restricted knockout of IL-1α or IL-6 (or neutralizing antibodies) reduces senescence markers in non-vascular tissues and extends lifespan more than equivalent macrophage-restricted cytokine knockout, without restoring microvascular density.\n\n[H2] Vascular aging shortens lifespan by upregulating endothelial CD38, which depletes circulating NAD+ and NAD precursors and thereby impairs SIRT1/SIRT3 activity across organs. Restoring systemic NAD+ or endothelium-specific CD38 inhibition should reverse organism-wide senescence downstream of vascular decline. Mechanism: Aged endothelium ↑CD38 → systemic NAD+ exhaustion → loss of sirtuin-dependent proteostasis and mitochondrial quality control Prediction: Plasma NAD+/NMN falls with endothelial CD38 induction; endothelium-specific Cd38 deletion raises NAD+ in muscle, liver, and brain and extends lifespan more than tissue-specific Cd38 deletion outside endothelium, with little change in circulating IL-6.\n\n[H3] Aged microvasculature actively secretes TGF-β1 (and related ligands) that circulate and drive SMAD2/3-dependent senescence and fibrotic remodeling in multiple organs, converting local vascular deterioration into organism-wide aging. Endothelium-specific TGF-β1 deletion or systemic TGF-β receptor blockade should therefore uncouple vascular aging from shortened lifespan. Mechanism: Endothelial TGF-β1 release → circulating ligand → SMAD2/3 transcriptional senescence and ECM programs in remote tissues Prediction: Plasma TGF-β1 rises with endothelial senescence; endothelium-specific Tgfb1 knockout lowers SMAD phosphorylation and senescence in non-vascular organs and extends lifespan, whereas neutralizing IL-6 alone does not.\n\n[H4] Loss of endothelial nitric oxide bioavailability is the causal bridge from microvascular aging to systemic senescence: eNOS uncoupling and reduced NO/cGMP signaling fail to restrain mitochondrial ROS and DNA-damage responses in perfused tissues. Pharmacologic or genetic restoration of endothelial NO should therefore suppress organism-wide senescence independently of cytokine levels. Mechanism: Endothelial eNOS uncoupling → ↓NO/cGMP → ↑mitochondrial ROS and ATM/p53 activation in downstream organs Prediction: Endothelium-targeted eNOS rescue or soluble guanylate cyclase agonists reduce p16+ cells in kidney, fat, and muscle and extend lifespan without lowering plasma SASP cytokines or raising NAD+.\n\n[H5] Senescent endothelial cells shed extracellular vesicles enriched in pro-senescence microRNAs (e.g., miR-34a, miR-217) that are taken up by distant cells, silence SIRT1 and related longevity pathways, and propagate systemic senescence. Blocking endothelial EV release or depleting these miRNAs in endothelium should prevent systemic aging despite persistent microvascular rarefaction. Mechanism: Endothelial EVs carrying miR-34a/miR-217 → remote SIRT1 repression → secondary cellular senescence Prediction: Circulating EVs from aged endothelium transfer senescence to young cells in vitro; endothelium-specific Drosha or Rab27a deletion (or antagomirs to EV miRNAs) reduces distant-tissue senescence and extends lifespan without restoring NAD+ or NO levels.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.", "candidateIds": [ "H1", "H2", "H3", "H4", "H5" ], "promptChars": 5031, "promptSha256": "8e311059ed866358b8da2c3ee7cfbffacd0a11e52cc2489cc458d86c9f0b1340" } ] } ] }